Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-03-25 16:55 Tx date 2024-03-25 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,842,750
+351,000 vol $5.25 each |
12,750,500 | |
Filed 2024-03-25 16:51 Tx date 2024-03-21 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,257
+7,300 vol $5.24 each |
12,399,500 | |
Filed 2024-03-19 20:26 Tx date 2024-03-15 |
$GUD
Knight Therapeutics Inc. |
Dos Santos Dias, Henrique José
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,782
+525 vol $5.30 each |
1,603 | |
Filed 2024-03-19 20:22 Tx date 2024-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$14,341
+2,706 vol $5.30 each |
199,189 | |
Filed 2024-03-19 20:20 Tx date 2024-03-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,667
+1,258 vol $5.30 each |
12,080 | |
Filed 2024-03-19 20:18 Tx date 2024-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,506
+1,039 vol $5.30 each |
821,766 | |
Filed 2024-03-19 20:12 Tx date 2024-03-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,017
+1,324 vol $5.30 each |
22,475 | |
Filed 2024-03-19 20:09 Tx date 2024-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,426
+2,156 vol $5.30 each |
142,139 | |
Filed 2024-03-13 15:27 Tx date 2024-03-12 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$402,150
+76,600 vol $5.25 each |
12,392,200 | |
Filed 2024-03-13 15:26 Tx date 2024-03-12 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$262,500
+50,000 vol $5.25 each |
12,315,600 | |
Filed 2024-02-01 08:51 Tx date 2024-01-31 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$786,391
+147,000 vol $5.35 each |
12,265,600 | |
Filed 2024-01-23 12:51 Tx date 2024-01-22 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-162,150
-28,200 vol $5.75 each |
12,118,600 | |
Filed 2024-01-04 20:05 Tx date 2023-12-31 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$17,495
+3,371 vol $5.19 each |
44,438 | |
Filed 2024-01-03 11:44 Tx date 2023-12-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,036,997 vol |
0 | |
Filed 2024-01-03 11:42 Tx date 2023-12-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,297,434
+2,999,497 vol $5.10 each |
3,036,997 | |
Filed 2024-01-03 11:41 Tx date 2023-12-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,605
+700 vol $5.15 each |
37,500 | |
Filed 2024-01-03 11:39 Tx date 2023-12-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$120,940
+23,500 vol $5.15 each |
36,800 | |
Filed 2024-01-03 11:37 Tx date 2023-12-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$28,219
+5,500 vol $5.13 each |
13,300 | |
Filed 2024-01-03 11:36 Tx date 2023-12-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,085
+600 vol $5.14 each |
7,800 | |
Filed 2024-01-03 11:34 Tx date 2023-12-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,541
+300 vol $5.14 each |
7,200 | |
Filed 2024-01-03 11:33 Tx date 2023-12-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$35,374
+6,900 vol $5.13 each |
6,900 | |
Filed 2023-12-19 10:41 Tx date 2023-12-15 |
$GUD
Knight Therapeutics Inc. |
Dos Santos Dias, Henrique José
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,610
+502 vol $5.20 each |
1,078 | |
Filed 2023-12-19 10:39 Tx date 2023-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$16,728
+3,217 vol $5.20 each |
196,483 | |
Filed 2023-12-19 10:37 Tx date 2023-12-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,347
+1,413 vol $5.20 each |
10,822 | |
Filed 2023-12-19 10:35 Tx date 2023-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,682
+1,285 vol $5.20 each |
820,727 | |
Filed 2023-12-19 10:32 Tx date 2023-12-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,047
+1,163 vol $5.20 each |
21,151 | |
Filed 2023-12-19 10:00 Tx date 2023-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,332
+2,564 vol $5.20 each |
139,983 | |
Filed 2023-12-05 11:56 Tx date 2023-11-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-174,200 vol |
0 | |
Filed 2023-12-05 11:55 Tx date 2023-11-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,607
+4,800 vol $5.13 each |
174,200 | |
Filed 2023-12-05 11:54 Tx date 2023-11-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$85,760
+16,800 vol $5.10 each |
169,400 | |
Filed 2023-12-05 11:53 Tx date 2023-11-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,000
+1,200 vol $5.00 each |
152,600 | |
Filed 2023-12-05 11:52 Tx date 2023-11-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$113,226
+22,900 vol $4.94 each |
151,400 | |
Filed 2023-12-05 11:50 Tx date 2023-11-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,769
+2,700 vol $4.73 each |
128,500 | |
Filed 2023-12-05 11:48 Tx date 2023-11-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,028
+4,800 vol $4.80 each |
125,800 | |
Filed 2023-12-05 11:47 Tx date 2023-11-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$89,404
+18,600 vol $4.81 each |
121,000 | |
Filed 2023-12-05 11:45 Tx date 2023-11-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$109,260
+23,500 vol $4.65 each |
102,400 | |
Filed 2023-12-05 11:07 Tx date 2023-11-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$108,168
+23,500 vol $4.60 each |
78,900 | |
Filed 2023-12-05 11:06 Tx date 2023-11-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$72,125
+15,700 vol $4.59 each |
55,400 | |
Filed 2023-11-13 14:39 Tx date 2023-11-10 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$24,871
+4,925 vol $5.05 each |
4,925 | |
Filed 2023-11-13 14:38 Tx date 2023-09-18 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-11-13 14:36 Tx date 2023-11-10 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$24,871
+4,925 vol $5.05 each |
4,925 | |
Filed 2023-11-13 14:32 Tx date 2023-09-18 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-11-07 10:28 Tx date 2023-10-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-684,075 vol |
39,700 | |
Filed 2023-11-07 10:26 Tx date 2023-10-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$87,589
+19,300 vol $4.54 each |
723,775 | |
Filed 2023-11-07 10:25 Tx date 2023-10-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$92,167
+20,400 vol $4.52 each |
704,475 | |
Filed 2023-11-07 10:23 Tx date 2023-10-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$105,077
+23,500 vol $4.47 each |
684,075 | |
Filed 2023-11-07 10:22 Tx date 2023-10-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$676,350
+150,300 vol $4.50 each |
660,575 | |
Filed 2023-11-07 10:20 Tx date 2023-10-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$106,224
+23,500 vol $4.52 each |
510,275 | |
Filed 2023-11-07 10:18 Tx date 2023-10-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$106,713
+23,500 vol $4.54 each |
486,775 | |
Filed 2023-11-07 10:16 Tx date 2023-10-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$95,348
+21,600 vol $4.41 each |
463,275 | |
Filed 2023-11-07 10:13 Tx date 2023-10-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$103,259
+23,500 vol $4.39 each |
441,675 | |
Filed 2023-11-07 10:11 Tx date 2023-10-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$85,155
+19,300 vol $4.41 each |
418,175 | |
Filed 2023-11-07 10:09 Tx date 2023-10-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$561,405
+123,375 vol $4.55 each |
398,875 | |
Filed 2023-11-07 10:07 Tx date 2023-10-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$108,060
+23,500 vol $4.60 each |
275,500 | |
Filed 2023-11-07 10:04 Tx date 2023-10-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$93,336
+20,200 vol $4.62 each |
252,000 | |
Filed 2023-11-07 10:02 Tx date 2023-10-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$69,977
+15,300 vol $4.57 each |
231,800 | |
Filed 2023-11-07 09:58 Tx date 2023-10-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$107,420
+23,500 vol $4.57 each |
216,500 | |
Filed 2023-11-07 09:55 Tx date 2023-10-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$82,141
+17,900 vol $4.59 each |
193,000 | |
Filed 2023-11-07 09:53 Tx date 2023-10-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$49,036
+10,600 vol $4.63 each |
175,100 | |
Filed 2023-11-07 09:49 Tx date 2023-10-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$109,195
+23,500 vol $4.65 each |
164,500 | |
Filed 2023-11-07 09:47 Tx date 2023-10-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$110,236
+23,500 vol $4.69 each |
141,000 | |
Filed 2023-11-07 09:45 Tx date 2023-10-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$108,010
+23,500 vol $4.60 each |
117,500 | |
Filed 2023-11-07 09:43 Tx date 2023-10-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$106,212
+23,500 vol $4.52 each |
94,000 | |
Filed 2023-11-07 09:40 Tx date 2023-10-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$106,100
+23,500 vol $4.51 each |
70,500 | |
Filed 2023-10-30 14:15 Tx date 2023-10-23 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,785
+1,100 vol $4.35 each |
12,237,800 | |
Filed 2023-10-05 15:35 Tx date 2023-09-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,372,857 vol |
47,000 | |
Filed 2023-10-05 15:34 Tx date 2023-09-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$105,590
+23,500 vol $4.49 each |
1,419,857 | |
Filed 2023-10-05 15:32 Tx date 2023-09-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$105,216
+23,500 vol $4.48 each |
1,396,357 | |
Filed 2023-10-05 15:31 Tx date 2023-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$871,232
+199,157 vol $4.37 each |
1,372,857 | |
Filed 2023-10-05 15:28 Tx date 2023-09-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$103,164
+23,500 vol $4.39 each |
1,173,700 | |
Filed 2023-10-05 15:26 Tx date 2023-09-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$49,957
+11,300 vol $4.42 each |
1,150,200 | |
Filed 2023-10-05 15:21 Tx date 2023-09-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$103,773
+23,500 vol $4.42 each |
1,138,900 | |
Filed 2023-10-05 15:20 Tx date 2023-09-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$81,840
+18,600 vol $4.40 each |
1,115,400 | |
Filed 2023-10-05 15:18 Tx date 2023-09-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$103,729
+23,500 vol $4.41 each |
1,096,800 | |
Filed 2023-10-05 15:17 Tx date 2023-09-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,331,429
+753,700 vol $4.42 each |
1,073,300 | |
Filed 2023-10-05 15:15 Tx date 2023-09-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$103,599
+23,500 vol $4.41 each |
319,600 | |
Filed 2023-10-05 15:14 Tx date 2023-09-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$102,883
+23,500 vol $4.38 each |
296,100 | |
Filed 2023-10-05 15:12 Tx date 2023-09-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$498,148
+111,700 vol $4.46 each |
272,600 | |
Filed 2023-10-05 15:11 Tx date 2023-09-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$58,379
+13,200 vol $4.42 each |
160,900 | |
Filed 2023-10-05 15:09 Tx date 2023-09-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$103,667
+23,500 vol $4.41 each |
147,700 | |
Filed 2023-10-05 15:08 Tx date 2023-09-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$105,601
+23,500 vol $4.49 each |
124,200 | |
Filed 2023-10-05 15:07 Tx date 2023-09-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$87,323
+19,800 vol $4.41 each |
100,700 | |
Filed 2023-10-05 15:06 Tx date 2023-09-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$103,524
+23,500 vol $4.41 each |
80,900 | |
Filed 2023-10-05 15:04 Tx date 2023-09-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$104,126
+23,500 vol $4.43 each |
57,400 | |
Filed 2023-10-05 15:03 Tx date 2023-09-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$35,742
+7,900 vol $4.52 each |
33,900 | |
Filed 2023-10-05 15:01 Tx date 2023-09-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$49,963
+10,900 vol $4.58 each |
26,000 | |
Filed 2023-10-02 17:06 Tx date 2023-09-27 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,049
+3,000 vol $4.35 each |
12,236,700 | |
Filed 2023-10-02 17:05 Tx date 2023-09-26 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$217,499
+50,000 vol $4.35 each |
12,233,700 | |
Filed 2023-10-02 17:05 Tx date 2023-09-26 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$130,716
+29,900 vol $4.37 each |
12,183,700 | |
Filed 2023-09-26 12:54 Tx date 2023-09-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$110,500
+25,000 vol $4.42 each |
819,442 | |
Filed 2023-09-25 21:12 Tx date 2023-09-25 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,519
+5,800 vol $4.40 each |
12,153,800 | |
Filed 2023-09-25 21:11 Tx date 2023-09-22 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,305
+2,800 vol $4.39 each |
12,148,000 | |
Filed 2023-09-25 21:11 Tx date 2023-09-21 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$94,496
+21,500 vol $4.40 each |
12,145,200 | |
Filed 2023-09-25 21:10 Tx date 2023-09-20 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$57,519
+13,200 vol $4.36 each |
12,123,700 | |
Filed 2023-09-21 14:07 Tx date 2023-09-18 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$17,498
+3,950 vol $4.43 each |
41,067 | |
Filed 2023-09-20 09:33 Tx date 2023-09-19 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$78,717
+18,000 vol $4.37 each |
12,110,500 | |
Filed 2023-09-19 11:30 Tx date 2023-09-15 |
$GUD
Knight Therapeutics Inc. |
Dos Santos Dias, Henrique José
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,545
+576 vol $4.42 each |
576 | |
Filed 2023-09-19 11:29 Tx date 2023-06-30 |
$GUD
Knight Therapeutics Inc. |
Dos Santos Dias, Henrique José
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-09-19 11:27 Tx date 2023-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$14,723
+3,331 vol $4.42 each |
193,266 | |
Filed 2023-09-19 11:26 Tx date 2023-09-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,302
+1,426 vol $4.42 each |
9,409 | |
Filed 2023-09-19 11:24 Tx date 2023-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,581
+1,489 vol $4.42 each |
794,442 | |
Filed 2023-09-19 11:22 Tx date 2023-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,046
+1,368 vol $4.42 each |
19,988 | |
Filed 2023-09-19 11:19 Tx date 2023-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,739
+2,656 vol $4.42 each |
137,419 | |
Filed 2023-09-18 10:02 Tx date 2023-09-15 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$115,737
+26,400 vol $4.38 each |
12,092,500 | |
Filed 2023-09-18 10:02 Tx date 2023-09-14 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$440.00
+100 vol $4.40 each |
12,066,100 | |
Filed 2023-09-18 10:01 Tx date 2023-09-13 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,068
+8,200 vol $4.40 each |
12,066,000 | |
Filed 2023-09-11 21:50 Tx date 2023-09-07 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$108,383
+24,700 vol $4.39 each |
12,031,100 | |
Filed 2023-09-11 21:45 Tx date 2023-09-08 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$116,751
+26,700 vol $4.37 each |
12,057,800 | |
Filed 2023-09-11 21:44 Tx date 2023-09-07 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$116,751
+26,700 vol $4.37 each |
||
Filed 2023-09-05 10:31 Tx date 2023-08-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-370,200 vol |
15,100 | |
Filed 2023-09-05 10:30 Tx date 2023-08-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$42,514
+9,200 vol $4.62 each |
385,300 | |
Filed 2023-09-05 10:29 Tx date 2023-08-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,295
+5,900 vol $4.63 each |
376,100 | |
Filed 2023-09-05 10:28 Tx date 2023-08-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,246
+5,300 vol $4.57 each |
370,200 | |
Filed 2023-09-05 10:26 Tx date 2023-08-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,123
+5,500 vol $4.57 each |
364,900 | |
Filed 2023-09-05 10:21 Tx date 2023-08-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,402
+5,300 vol $4.60 each |
359,400 | |
Filed 2023-09-05 10:20 Tx date 2023-08-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$37,183
+8,100 vol $4.59 each |
354,100 | |
Filed 2023-09-05 10:18 Tx date 2023-08-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$28,119
+6,100 vol $4.61 each |
346,000 | |
Filed 2023-09-05 10:17 Tx date 2023-08-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$42,525
+9,300 vol $4.57 each |
339,900 | |
Filed 2023-09-05 10:16 Tx date 2023-08-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$48,708
+10,600 vol $4.60 each |
330,600 | |
Filed 2023-09-05 10:15 Tx date 2023-08-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$64,647
+14,000 vol $4.62 each |
320,000 | |
Filed 2023-09-05 10:14 Tx date 2023-08-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$55,002
+11,900 vol $4.62 each |
306,000 | |
Filed 2023-09-05 10:12 Tx date 2023-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$108,386
+23,500 vol $4.61 each |
294,100 | |
Filed 2023-09-05 10:11 Tx date 2023-08-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$108,882
+23,500 vol $4.63 each |
270,600 | |
Filed 2023-09-05 10:10 Tx date 2023-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$109,987
+23,500 vol $4.68 each |
247,100 | |
Filed 2023-09-05 10:08 Tx date 2023-08-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$111,507
+23,500 vol $4.75 each |
223,600 | |
Filed 2023-09-05 10:07 Tx date 2023-08-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$113,610
+23,500 vol $4.83 each |
200,100 | |
Filed 2023-09-05 10:06 Tx date 2023-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$113,364
+23,500 vol $4.82 each |
176,600 | |
Filed 2023-09-05 09:59 Tx date 2023-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$82,675
+17,200 vol $4.81 each |
153,100 | |
Filed 2023-09-05 09:58 Tx date 2023-08-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$112,327
+23,500 vol $4.78 each |
135,900 | |
Filed 2023-09-05 09:57 Tx date 2023-08-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$111,803
+23,500 vol $4.76 each |
112,400 | |
Filed 2023-09-05 09:55 Tx date 2023-08-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$113,009
+23,500 vol $4.81 each |
88,900 | |
Filed 2023-09-05 09:54 Tx date 2023-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$113,293
+23,500 vol $4.82 each |
65,400 | |
Filed 2023-08-21 10:20 Tx date 2023-08-14 |
$GUD
Knight Therapeutics Inc. |
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$27,154
+5,741 vol $4.73 each |
5,741 | |
Filed 2023-08-21 10:18 Tx date 2023-08-01 |
$GUD
Knight Therapeutics Inc. |
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-08-21 10:14 Tx date 2023-08-14 |
$GUD
Knight Therapeutics Inc. |
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$27,154
+5,741 vol $4.73 each |
5,741 | |
Filed 2023-08-21 10:09 Tx date 2023-08-01 |
$GUD
Knight Therapeutics Inc. |
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-08-21 10:04 Tx date 2023-08-01 |
$GUD
Knight Therapeutics Inc. |
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-08-10 11:15 Tx date 2023-07-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-412,634 vol |
41,900 | |
Filed 2023-08-10 11:13 Tx date 2023-07-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$113,474
+23,500 vol $4.83 each |
454,534 | |
Filed 2023-08-10 11:12 Tx date 2023-07-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$88,367
+18,400 vol $4.80 each |
431,034 | |
Filed 2023-08-10 11:11 Tx date 2023-07-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$113,340
+23,500 vol $4.82 each |
412,634 | |
Filed 2023-08-10 11:10 Tx date 2023-07-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$74,283
+15,300 vol $4.86 each |
389,134 | |
Filed 2023-08-10 11:09 Tx date 2023-07-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$114,447
+23,500 vol $4.87 each |
373,834 | |
Filed 2023-08-10 11:08 Tx date 2023-07-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$81,499
+16,700 vol $4.88 each |
350,334 | |
Filed 2023-08-10 11:06 Tx date 2023-07-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$73,300
+15,139 vol $4.84 each |
333,634 | |
Filed 2023-08-10 11:05 Tx date 2023-07-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$113,712
+23,539 vol $4.83 each |
318,495 | |
Filed 2023-08-10 11:04 Tx date 2023-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$53,149
+10,839 vol $4.90 each |
294,956 | |
Filed 2023-08-10 11:03 Tx date 2023-07-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,005
+7,339 vol $4.91 each |
284,117 | |
Filed 2023-08-10 11:01 Tx date 2023-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$51,938
+10,639 vol $4.88 each |
276,778 | |
Filed 2023-08-10 10:59 Tx date 2023-07-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$44,756
+9,039 vol $4.95 each |
266,139 | |
Filed 2023-08-10 10:57 Tx date 2023-07-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$246,324
+49,100 vol $5.02 each |
257,100 | |
Filed 2023-08-10 10:55 Tx date 2023-07-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$76,162
+15,400 vol $4.95 each |
208,000 | |
Filed 2023-08-10 10:54 Tx date 2023-07-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$126,952
+26,000 vol $4.88 each |
192,600 | |
Filed 2023-08-10 10:53 Tx date 2023-07-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$216,650
+44,100 vol $4.91 each |
166,600 | |
Filed 2023-08-10 10:52 Tx date 2023-07-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$72,829
+14,900 vol $4.89 each |
122,500 | |
Filed 2023-08-10 10:50 Tx date 2023-07-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$145,349
+30,200 vol $4.81 each |
107,600 | |
Filed 2023-08-10 10:49 Tx date 2023-07-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$116,099
+23,900 vol $4.86 each |
77,400 | |
Filed 2023-08-10 10:47 Tx date 2023-07-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$43,866
+8,900 vol $4.93 each |
53,500 | |
Filed 2023-07-04 13:36 Tx date 2023-06-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-776,700 vol |
44,600 | |
Filed 2023-07-04 13:35 Tx date 2023-06-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$76,680
+15,700 vol $4.88 each |
821,300 | |
Filed 2023-07-04 13:33 Tx date 2023-06-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$138,809
+28,900 vol $4.80 each |
805,600 | |
Filed 2023-07-04 13:32 Tx date 2023-06-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$109,866
+23,000 vol $4.78 each |
776,700 | |
Filed 2023-07-04 13:31 Tx date 2023-06-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$90,873
+19,200 vol $4.73 each |
753,700 | |
Filed 2023-07-04 13:29 Tx date 2023-06-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$126,567
+27,100 vol $4.67 each |
734,500 | |
Filed 2023-07-04 13:28 Tx date 2023-06-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$107,865
+22,700 vol $4.75 each |
707,400 | |
Filed 2023-07-04 13:27 Tx date 2023-06-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$87,265
+18,300 vol $4.77 each |
684,700 | |
Filed 2023-07-04 13:25 Tx date 2023-06-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$136,116
+28,500 vol $4.78 each |
666,400 | |
Filed 2023-07-04 13:23 Tx date 2023-06-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$70,227
+14,700 vol $4.78 each |
637,900 | |
Filed 2023-07-04 13:22 Tx date 2023-06-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$105,165
+21,800 vol $4.82 each |
623,200 | |
Filed 2023-07-04 13:21 Tx date 2023-06-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$236,342
+49,200 vol $4.80 each |
601,400 | |
Filed 2023-07-04 13:20 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$238,506
+49,200 vol $4.85 each |
552,200 | |
Filed 2023-07-04 13:18 Tx date 2023-06-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$137,658
+28,200 vol $4.88 each |
503,000 | |
Filed 2023-07-04 13:17 Tx date 2023-06-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$242,546
+49,200 vol $4.93 each |
474,800 | |
Filed 2023-07-04 13:16 Tx date 2023-06-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$244,425
+49,200 vol $4.97 each |
425,600 | |
Filed 2023-07-04 13:14 Tx date 2023-06-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$75,130
+15,100 vol $4.98 each |
376,400 | |
Filed 2023-07-04 13:13 Tx date 2023-06-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$501,031
+101,200 vol $4.95 each |
361,300 | |
Filed 2023-07-04 13:12 Tx date 2023-06-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$180,589
+36,700 vol $4.92 each |
260,100 | |
Filed 2023-07-04 13:09 Tx date 2023-06-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$222,690
+45,500 vol $4.89 each |
223,400 | |
Filed 2023-07-04 13:06 Tx date 2023-06-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$102,259
+21,000 vol $4.87 each |
177,900 | |
Filed 2023-07-04 13:05 Tx date 2023-06-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$151,463
+31,100 vol $4.87 each |
156,900 | |
Filed 2023-07-04 13:03 Tx date 2023-06-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$197,526
+40,300 vol $4.90 each |
125,800 | |
Filed 2023-06-19 14:57 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,247
+1,473 vol $4.92 each |
7,983 | |
Filed 2023-06-19 14:55 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,742
+2,590 vol $4.92 each |
134,763 | |
Filed 2023-06-19 13:43 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,965
+3,245 vol $4.92 each |
189,935 | |
Filed 2023-06-19 13:40 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,252
+1,474 vol $4.92 each |
||
Filed 2023-06-19 13:40 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,252
+1,474 vol $4.92 each |
7,984 | |
Filed 2023-06-19 13:38 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,292
+466 vol $4.92 each |
873 | |
Filed 2023-06-19 13:35 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,661
+1,354 vol $4.92 each |
792,953 | |
Filed 2023-06-19 13:32 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,899
+1,199 vol $4.92 each |
18,620 | |
Filed 2023-06-19 13:28 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,737
+2,589 vol $4.92 each |
||
Filed 2023-06-19 13:28 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,737
+2,589 vol $4.92 each |
134,762 | |
Filed 2023-06-07 14:04 Tx date 2023-05-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,355,300 vol |
85,500 | |
Filed 2023-06-07 14:02 Tx date 2023-05-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$235,456
+49,200 vol $4.79 each |
1,440,800 | |
Filed 2023-06-07 14:00 Tx date 2023-05-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$178,134
+36,300 vol $4.91 each |
1,391,600 | |
Filed 2023-06-07 13:59 Tx date 2023-05-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$117,276
+23,800 vol $4.93 each |
1,355,300 | |
Filed 2023-06-07 13:58 Tx date 2023-05-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$335,125
+68,400 vol $4.90 each |
1,331,500 | |
Filed 2023-06-07 13:56 Tx date 2023-05-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$238,359
+49,200 vol $4.84 each |
1,263,100 | |
Filed 2023-06-07 13:55 Tx date 2023-05-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$231,805
+49,200 vol $4.71 each |
1,213,900 | |
Filed 2023-06-07 13:48 Tx date 2023-05-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$240,115
+49,200 vol $4.88 each |
1,164,700 | |
Filed 2023-06-07 13:46 Tx date 2023-05-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$241,301
+49,200 vol $4.90 each |
1,115,500 | |
Filed 2023-06-07 13:45 Tx date 2023-05-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$215,802
+44,900 vol $4.81 each |
1,066,300 | |
Filed 2023-06-07 13:44 Tx date 2023-05-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$232,656
+49,200 vol $4.73 each |
1,021,400 | |
Filed 2023-06-07 13:42 Tx date 2023-05-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$232,233
+49,200 vol $4.72 each |
972,200 | |
Filed 2023-06-07 13:41 Tx date 2023-05-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,519,603
+314,000 vol $4.84 each |
923,000 | |
Filed 2023-06-07 13:39 Tx date 2023-05-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$70,849
+14,600 vol $4.85 each |
609,000 | |
Filed 2023-06-07 13:38 Tx date 2023-05-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$236,322
+49,200 vol $4.80 each |
594,400 | |
Filed 2023-06-07 13:37 Tx date 2023-05-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$233,921
+49,200 vol $4.75 each |
545,200 | |
Filed 2023-06-07 13:35 Tx date 2023-05-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$118,689
+25,400 vol $4.67 each |
496,000 | |
Filed 2023-06-07 13:34 Tx date 2023-05-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$115,150
+24,500 vol $4.70 each |
470,600 | |
Filed 2023-06-07 13:33 Tx date 2023-05-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$140,203
+29,800 vol $4.70 each |
446,100 | |
Filed 2023-06-07 13:32 Tx date 2023-05-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$181,324
+38,900 vol $4.66 each |
416,300 | |
Filed 2023-06-07 13:30 Tx date 2023-05-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$229,842
+49,200 vol $4.67 each |
377,400 | |
Filed 2023-06-07 13:28 Tx date 2023-05-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$227,382
+49,200 vol $4.62 each |
328,200 | |
Filed 2023-06-07 13:26 Tx date 2023-05-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$155,760
+34,200 vol $4.55 each |
279,000 | |
Filed 2023-05-24 12:32 Tx date 2023-05-24 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,000
+20,000 vol $4.75 each |
186,690 | |
Filed 2023-05-15 11:56 Tx date 2023-05-12 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$44,998
+9,259 vol $4.86 each |
23,189 | |
Filed 2023-05-15 11:53 Tx date 2023-05-12 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$44,998
+9,259 vol $4.86 each |
37,117 | |
Filed 2023-05-15 11:50 Tx date 2023-05-12 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$54,995
+11,316 vol $4.86 each |
29,817 | |
Filed 2023-05-15 11:48 Tx date 2023-05-12 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$44,998
+9,259 vol $4.86 each |
23,189 | |
Filed 2023-05-15 11:43 Tx date 2023-05-12 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$44,998
+9,259 vol $4.86 each |
23,189 | |
Filed 2023-05-09 12:46 Tx date 2023-04-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-796,820 vol |
244,800 | |
Filed 2023-05-09 12:33 Tx date 2023-04-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$899,486
+195,600 vol $4.60 each |
1,041,620 | |
Filed 2023-05-09 12:31 Tx date 2023-04-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$230,575
+49,200 vol $4.69 each |
846,020 | |
Filed 2023-05-09 12:29 Tx date 2023-04-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$235,805
+49,200 vol $4.79 each |
796,820 | |
Filed 2023-05-09 12:16 Tx date 2023-04-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$235,436
+49,200 vol $4.79 each |
747,620 | |
Filed 2023-05-09 12:05 Tx date 2023-04-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$166,521
+34,700 vol $4.80 each |
698,420 | |
Filed 2023-05-09 12:04 Tx date 2023-04-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$237,153
+49,200 vol $4.82 each |
663,720 | |
Filed 2023-05-09 12:02 Tx date 2023-04-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$236,420
+49,200 vol $4.81 each |
614,520 | |
Filed 2023-05-09 12:01 Tx date 2023-04-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$110,533
+23,000 vol $4.81 each |
565,320 | |
Filed 2023-05-09 11:59 Tx date 2023-04-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$235,431
+49,200 vol $4.79 each |
542,320 | |
Filed 2023-05-09 11:58 Tx date 2023-04-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$106,548
+22,200 vol $4.80 each |
493,120 | |
Filed 2023-05-09 11:55 Tx date 2023-04-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$235,987
+49,200 vol $4.80 each |
470,920 | |
Filed 2023-05-09 11:53 Tx date 2023-04-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$234,565
+49,200 vol $4.77 each |
421,720 | |
Filed 2023-05-09 11:51 Tx date 2023-04-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$119,484
+25,300 vol $4.72 each |
372,520 | |
Filed 2023-05-09 11:45 Tx date 2023-04-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$230,757
+49,200 vol $4.69 each |
347,220 | |
Filed 2023-05-09 11:37 Tx date 2023-04-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$96,902
+20,900 vol $4.64 each |
298,020 | |
Filed 2023-05-09 11:34 Tx date 2023-04-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$226,743
+49,200 vol $4.61 each |
277,120 | |
Filed 2023-05-09 11:32 Tx date 2023-04-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$229,015
+49,220 vol $4.65 each |
227,920 | |
Filed 2023-05-09 11:31 Tx date 2023-04-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$140,167
+31,100 vol $4.51 each |
178,700 | |
Filed 2023-05-09 11:29 Tx date 2023-04-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$216,967
+49,200 vol $4.41 each |
147,600 | |
Filed 2023-04-10 15:41 Tx date 2023-03-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,326,005 vol |
98,400 | |
Filed 2023-04-10 15:34 Tx date 2023-03-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$217,995
+49,200 vol $4.43 each |
1,424,405 | |
Filed 2023-04-10 15:33 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$216,504
+49,200 vol $4.40 each |
1,375,205 | |
Filed 2023-04-10 15:31 Tx date 2023-03-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$213,867
+49,200 vol $4.35 each |
1,326,005 | |
Filed 2023-04-10 15:30 Tx date 2023-03-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$215,761
+49,200 vol $4.39 each |
1,276,805 | |
Filed 2023-04-10 15:28 Tx date 2023-03-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,885,598
+660,305 vol $4.37 each |
1,227,605 | |
Filed 2023-04-10 15:27 Tx date 2023-03-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$186,866
+41,200 vol $4.54 each |
567,300 | |
Filed 2023-04-10 15:26 Tx date 2023-03-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$166,975
+34,300 vol $4.87 each |
526,100 | |
Filed 2023-04-10 15:25 Tx date 2023-03-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$127,400
+25,800 vol $4.94 each |
491,800 | |
Filed 2023-04-10 15:23 Tx date 2023-03-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$94,148
+18,900 vol $4.98 each |
466,000 | |
Filed 2023-04-10 15:22 Tx date 2023-03-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$116,567
+23,500 vol $4.96 each |
447,100 | |
Filed 2023-04-10 15:20 Tx date 2023-03-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$243,613
+49,200 vol $4.95 each |
423,600 | |
Filed 2023-04-10 15:19 Tx date 2023-03-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$210,648
+41,900 vol $5.03 each |
374,400 | |
Filed 2023-04-10 15:17 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$244,435
+49,200 vol $4.97 each |
332,500 | |
Filed 2023-04-10 15:15 Tx date 2023-03-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$185,828
+36,900 vol $5.04 each |
283,300 | |
Filed 2023-04-10 15:13 Tx date 2023-03-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$106,789
+21,300 vol $5.01 each |
246,400 | |
Filed 2023-04-10 15:10 Tx date 2023-03-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$107,797
+21,300 vol $5.06 each |
225,100 | |
Filed 2023-04-10 15:08 Tx date 2023-03-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$189,255
+37,400 vol $5.06 each |
203,800 | |
Filed 2023-04-10 15:05 Tx date 2023-03-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$182,479
+35,900 vol $5.08 each |
166,400 | |
Filed 2023-04-10 15:03 Tx date 2023-03-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$49,342
+9,700 vol $5.09 each |
130,500 | |
Filed 2023-04-10 15:01 Tx date 2023-03-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$142,409
+27,900 vol $5.10 each |
120,800 | |
Filed 2023-04-10 14:59 Tx date 2023-03-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$67,476
+13,100 vol $5.15 each |
92,900 | |
Filed 2023-04-10 14:57 Tx date 2023-03-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$154,854
+30,500 vol $5.08 each |
79,800 | |
Filed 2023-04-10 14:54 Tx date 2023-03-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$103,832
+20,300 vol $5.11 each |
49,300 | |
Filed 2023-04-04 21:57 Tx date 2023-03-31 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$17,498
+3,977 vol $4.40 each |
27,858 | |
Filed 2023-04-03 22:06 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$17,493
+3,940 vol $4.44 each |
6,802 | |
Filed 2023-04-03 22:04 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$17,493
+3,940 vol $4.44 each |
6,802 | |
Filed 2023-04-03 22:02 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$19,988
+4,502 vol $4.44 each |
8,395 | |
Filed 2023-04-03 22:00 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$19,988
+4,502 vol $4.44 each |
8,395 | |
Filed 2023-04-03 21:58 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$20,019
+4,509 vol $4.44 each |
12,970 | |
Filed 2023-04-03 21:57 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$20,019
+4,509 vol $4.44 each |
12,970 | |
Filed 2023-04-03 21:55 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$22,128
+4,984 vol $4.44 each |
8,859 | |
Filed 2023-04-03 21:54 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
50 - Grant of options
|
$44,253
+9,967 vol $4.44 each |
17,718 | |
Filed 2023-04-03 21:49 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$71,284
+16,055 vol $4.44 each |
29,283 | |
Filed 2023-04-03 21:46 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$18,949
+4,268 vol $4.44 each |
11,299 | |
Filed 2023-04-03 21:44 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$37,908
+8,538 vol $4.44 each |
16,536 | |
Filed 2023-04-03 21:43 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$61,054
+13,751 vol $4.44 each |
30,770 | |
Filed 2023-04-03 21:41 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$23,887
+5,380 vol $4.44 each |
18,144 | |
Filed 2023-04-03 21:40 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$47,774
+10,760 vol $4.44 each |
23,692 | |
Filed 2023-04-03 21:38 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$76,954
+17,332 vol $4.44 each |
46,401 | |
Filed 2023-04-02 23:58 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$103,469
+23,304 vol $4.44 each |
56,159 | |
Filed 2023-04-02 23:57 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$51,734
+11,652 vol $4.44 each |
28,079 | |
Filed 2023-04-02 23:55 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$166,655
+37,535 vol $4.44 each |
317,544 | |
Filed 2023-04-02 23:53 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$391,030
+88,070 vol $4.44 each |
210,985 | |
Filed 2023-04-02 23:51 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$419,886
+94,569 vol $4.44 each |
863,388 | |
Filed 2023-04-02 23:47 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$41,736
+9,400 vol $4.44 each |
24,283 | |
Filed 2023-04-02 23:44 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$20,868
+4,700 vol $4.44 each |
15,196 | |
Filed 2023-04-02 23:42 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$67,226
+15,141 vol $4.44 each |
90,443 | |
Filed 2023-04-02 23:39 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$103,469
+23,304 vol $4.44 each |
56,159 | |
Filed 2023-04-02 23:32 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$51,734
+11,652 vol $4.44 each |
28,079 | |
Filed 2023-04-02 23:28 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$166,655
+37,535 vol $4.44 each |
337,293 | |
Filed 2023-04-02 23:22 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$145,125
+32,686 vol $4.44 each |
99,085 | |
Filed 2023-04-02 23:12 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$155,835
+35,098 vol $4.44 each |
1,964,646 | |
Filed 2023-03-30 10:56 Tx date 2023-03-29 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$155,980
+36,100 vol $4.32 each |
12,006,400 | |
Filed 2023-03-30 10:54 Tx date 2023-03-28 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$146,414
+33,800 vol $4.33 each |
11,970,300 | |
Filed 2023-03-30 10:53 Tx date 2023-03-27 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,205,472
+735,200 vol $4.36 each |
11,936,500 | |
Filed 2023-03-24 09:22 Tx date 2023-03-23 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
11,201,300 | ||
Filed 2023-03-21 21:36 Tx date 2023-03-17 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-970,000
-125,000 vol $7.76 each |
299,758 | |
Filed 2023-03-21 21:28 Tx date 2023-03-17 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-1,940,000
-250,000 vol $7.76 each |
1,929,548 | |
Filed 2023-03-21 21:24 Tx date 2023-03-17 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-155,200
-20,000 vol $7.76 each |
100,000 | |
Filed 2023-03-21 21:20 Tx date 2023-03-17 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-155,200
-20,000 vol $7.76 each |
110,000 | |
Filed 2023-03-20 23:29 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,274
+1,245 vol $5.04 each |
791,599 | |
Filed 2023-03-19 23:19 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,051
+407 vol $5.04 each |
407 | |
Filed 2023-03-19 23:16 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-03-19 23:08 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,997
+1,190 vol $5.04 each |
6,510 | |
Filed 2023-03-19 23:04 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,494
+495 vol $5.04 each |
8,493 | |
Filed 2023-03-19 23:01 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,174
+2,614 vol $5.04 each |
166,690 | |
Filed 2023-03-19 23:00 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,523
+1,096 vol $5.04 each |
17,421 | |
Filed 2023-03-19 22:55 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,664
+2,116 vol $5.04 each |
132,173 | |
Filed 2023-03-10 17:56 Tx date 2023-02-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-481,700 vol |
29,000 | |
Filed 2023-03-10 17:50 Tx date 2023-02-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$74,039
+14,500 vol $5.11 each |
510,700 | |
Filed 2023-03-10 17:49 Tx date 2023-02-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$74,176
+14,500 vol $5.12 each |
496,200 | |
Filed 2023-03-10 17:48 Tx date 2023-02-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$89,792
+17,500 vol $5.13 each |
481,700 | |
Filed 2023-03-10 17:45 Tx date 2023-02-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$162,139
+31,600 vol $5.13 each |
464,200 | |
Filed 2023-03-10 17:43 Tx date 2023-02-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$94,607
+18,500 vol $5.11 each |
432,600 | |
Filed 2023-03-10 17:42 Tx date 2023-02-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$128,565
+24,700 vol $5.21 each |
414,100 | |
Filed 2023-03-10 17:40 Tx date 2023-02-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$162,076
+31,600 vol $5.13 each |
389,400 | |
Filed 2023-03-10 17:39 Tx date 2023-02-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$80,027
+15,700 vol $5.10 each |
357,800 | |
Filed 2023-03-10 17:38 Tx date 2023-02-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$81,808
+15,900 vol $5.15 each |
342,100 | |
Filed 2023-03-10 17:36 Tx date 2023-02-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$170,114
+33,100 vol $5.14 each |
326,200 | |
Filed 2023-03-10 17:35 Tx date 2023-02-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$74,496
+14,400 vol $5.17 each |
293,100 | |
Filed 2023-03-10 17:34 Tx date 2023-02-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$62,800
+12,100 vol $5.19 each |
278,700 | |
Filed 2023-03-10 17:33 Tx date 2023-02-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$260,292
+49,200 vol $5.29 each |
266,600 | |
Filed 2023-03-10 17:32 Tx date 2023-02-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$119,129
+22,800 vol $5.22 each |
217,400 | |
Filed 2023-03-10 17:30 Tx date 2023-02-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$51,446
+9,900 vol $5.20 each |
194,600 | |
Filed 2023-03-10 17:29 Tx date 2023-02-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$119,683
+23,100 vol $5.18 each |
184,700 | |
Filed 2023-03-10 17:28 Tx date 2023-02-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$215,265
+40,600 vol $5.30 each |
161,600 | |
Filed 2023-03-10 17:27 Tx date 2023-02-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$140,925
+26,700 vol $5.28 each |
121,000 | |
Filed 2023-03-10 16:10 Tx date 2023-02-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$101,957
+19,700 vol $5.18 each |
94,300 | |
Filed 2023-02-03 13:50 Tx date 2023-01-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-827,300 vol |
74,600 | |
Filed 2023-02-03 13:50 Tx date 2023-01-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$182,044
+35,600 vol $5.11 each |
901,900 | |
Filed 2023-02-03 13:49 Tx date 2023-01-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$199,500
+39,000 vol $5.12 each |
866,300 | |
Filed 2023-02-03 13:48 Tx date 2023-01-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$187,138
+36,100 vol $5.18 each |
827,300 | |
Filed 2023-02-03 13:47 Tx date 2023-01-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$165,789
+32,300 vol $5.13 each |
791,200 | |
Filed 2023-02-03 13:47 Tx date 2023-01-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$145,501
+28,500 vol $5.11 each |
758,900 | |
Filed 2023-02-03 13:46 Tx date 2023-01-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$155,587
+30,300 vol $5.13 each |
730,400 | |
Filed 2023-02-03 13:45 Tx date 2023-01-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$127,442
+24,700 vol $5.16 each |
700,100 | |
Filed 2023-02-03 13:45 Tx date 2023-01-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$196,613
+37,900 vol $5.19 each |
675,400 | |
Filed 2023-02-03 13:44 Tx date 2023-01-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$150,438
+29,100 vol $5.17 each |
637,500 | |
Filed 2023-02-03 13:43 Tx date 2023-01-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$129,767
+24,600 vol $5.28 each |
608,400 | |
Filed 2023-02-03 13:43 Tx date 2023-01-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$228,914
+43,300 vol $5.29 each |
583,800 | |
Filed 2023-02-03 13:42 Tx date 2023-01-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$125,811
+23,800 vol $5.29 each |
540,500 | |
Filed 2023-02-03 13:41 Tx date 2023-01-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$142,802
+27,200 vol $5.25 each |
516,700 | |
Filed 2023-01-17 17:45 Tx date 2023-01-13 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,998
+1,883 vol $5.31 each |
7,998 | |
Filed 2023-01-10 11:59 Tx date 2022-12-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,860
+1,500 vol $5.24 each |
489,500 | |
Filed 2023-01-10 11:58 Tx date 2022-12-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$117,222
+22,500 vol $5.21 each |
488,000 | |
Filed 2023-01-10 11:58 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$77,964
+15,000 vol $5.20 each |
465,500 | |
Filed 2023-01-10 11:57 Tx date 2022-12-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,635
+6,400 vol $5.26 each |
450,500 | |
Filed 2023-01-10 11:56 Tx date 2022-12-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$155,768
+29,500 vol $5.28 each |
444,100 | |
Filed 2023-01-10 11:55 Tx date 2022-12-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$78,699
+14,700 vol $5.35 each |
414,600 | |
Filed 2023-01-10 11:47 Tx date 2022-12-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$133,017
+24,600 vol $5.41 each |
399,900 | |
Filed 2023-01-10 11:46 Tx date 2022-12-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$931,707
+177,600 vol $5.25 each |
375,300 | |
Filed 2023-01-10 11:45 Tx date 2022-12-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$49,057
+9,200 vol $5.33 each |
197,700 | |
Filed 2023-01-10 11:44 Tx date 2022-12-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$154,155
+29,000 vol $5.32 each |
188,500 | |
Filed 2023-01-10 11:43 Tx date 2022-12-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$131,500
+25,000 vol $5.26 each |
159,500 | |
Filed 2023-01-10 11:42 Tx date 2022-12-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$190,717
+36,000 vol $5.30 each |
134,500 | |
Filed 2023-01-10 11:42 Tx date 2022-12-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$77,866
+14,400 vol $5.41 each |
98,500 | |
Filed 2023-01-10 11:40 Tx date 2022-12-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$113,867
+20,900 vol $5.45 each |
84,100 | |
Filed 2023-01-10 11:40 Tx date 2022-12-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$129,506
+23,900 vol $5.42 each |
63,200 | |
Filed 2023-01-02 10:29 Tx date 2022-12-31 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$17,503
+3,379 vol $5.18 each |
23,881 | |
Filed 2022-12-23 15:59 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,998
+1,318 vol $5.31 each |
5,320 | |
Filed 2022-12-23 15:55 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,701
+321 vol $5.30 each |
164,076 | |
Filed 2022-12-23 15:54 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,057
+2,459 vol $5.31 each |
163,755 | |
Filed 2022-12-23 15:53 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,812
+342 vol $5.30 each |
790,354 | |
Filed 2022-12-23 15:51 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,842
+912 vol $5.31 each |
790,012 | |
Filed 2022-12-23 15:49 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$583.00
+110 vol $5.30 each |
16,325 | |
Filed 2022-12-23 15:49 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,207
+604 vol $5.31 each |
16,215 | |
Filed 2022-12-23 15:47 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,526
+288 vol $5.30 each |
130,057 | |
Filed 2022-12-23 15:46 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,365
+1,952 vol $5.31 each |
129,769 | |
Filed 2022-12-23 13:17 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,894
+2,240 vol $5.31 each |
130,057 | |
Filed 2022-12-23 13:17 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,894
+2,240 vol $5.31 each |
||
Filed 2022-12-05 11:46 Tx date 2022-11-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-449,400 vol |
39,300 | |
Filed 2022-12-05 11:46 Tx date 2022-11-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$148,260
+27,800 vol $5.33 each |
488,700 | |
Filed 2022-12-05 11:45 Tx date 2022-11-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$60,798
+11,500 vol $5.29 each |
460,900 | |
Filed 2022-12-05 11:44 Tx date 2022-11-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$49,991
+9,400 vol $5.32 each |
449,400 | |
Filed 2022-12-05 11:43 Tx date 2022-11-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$117,941
+22,100 vol $5.34 each |
440,000 | |
Filed 2022-12-05 11:42 Tx date 2022-11-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$62,171
+11,800 vol $5.27 each |
417,900 | |
Filed 2022-12-05 11:41 Tx date 2022-11-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$43,428
+8,300 vol $5.23 each |
406,100 | |
Filed 2022-12-05 11:39 Tx date 2022-11-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$105,318
+20,200 vol $5.21 each |
397,800 | |
Filed 2022-12-05 11:38 Tx date 2022-11-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,252
+4,800 vol $5.26 each |
377,600 | |
Filed 2022-12-05 11:37 Tx date 2022-11-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$216,872
+40,900 vol $5.30 each |
372,800 | |
Filed 2022-12-05 11:37 Tx date 2022-11-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$122,822
+23,100 vol $5.32 each |
220,100 | |
Filed 2022-12-05 11:35 Tx date 2022-11-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$126,647
+24,100 vol $5.26 each |
303,000 | |
Filed 2022-12-05 11:34 Tx date 2022-11-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$151,814
+28,900 vol $5.25 each |
331,900 | |
Filed 2022-12-05 11:33 Tx date 2022-11-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$162,793
+30,800 vol $5.29 each |
278,900 | |
Filed 2022-12-05 11:32 Tx date 2022-11-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$148,178
+28,000 vol $5.29 each |
248,100 | |
Filed 2022-12-05 11:31 Tx date 2022-11-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$126,723
+23,800 vol $5.32 each |
197,000 | |
Filed 2022-12-05 11:30 Tx date 2022-11-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$120,821
+22,200 vol $5.44 each |
173,200 | |
Filed 2022-12-05 11:29 Tx date 2022-11-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$45,704
+8,400 vol $5.44 each |
151,000 | |
Filed 2022-12-05 11:28 Tx date 2022-11-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$31,513
+5,900 vol $5.34 each |
142,600 | |
Filed 2022-12-05 11:27 Tx date 2022-11-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$129,785
+24,100 vol $5.39 each |
136,700 | |
Filed 2022-12-05 11:26 Tx date 2022-11-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$88,392
+16,400 vol $5.39 each |
112,600 | |
Filed 2022-12-05 11:25 Tx date 2022-11-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$241,024
+44,100 vol $5.47 each |
96,200 | |
Filed 2022-12-05 11:24 Tx date 2022-11-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$85,200
+15,400 vol $5.53 each |
52,100 | |
Filed 2022-11-02 18:32 Tx date 2022-10-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$129,732
+24,000 vol $5.41 each |
534,700 | |
Filed 2022-11-02 18:27 Tx date 2022-10-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-836,800 vol |
36,700 | |
Filed 2022-11-02 18:27 Tx date 2022-10-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$115,420
+20,900 vol $5.52 each |
873,500 | |
Filed 2022-11-02 18:26 Tx date 2022-10-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$84,955
+15,800 vol $5.38 each |
852,600 | |
Filed 2022-11-02 18:25 Tx date 2022-10-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$134,120
+25,000 vol $5.36 each |
836,800 | |
Filed 2022-11-02 18:24 Tx date 2022-10-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$265,542
+49,200 vol $5.40 each |
811,800 | |
Filed 2022-11-02 18:24 Tx date 2022-10-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$178,283
+33,900 vol $5.26 each |
762,600 | |
Filed 2022-11-02 18:23 Tx date 2022-10-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$111,643
+21,200 vol $5.27 each |
728,700 | |
Filed 2022-11-02 18:22 Tx date 2022-10-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$134,053
+25,200 vol $5.32 each |
707,500 | |
Filed 2022-11-02 18:22 Tx date 2022-10-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$262,339
+49,200 vol $5.33 each |
682,300 | |
Filed 2022-11-02 18:21 Tx date 2022-10-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$260,715
+49,200 vol $5.30 each |
633,100 | |
Filed 2022-11-02 18:20 Tx date 2022-10-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$266,304
+49,200 vol $5.41 each |
583,900 | |
Filed 2022-11-02 18:19 Tx date 2022-10-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$129,732
+24,000 vol $5.41 each |
||
Filed 2022-11-02 18:18 Tx date 2022-10-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$207,836
+39,100 vol $5.32 each |
510,700 | |
Filed 2022-11-02 17:33 Tx date 2022-10-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$162,469
+30,400 vol $5.34 each |
471,600 | |
Filed 2022-11-02 17:31 Tx date 2022-10-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$256,174
+49,200 vol $5.21 each |
441,200 | |
Filed 2022-11-02 17:29 Tx date 2022-10-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$149,871
+28,700 vol $5.22 each |
392,000 | |
Filed 2022-11-02 17:28 Tx date 2022-10-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$240,320
+44,800 vol $5.36 each |
314,600 | |
Filed 2022-11-02 17:25 Tx date 2022-10-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$256,473
+48,700 vol $5.27 each |
363,300 | |
Filed 2022-11-02 17:22 Tx date 2022-10-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$264,267
+49,200 vol $5.37 each |
269,800 | |
Filed 2022-11-02 17:20 Tx date 2022-10-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$263,372
+49,200 vol $5.35 each |
220,600 | |
Filed 2022-11-02 17:19 Tx date 2022-10-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$263,229
+49,200 vol $5.35 each |
171,400 | |
Filed 2022-10-07 11:27 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,185
+2,342 vol $5.63 each |
161,296 | |
Filed 2022-10-07 11:22 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,277
+1,115 vol $5.63 each |
789,100 | |
Filed 2022-10-07 11:20 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,438
+966 vol $5.63 each |
15,611 | |
Filed 2022-10-07 11:18 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,674
+1,896 vol $5.63 each |
127,817 | |
Filed 2022-09-21 16:29 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$22,401
+3,979 vol $5.63 each |
||
Filed 2022-09-21 16:27 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,326
+1,479 vol $5.63 each |
||
Filed 2022-09-21 16:25 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$18,950
+3,366 vol $5.63 each |
||
Filed 2022-09-21 16:22 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$16,118
+2,863 vol $5.63 each |
||
Filed 2022-10-06 15:59 Tx date 2022-09-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$280,267
+49,200 vol $5.70 each |
144,600 | |
Filed 2022-10-06 15:39 Tx date 2022-09-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-495,700 vol |
122,200 | |
Filed 2022-10-06 15:38 Tx date 2022-09-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$262,816
+49,200 vol $5.34 each |
617,900 | |
Filed 2022-10-06 15:38 Tx date 2022-09-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$244,324
+45,800 vol $5.33 each |
568,700 | |
Filed 2022-10-06 15:37 Tx date 2022-09-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$148,136
+27,200 vol $5.45 each |
522,900 | |
Filed 2022-10-06 15:36 Tx date 2022-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$200,361
+36,000 vol $5.57 each |
495,700 | |
Filed 2022-10-06 15:36 Tx date 2022-09-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$145,445
+26,900 vol $5.41 each |
459,700 | |
Filed 2022-10-06 15:35 Tx date 2022-09-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$224,292
+41,400 vol $5.42 each |
432,800 | |
Filed 2022-10-06 15:34 Tx date 2022-09-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$131,188
+24,200 vol $5.42 each |
391,400 | |
Filed 2022-10-06 15:33 Tx date 2022-09-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$256,294
+46,500 vol $5.51 each |
367,200 | |
Filed 2022-10-06 15:33 Tx date 2022-09-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$104,622
+19,100 vol $5.48 each |
320,700 | |
Filed 2022-10-06 15:32 Tx date 2022-09-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$72,908
+13,200 vol $5.52 each |
301,600 | |
Filed 2022-10-06 15:31 Tx date 2022-09-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$174,663
+31,300 vol $5.58 each |
288,400 | |
Filed 2022-10-06 15:31 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$275,303
+49,200 vol $5.60 each |
257,100 | |
Filed 2022-10-06 15:30 Tx date 2022-09-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$96,165
+17,300 vol $5.56 each |
207,900 | |
Filed 2022-10-06 15:29 Tx date 2022-09-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$179,447
+31,900 vol $5.63 each |
190,600 | |
Filed 2022-10-06 15:28 Tx date 2022-09-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$80,213
+14,100 vol $5.69 each |
158,700 | |
Filed 2022-10-06 15:27 Tx date 2022-09-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$280,267
+49,200 vol $5.70 each |
||
Filed 2022-10-06 15:26 Tx date 2022-09-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$80,017
+14,200 vol $5.63 each |
95,400 | |
Filed 2022-10-06 15:26 Tx date 2022-09-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$164,957
+29,600 vol $5.57 each |
81,200 | |
Filed 2022-10-06 15:25 Tx date 2022-09-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$190,465
+34,400 vol $5.54 each |
51,600 | |
Filed 2022-10-03 10:27 Tx date 2022-09-30 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$17,496
+3,295 vol $5.31 each |
20,502 | |
Filed 2022-09-21 16:31 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,503
+267 vol $5.63 each |
4,002 | |
Filed 2022-09-21 16:29 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$22,401
+3,979 vol $5.63 each |
162,933 | |
Filed 2022-09-21 16:27 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,326
+1,479 vol $5.63 each |
16,124 | |
Filed 2022-09-21 16:25 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$18,950
+3,366 vol $5.63 each |
129,287 | |
Filed 2022-09-21 16:22 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$16,118
+2,863 vol $5.63 each |
790,848 | |
Filed 2022-09-15 10:54 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$20,188
+3,875 vol $5.21 each |
3,875 | |
Filed 2022-09-15 10:52 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$14,939
+2,862 vol $5.22 each |
2,862 | |
Filed 2022-09-15 10:50 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$14,939
+2,862 vol $5.22 each |
2,862 | |
Filed 2022-09-15 10:49 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$20,188
+3,875 vol $5.21 each |
||
Filed 2022-09-15 10:48 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$40,382
+7,751 vol $5.21 each |
7,751 | |
Filed 2022-09-15 10:47 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$68,917
+13,228 vol $5.21 each |
13,228 | |
Filed 2022-09-15 09:58 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$20,282
+3,893 vol $5.21 each |
3,893 | |
Filed 2022-09-15 09:57 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$20,282
+3,893 vol $5.21 each |
3,893 | |
Filed 2022-09-15 09:51 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$22,861
+4,388 vol $5.21 each |
10,496 | |
Filed 2022-09-15 09:50 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$45,717
+8,775 vol $5.21 each |
14,883 | |
Filed 2022-09-15 09:49 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$78,024
+14,976 vol $5.21 each |
75,302 | |
Filed 2022-09-15 09:47 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$15,567
+2,988 vol $5.21 each |
7,031 | |
Filed 2022-09-15 09:46 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$31,134
+5,976 vol $5.21 each |
7,998 | |
Filed 2022-09-15 09:44 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,064
+4,043 vol $5.21 each |
4,043 | |
Filed 2022-09-15 09:41 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$10,534
+2,022 vol $5.21 each |
2,022 | |
Filed 2022-09-15 09:39 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$14,942
+2,868 vol $5.21 each |
6,750 | |
Filed 2022-09-15 09:38 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$29,894
+5,738 vol $5.21 each |
7,679 | |
Filed 2022-09-15 09:36 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$20,225
+3,882 vol $5.21 each |
3,882 | |
Filed 2022-09-15 09:35 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$10,112
+1,941 vol $5.21 each |
1,941 | |
Filed 2022-09-15 09:34 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,016
+9,792 vol $5.21 each |
16,340 | |
Filed 2022-09-15 09:30 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,442
+6,548 vol $5.26 each |
6,548 | |
Filed 2022-09-15 09:27 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$53,131
+10,198 vol $5.21 each |
17,019 | |
Filed 2022-09-15 09:25 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,878
+6,821 vol $5.26 each |
6,821 | |
Filed 2022-09-15 09:22 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
2,211 | ||
Filed 2022-09-15 09:20 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
2,211 | ||
Filed 2022-05-17 14:47 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$16,187
+3,101 vol $5.22 each |
||
Filed 2022-05-17 14:46 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$16,187
+3,101 vol $5.22 each |
||
Filed 2022-04-27 10:24 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2022-04-27 10:23 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2022-04-27 10:21 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$24,268
+4,658 vol $5.21 each |
||
Filed 2022-04-27 10:20 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$12,134
+2,329 vol $5.21 each |
||
Filed 2022-03-29 11:45 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$24,346
+4,673 vol $5.21 each |
||
Filed 2022-03-29 11:44 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$24,346
+4,673 vol $5.21 each |
||
Filed 2022-03-29 11:41 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$21,876
+4,199 vol $5.21 each |
||
Filed 2022-03-29 11:40 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$43,748
+8,397 vol $5.21 each |
||
Filed 2022-03-29 11:39 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$74,659
+14,330 vol $5.21 each |
||
Filed 2022-03-29 11:37 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$27,430
+5,265 vol $5.21 each |
||
Filed 2022-03-29 11:36 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$54,866
+10,531 vol $5.21 each |
||
Filed 2022-03-29 11:35 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$93,628
+17,971 vol $5.21 each |
||
Filed 2022-03-29 11:32 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$18,683
+3,586 vol $5.21 each |
||
Filed 2022-03-29 11:31 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$37,360
+7,171 vol $5.21 each |
||
Filed 2022-03-29 11:30 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$63,759
+12,238 vol $5.21 each |
||
Filed 2022-03-29 11:24 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$17,938
+3,443 vol $5.21 each |
||
Filed 2022-03-29 11:23 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$35,876
+6,886 vol $5.21 each |
||
Filed 2022-03-29 11:22 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$61,222
+11,751 vol $5.21 each |
||
Filed 2022-01-06 21:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$43,053
+8,185 vol $5.26 each |
||
Filed 2022-01-06 21:51 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,333
+7,858 vol $5.26 each |
||
Filed 2022-01-06 16:05 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,134
+2,329 vol $5.21 each |
||
Filed 2022-01-06 16:05 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$24,268
+4,658 vol $5.21 each |
||
Filed 2022-01-06 16:01 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2022-01-06 16:00 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2022-01-06 15:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
||
Filed 2022-01-06 15:50 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,883
+8,533 vol $5.26 each |
||
Filed 2021-12-10 14:00 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$24,268
+4,658 vol $5.21 each |
||
Filed 2021-12-10 13:58 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,134
+2,329 vol $5.21 each |
||
Filed 2021-12-10 13:55 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,883
+8,533 vol $5.26 each |
||
Filed 2021-12-10 13:53 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
||
Filed 2021-12-10 13:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-12-10 13:51 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2021-12-10 13:41 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-09-03 09:10 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-03 09:07 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 16:31 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 16:24 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-09-07 15:21 Tx date 2022-08-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-182,800 vol |
17,200 | |
Filed 2022-09-07 15:20 Tx date 2022-08-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$97,398
+17,200 vol $5.66 each |
200,000 | |
Filed 2022-09-07 15:20 Tx date 2022-08-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$207,192
+36,400 vol $5.69 each |
182,800 | |
Filed 2022-09-07 15:19 Tx date 2022-08-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$132,139
+23,000 vol $5.75 each |
146,400 | |
Filed 2022-09-07 15:18 Tx date 2022-08-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$73,025
+12,700 vol $5.75 each |
123,400 | |
Filed 2022-09-07 15:17 Tx date 2022-08-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$61,525
+10,700 vol $5.75 each |
110,700 | |
Filed 2022-09-07 15:17 Tx date 2022-08-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$579,620
+100,000 vol $5.80 each |
100,000 | |
Filed 2022-08-31 09:36 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-25,000 vol |
21,523,233 | |
Filed 2022-08-31 09:35 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-45,000 vol |
21,523,233 | |
Filed 2022-08-16 16:09 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
248,482 | |
Filed 2022-08-16 16:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,374 vol |
689,387 | |
Filed 2022-08-16 15:58 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
2,440,068 | |
Filed 2022-08-16 15:53 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
528,231 | |
Filed 2021-12-10 14:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
||
Filed 2021-12-10 14:09 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
||
Filed 2021-12-10 14:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,374 vol |
||
Filed 2021-12-10 14:06 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
||
Filed 2021-12-10 13:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
||
Filed 2021-12-10 13:09 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
||
Filed 2021-12-10 13:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
||
Filed 2021-12-10 13:06 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,374 vol |
||
Filed 2021-12-10 13:01 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
||
Filed 2021-05-20 12:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 12:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 12:32 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
Filed 2021-05-20 12:17 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
Filed 2021-05-20 11:16 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 11:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 10:55 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
Filed 2021-05-20 10:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
Filed 2022-08-15 15:00 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
60,326 | ||
Filed 2022-03-29 11:35 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-08-14 16:54 Tx date 2022-08-11 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-380,103.05
-65,500 vol $5.80 each |
11,404,478 | |
Filed 2022-08-03 16:31 Tx date 2022-08-02 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-201,338.55
-34,500 vol $5.84 each |
11,469,978 | |
Filed 2022-08-02 09:21 Tx date 2022-07-29 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-580,110
-100,000 vol $5.80 each |
11,504,478 | |
Filed 2022-07-07 14:09 Tx date 2022-06-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-195,970 vol |
0 | |
Filed 2022-07-07 14:09 Tx date 2022-06-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$75,435
+14,370 vol $5.25 each |
195,970 | |
Filed 2022-07-07 14:08 Tx date 2022-06-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$232,067
+44,100 vol $5.26 each |
181,600 | |
Filed 2022-07-07 14:07 Tx date 2022-06-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$423,215
+80,000 vol $5.29 each |
137,500 | |
Filed 2022-07-07 14:07 Tx date 2022-06-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$232,643
+43,900 vol $5.30 each |
57,500 | |
Filed 2022-07-07 14:06 Tx date 2022-06-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$71,954
+13,600 vol $5.29 each |
13,600 | |
Filed 2022-07-05 16:57 Tx date 2022-07-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$82,950
+15,800 vol $5.25 each |
21,678,733 | |
Filed 2022-07-05 16:56 Tx date 2022-07-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,645
+9,800 vol $5.27 each |
21,662,933 | |
Filed 2022-07-05 16:55 Tx date 2022-07-04 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$82,950
+15,800 vol $5.25 each |
21,748,733 | |
Filed 2022-07-05 16:54 Tx date 2022-07-04 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,645
+9,800 vol $5.27 each |
21,732,933 | |
Filed 2022-07-04 14:50 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,220
+18,000 vol $5.29 each |
21,685,133 | |
Filed 2022-04-13 12:29 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,452
+18,800 vol $5.29 each |
||
Filed 2021-11-22 22:19 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,220
+18,000 vol $5.29 each |
||
Filed 2022-07-03 11:10 Tx date 2022-06-30 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$17,499
+3,277 vol $5.34 each |
17,207 | |
Filed 2022-06-24 09:52 Tx date 2022-06-23 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Noah Ezra Goodman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$515.00
+100 vol $5.15 each |
400 | |
Filed 2022-06-20 14:22 Tx date 2022-06-20 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,998
+19,455 vol $5.14 each |
158,954 | |
Filed 2022-06-17 21:53 Tx date 2022-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,748
+335 vol $5.22 each |
3,735 | |
Filed 2022-06-17 21:37 Tx date 2022-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$14,433
+2,765 vol $5.22 each |
139,499 | |
Filed 2022-06-17 21:29 Tx date 2022-06-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,906
+2,281 vol $5.22 each |
14,645 | |
Filed 2022-06-17 21:19 Tx date 2022-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,661
+2,234 vol $5.22 each |
125,921 | |
Filed 2022-06-17 21:11 Tx date 2022-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,665
+1,277 vol $5.22 each |
787,985 | |
Filed 2022-06-16 21:36 Tx date 2022-06-16 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,360
+2,000 vol $5.18 each |
42,700 | |
Filed 2022-06-16 21:32 Tx date 2022-06-16 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$93,240
+18,000 vol $5.18 each |
21,653,133 | |
Filed 2022-06-16 21:29 Tx date 2022-06-16 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$93,240
+18,000 vol $5.18 each |
||
Filed 2022-06-16 21:22 Tx date 2022-06-16 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$93,240
+18,000 vol $5.18 each |
21,723,933 | |
Filed 2022-06-15 09:24 Tx date 2022-06-14 |
$GUD
Knight Therapeutics Inc. |
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
11,604,478 | ||
Filed 2022-06-06 14:27 Tx date 2022-05-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-488,844 vol |
0 | |
Filed 2022-06-06 14:26 Tx date 2022-05-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,240
+800 vol $5.30 each |
488,844 | |
Filed 2022-06-06 14:26 Tx date 2022-05-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,638
+3,900 vol $5.29 each |
488,044 | |
Filed 2022-06-06 14:25 Tx date 2022-05-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$59,308
+11,200 vol $5.30 each |
484,144 | |
Filed 2022-06-06 14:24 Tx date 2022-05-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$112,793
+21,600 vol $5.22 each |
472,944 | |
Filed 2022-06-06 14:24 Tx date 2022-05-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$261,115
+50,200 vol $5.20 each |
451,344 | |
Filed 2022-06-06 14:23 Tx date 2022-05-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$221,793
+42,000 vol $5.28 each |
401,144 | |
Filed 2022-06-06 14:22 Tx date 2022-05-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$259,545
+50,000 vol $5.19 each |
359,144 | |
Filed 2022-06-06 14:21 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$223,963
+42,800 vol $5.23 each |
309,144 | |
Filed 2022-06-06 14:20 Tx date 2022-05-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$417,400
+80,000 vol $5.22 each |
266,344 | |
Filed 2022-06-06 14:19 Tx date 2022-05-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$364,508
+68,900 vol $5.29 each |
186,344 | |
Filed 2022-06-06 14:18 Tx date 2022-05-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$35,798
+6,729 vol $5.32 each |
117,444 | |
Filed 2022-05-18 16:53 Tx date 2022-05-18 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$103,400
+20,000 vol $5.17 each |
21,705,933 | |
Filed 2022-05-18 16:51 Tx date 2022-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$103,400
+20,000 vol $5.17 each |
21,635,133 | |
Filed 2022-05-18 16:50 Tx date 2022-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$103,400
+20,000 vol $5.17 each |
||
Filed 2022-05-18 14:48 Tx date 2022-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,999
+19,305 vol $5.18 each |
136,734 | |
Filed 2022-05-17 14:47 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$16,187
+3,101 vol $5.22 each |
3,101 | |
Filed 2022-05-17 14:46 Tx date 2022-04-21 |
$GUD
Knight Therapeutics Inc. |
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-17 14:46 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$16,187
+3,101 vol $5.22 each |
3,101 | |
Filed 2022-05-17 14:43 Tx date 2022-04-21 |
$GUD
Knight Therapeutics Inc. |
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-16 10:06 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$44,996
+8,620 vol $5.22 each |
13,930 | |
Filed 2022-05-16 10:05 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$44,996
+8,620 vol $5.22 each |
13,930 | |
Filed 2022-05-16 10:04 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$44,996
+8,620 vol $5.22 each |
13,930 | |
Filed 2022-05-16 10:03 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$44,996
+8,620 vol $5.22 each |
13,930 | |
Filed 2022-05-16 10:00 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$54,997
+10,536 vol $5.22 each |
18,501 | |
Filed 2022-05-10 17:02 Tx date 2022-04-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,256,400 vol |
110,715 | |
Filed 2022-05-10 16:59 Tx date 2022-04-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$282,972
+52,900 vol $5.35 each |
1,367,115 | |
Filed 2022-05-10 16:58 Tx date 2022-04-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$309,813
+57,815 vol $5.36 each |
1,314,215 | |
Filed 2022-05-10 16:57 Tx date 2022-04-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$223,323
+41,915 vol $5.33 each |
1,256,400 | |
Filed 2022-05-10 16:56 Tx date 2022-04-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$243,203
+45,715 vol $5.32 each |
1,214,485 | |
Filed 2022-05-10 16:55 Tx date 2022-04-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$319,766
+59,915 vol $5.34 each |
1,168,770 | |
Filed 2022-05-10 16:55 Tx date 2022-04-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$341,837
+63,715 vol $5.37 each |
1,108,855 | |
Filed 2022-05-10 16:26 Tx date 2022-04-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$170,245
+31,815 vol $5.35 each |
1,045,140 | |
Filed 2022-05-10 16:25 Tx date 2022-04-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$142,211
+26,615 vol $5.34 each |
1,013,325 | |
Filed 2022-05-10 16:24 Tx date 2022-04-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$95,477
+17,815 vol $5.36 each |
986,710 | |
Filed 2022-05-10 16:24 Tx date 2022-04-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$159,856
+29,915 vol $5.34 each |
968,895 | |
Filed 2022-05-10 16:23 Tx date 2022-04-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$135,436
+25,415 vol $5.33 each |
938,980 | |
Filed 2022-05-10 16:22 Tx date 2022-04-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$276,686
+51,815 vol $5.34 each |
913,565 | |
Filed 2022-05-10 16:21 Tx date 2022-04-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$309,914
+58,415 vol $5.31 each |
861,750 | |
Filed 2022-05-10 16:20 Tx date 2022-04-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$201,067
+37,915 vol $5.30 each |
803,335 | |
Filed 2022-05-10 16:19 Tx date 2022-04-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$217,813
+40,715 vol $5.35 each |
765,420 | |
Filed 2022-05-10 16:18 Tx date 2022-04-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$149,551
+27,915 vol $5.36 each |
724,705 | |
Filed 2022-05-10 16:17 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$288,385
+54,215 vol $5.32 each |
696,790 | |
Filed 2022-05-10 16:16 Tx date 2022-04-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$426,511
+80,015 vol $5.33 each |
642,575 | |
Filed 2022-05-10 16:15 Tx date 2022-04-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$239,326
+45,515 vol $5.26 each |
562,560 | |
Filed 2022-05-10 16:14 Tx date 2022-04-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$190,188
+36,515 vol $5.21 each |
517,045 | |
Filed 2022-04-27 10:27 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
8,397 | |
Filed 2022-04-27 10:26 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
4,199 | |
Filed 2022-04-27 10:24 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
4,852 | |
Filed 2022-04-27 10:23 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
2,426 | |
Filed 2022-04-27 10:21 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$24,268
+4,658 vol $5.21 each |
4,658 | |
Filed 2022-04-27 10:20 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$12,134
+2,329 vol $5.21 each |
2,329 | |
Filed 2022-01-06 16:05 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,134
+2,329 vol $5.21 each |
||
Filed 2022-01-06 16:05 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$24,268
+4,658 vol $5.21 each |
||
Filed 2022-01-06 16:03 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
||
Filed 2022-01-06 16:02 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
||
Filed 2022-01-06 16:01 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2022-01-06 16:00 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-12-10 14:04 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
||
Filed 2021-12-10 14:03 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
||
Filed 2021-12-10 14:00 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$24,268
+4,658 vol $5.21 each |
||
Filed 2021-12-10 13:58 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,134
+2,329 vol $5.21 each |
||
Filed 2021-12-10 13:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-12-10 13:51 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2021-12-10 13:41 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2022-04-17 19:16 Tx date 2022-04-13 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,070
+1,900 vol $5.30 each |
6,115 | |
Filed 2022-04-14 18:15 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,240
+1,200 vol $5.20 each |
22,700 | |
Filed 2022-04-14 17:55 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,032
+19,200 vol $5.21 each |
727,284 | |
Filed 2022-04-14 17:53 Tx date 2022-01-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,040
+18,000 vol $5.28 each |
40,500 | |
Filed 2022-04-14 17:35 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$98,990
+19,000 vol $5.21 each |
||
Filed 2022-04-14 17:34 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,032
+19,200 vol $5.21 each |
||
Filed 2022-04-14 17:02 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,032
+19,200 vol $5.21 each |
||
Filed 2022-04-14 09:47 Tx date 2020-09-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+414 vol $6.04 each |
46,128 | |
Filed 2022-04-14 09:19 Tx date 2020-09-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,918
+414 vol $7.05 each |
||
Filed 2022-01-04 22:04 Tx date 2022-01-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,040
+18,000 vol $5.28 each |
||
Filed 2021-12-06 09:25 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,200
+1,000 vol $5.20 each |
||
Filed 2021-12-06 09:24 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,032
+19,200 vol $5.21 each |
||
Filed 2022-04-13 12:34 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250,000
+25,000 vol $10.00 each |
||
Filed 2022-04-13 12:33 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360,000
+45,000 vol $8.00 each |
||
Filed 2022-04-13 12:29 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,452
+18,800 vol $5.29 each |
21,685,933 | |
Filed 2022-04-13 12:19 Tx date 2022-04-08 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$532.00
+100 vol $5.32 each |
267,764 | |
Filed 2022-04-13 12:18 Tx date 2022-04-08 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$267.00
+50 vol $5.34 each |
267,664 | |
Filed 2022-04-13 12:14 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$89,590
+17,000 vol $5.27 each |
72,714 | |
Filed 2022-01-03 18:37 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250,000
+25,000 vol $10.00 each |
||
Filed 2022-01-03 18:36 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360,000
+45,000 vol $8.00 each |
||
Filed 2021-11-22 22:19 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,220
+18,000 vol $5.29 each |
||
Filed 2021-01-13 16:05 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,699
+10,000 vol $5.27 each |
||
Filed 2022-04-08 10:54 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,120
+400 vol $5.30 each |
11,800 | |
Filed 2022-04-08 10:54 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,620
+2,000 vol $5.31 each |
11,400 | |
Filed 2022-04-08 10:54 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,942
+1,500 vol $5.29 each |
9,400 | |
Filed 2022-04-08 10:53 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,120
+400 vol $5.30 each |
7,900 | |
Filed 2022-04-08 10:53 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$531.00
+100 vol $5.31 each |
7,500 | |
Filed 2022-04-08 10:53 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,600
+2,000 vol $5.30 each |
7,400 | |
Filed 2022-04-08 10:52 Tx date 2022-04-06 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,161
+600 vol $5.27 each |
5,400 | |
Filed 2022-04-04 19:51 Tx date 2022-03-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-496,565 vol |
480,530 | |
Filed 2022-04-04 19:50 Tx date 2022-03-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$286,189
+54,915 vol $5.21 each |
977,095 | |
Filed 2022-04-04 19:50 Tx date 2022-03-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,232,478
+425,615 vol $5.25 each |
922,180 | |
Filed 2022-04-04 19:49 Tx date 2022-03-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$417,574
+80,015 vol $5.22 each |
496,565 | |
Filed 2022-04-04 19:49 Tx date 2022-03-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$413,101
+80,015 vol $5.16 each |
416,550 | |
Filed 2022-04-04 19:48 Tx date 2022-03-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$414,429
+80,015 vol $5.18 each |
336,535 | |
Filed 2022-04-04 19:47 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$421,615
+80,015 vol $5.27 each |
256,520 | |
Filed 2022-04-04 19:46 Tx date 2022-03-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$300,248
+55,615 vol $5.40 each |
176,505 | |
Filed 2022-04-04 19:46 Tx date 2022-03-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$298,161
+55,215 vol $5.40 each |
120,890 | |
Filed 2022-04-04 19:45 Tx date 2022-03-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$29,762
+5,515 vol $5.40 each |
65,675 | |
Filed 2022-04-04 19:44 Tx date 2022-03-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$72,886
+13,515 vol $5.39 each |
60,160 | |
Filed 2022-04-04 19:43 Tx date 2022-03-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$60,511
+11,215 vol $5.40 each |
46,645 | |
Filed 2022-04-04 19:43 Tx date 2022-03-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$93,417
+17,315 vol $5.40 each |
35,430 | |
Filed 2022-03-30 17:01 Tx date 2022-03-25 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-175,000
-20,000 vol $8.75 each |
120,000 | |
Filed 2022-03-30 17:00 Tx date 2022-03-25 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-175,000
-20,000 vol $8.75 each |
130,000 | |
Filed 2022-03-30 16:57 Tx date 2022-03-25 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
$-2,537,500
-290,000 vol $8.75 each |
2,179,548 | |
Filed 2022-03-30 16:52 Tx date 2022-03-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-1,181,250
-135,000 vol $8.75 each |
424,758 | |
Filed 2022-03-30 16:06 Tx date 2022-03-30 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$103,600
+20,000 vol $5.18 each |
117,429 | |
Filed 2022-03-29 11:45 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$24,346
+4,673 vol $5.21 each |
4,673 | |
Filed 2022-03-29 11:45 Tx date 2022-01-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-29 11:44 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$24,346
+4,673 vol $5.21 each |
4,673 | |
Filed 2022-03-29 11:44 Tx date 2022-01-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-29 11:43 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$24,174
+4,640 vol $5.21 each |
8,461 | |
Filed 2022-03-29 11:43 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$24,174
+4,640 vol $5.21 each |
8,461 | |
Filed 2022-03-29 11:41 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$21,876
+4,199 vol $5.21 each |
4,199 | |
Filed 2022-03-29 11:40 Tx date 2022-03-14 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-29 11:40 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$43,748
+8,397 vol $5.21 each |
8,397 | |
Filed 2022-03-29 11:39 Tx date 2022-03-14 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-29 11:39 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$74,659
+14,330 vol $5.21 each |
14,330 | |
Filed 2022-03-29 11:38 Tx date 2022-03-14 |
$GUD
Knight Therapeutics Inc. |
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-29 11:37 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$27,430
+5,265 vol $5.21 each |
11,373 | |
Filed 2022-03-29 11:36 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$54,866
+10,531 vol $5.21 each |
16,639 | |
Filed 2022-03-29 11:35 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$93,628
+17,971 vol $5.21 each |
17,971 | |
Filed 2022-03-29 11:35 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-29 11:32 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$18,683
+3,586 vol $5.21 each |
6,012 | |
Filed 2022-03-29 11:31 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$37,360
+7,171 vol $5.21 each |
12,023 | |
Filed 2022-03-29 11:30 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$63,759
+12,238 vol $5.21 each |
20,423 | |
Filed 2022-03-29 11:24 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$17,938
+3,443 vol $5.21 each |
5,772 | |
Filed 2022-03-29 11:23 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$35,876
+6,886 vol $5.21 each |
11,544 | |
Filed 2022-03-29 11:22 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$61,222
+11,751 vol $5.21 each |
19,609 | |
Filed 2022-03-29 11:21 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$22,752
+4,367 vol $5.21 each |
8,566 | |
Filed 2022-03-29 11:20 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$45,498
+8,733 vol $5.21 each |
17,130 | |
Filed 2022-03-29 11:20 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,649
+14,904 vol $5.21 each |
29,069 | |
Filed 2022-03-29 11:18 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$28,436
+5,458 vol $5.21 each |
10,181 | |
Filed 2022-03-29 11:17 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$56,877
+10,917 vol $5.21 each |
20,363 | |
Filed 2022-03-29 11:16 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$97,062
+18,630 vol $5.21 each |
35,009 | |
Filed 2022-03-29 11:14 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$48,124
+9,237 vol $5.21 each |
16,427 | |
Filed 2022-03-29 11:13 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$96,249
+18,474 vol $5.21 each |
32,855 | |
Filed 2022-03-29 11:12 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$164,255
+31,527 vol $5.21 each |
559,758 | |
Filed 2022-03-29 11:04 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$153,590
+29,480 vol $5.21 each |
2,469,548 | |
Filed 2022-03-29 10:43 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$164,255
+31,527 vol $5.21 each |
280,009 | |
Filed 2022-03-29 10:30 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$48,124
+9,237 vol $5.21 each |
16,427 | |
Filed 2022-03-29 09:43 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$96,249
+18,474 vol $5.21 each |
32,855 | |
Filed 2022-03-29 09:41 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$413,840
+79,432 vol $5.21 each |
768,819 | |
Filed 2022-03-29 09:37 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$363,751
+69,818 vol $5.21 each |
122,915 | |
Filed 2022-03-29 09:35 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$135,001
+25,912 vol $5.21 each |
66,399 | |
Filed 2022-03-28 19:47 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$135,001
+25,912 vol $5.21 each |
||
Filed 2022-03-28 19:47 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$135,001
+25,912 vol $5.21 each |
66,399 | |
Filed 2022-03-28 16:48 Tx date 2022-03-22 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,214
+2,054 vol $5.46 each |
97,429 | |
Filed 2022-03-28 16:47 Tx date 2022-03-22 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,736
+1,417 vol $5.46 each |
12,364 | |
Filed 2022-03-28 16:43 Tx date 2022-03-22 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,282
+1,700 vol $5.46 each |
123,687 | |
Filed 2022-03-28 16:39 Tx date 2022-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,273
+1,149 vol $5.46 each |
767,508 | |
Filed 2022-03-09 22:30 Tx date 2022-02-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-171,875 vol |
18,115 | |
Filed 2022-03-09 22:28 Tx date 2022-02-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$97,777
+18,115 vol $5.40 each |
189,990 | |
Filed 2022-03-09 22:27 Tx date 2022-02-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$124,907
+23,315 vol $5.36 each |
171,875 | |
Filed 2022-03-09 22:26 Tx date 2022-02-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$219,947
+40,815 vol $5.39 each |
148,560 | |
Filed 2022-03-09 22:25 Tx date 2022-02-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$130,018
+24,115 vol $5.39 each |
107,745 | |
Filed 2022-03-09 22:24 Tx date 2022-02-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$193,246
+35,815 vol $5.40 each |
83,630 | |
Filed 2022-02-10 10:03 Tx date 2022-01-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-585,335 vol |
47,815 | |
Filed 2022-02-10 10:03 Tx date 2022-01-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$256,771
+47,815 vol $5.37 each |
633,150 | |
Filed 2022-02-10 10:02 Tx date 2022-01-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-585,335 vol |
||
Filed 2022-02-10 09:37 Tx date 2022-01-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$256,771
+47,815 vol $5.37 each |
633,150 | |
Filed 2022-02-10 09:37 Tx date 2022-01-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$256,771
+47,815 vol $5.37 each |
||
Filed 2022-02-09 18:29 Tx date 2022-01-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-585,335 vol |
||
Filed 2022-02-08 17:31 Tx date 2022-01-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-633,150 vol |
||
Filed 2022-02-09 18:29 Tx date 2022-01-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-585,335 vol |
0 | |
Filed 2022-02-09 18:28 Tx date 2022-01-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$256,771
+47,815 vol $5.37 each |
||
Filed 2022-02-08 17:31 Tx date 2022-01-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-633,150 vol |
||
Filed 2022-02-08 17:31 Tx date 2022-01-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$256,771
+47,815 vol $5.37 each |
||
Filed 2022-02-08 17:31 Tx date 2022-01-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-633,150 vol |
0 | |
Filed 2022-02-08 17:31 Tx date 2022-01-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$256,771
+47,815 vol $5.37 each |
633,150 | |
Filed 2022-02-08 17:30 Tx date 2022-01-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$427,728
+80,015 vol $5.35 each |
585,335 | |
Filed 2022-02-08 17:29 Tx date 2022-01-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$426,511
+80,015 vol $5.33 each |
505,320 | |
Filed 2022-02-08 17:29 Tx date 2022-01-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$424,047
+80,015 vol $5.30 each |
425,305 | |
Filed 2022-02-08 17:28 Tx date 2022-01-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$423,327
+80,015 vol $5.29 each |
345,290 | |
Filed 2022-02-08 17:27 Tx date 2022-01-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$425,407
+80,015 vol $5.32 each |
265,275 | |
Filed 2022-02-08 17:27 Tx date 2022-01-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$413,481
+77,415 vol $5.34 each |
185,260 | |
Filed 2022-02-08 17:26 Tx date 2022-01-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$226,152
+41,915 vol $5.40 each |
107,845 | |
Filed 2022-02-08 17:25 Tx date 2022-01-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$77,732
+14,415 vol $5.39 each |
65,930 | |
Filed 2022-02-08 17:24 Tx date 2022-01-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$143,680
+26,815 vol $5.36 each |
51,515 | |
Filed 2022-02-08 17:23 Tx date 2022-01-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$131,317
+24,700 vol $5.32 each |
24,700 | |
Filed 2022-01-28 10:51 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,220
+18,000 vol $5.29 each |
21,685,133 | |
Filed 2021-11-22 16:52 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,220
+18,000 vol $5.29 each |
||
Filed 2022-01-19 14:29 Tx date 2021-11-19 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$80,850
+15,000 vol $5.39 each |
260,614 | |
Filed 2021-11-19 13:52 Tx date 2021-11-19 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$80,850
+15,000 vol $5.39 each |
||
Filed 2022-01-06 21:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$43,053
+8,185 vol $5.26 each |
8,185 | |
Filed 2022-01-06 21:51 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,333
+7,858 vol $5.26 each |
7,858 | |
Filed 2022-01-06 21:49 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$74,507
+14,165 vol $5.26 each |
14,165 | |
Filed 2022-01-06 16:05 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,134
+2,329 vol $5.21 each |
2,329 | |
Filed 2022-01-06 16:05 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$24,268
+4,658 vol $5.21 each |
4,658 | |
Filed 2022-01-06 16:03 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
4,199 | |
Filed 2022-01-06 16:02 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
8,397 | |
Filed 2022-01-06 16:01 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
4,852 | |
Filed 2022-01-06 16:00 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
2,426 | |
Filed 2022-01-06 15:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
||
Filed 2022-01-06 15:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
8,888 | |
Filed 2022-01-06 15:50 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,883
+8,533 vol $5.26 each |
8,533 | |
Filed 2022-01-06 15:50 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,883
+8,533 vol $5.26 each |
||
Filed 2022-01-06 15:48 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,904
+15,381 vol $5.26 each |
15,381 | |
Filed 2022-01-06 15:48 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,904
+15,381 vol $5.26 each |
||
Filed 2021-12-10 14:04 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
||
Filed 2021-12-10 14:03 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
||
Filed 2021-12-10 14:01 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,904
+15,381 vol $5.26 each |
||
Filed 2021-12-10 14:01 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,904
+15,381 vol $5.26 each |
||
Filed 2021-12-10 14:00 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$24,268
+4,658 vol $5.21 each |
||
Filed 2021-12-10 13:58 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,134
+2,329 vol $5.21 each |
||
Filed 2021-12-10 13:55 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,883
+8,533 vol $5.26 each |
||
Filed 2021-12-10 13:55 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,883
+8,533 vol $5.26 each |
||
Filed 2021-12-10 13:53 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
||
Filed 2021-12-10 13:53 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
||
Filed 2021-12-10 13:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-12-10 13:51 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
||
Filed 2021-12-10 13:41 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2022-01-05 20:29 Tx date 2021-12-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,021,080 vol |
0 | |
Filed 2022-01-05 20:28 Tx date 2021-12-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$170,146
+32,415 vol $5.25 each |
1,021,080 | |
Filed 2022-01-05 20:27 Tx date 2021-12-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$105,315
+20,100 vol $5.24 each |
988,665 | |
Filed 2022-01-05 20:27 Tx date 2021-12-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$234,346
+44,715 vol $5.24 each |
968,565 | |
Filed 2022-01-05 20:26 Tx date 2021-12-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$161,253
+30,515 vol $5.28 each |
923,850 | |
Filed 2022-01-05 20:25 Tx date 2021-12-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$151,823
+28,915 vol $5.25 each |
893,335 | |
Filed 2022-01-05 20:25 Tx date 2021-12-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$218,373
+41,715 vol $5.23 each |
864,420 | |
Filed 2022-01-05 20:24 Tx date 2021-12-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$135,753
+25,915 vol $5.24 each |
822,705 | |
Filed 2022-01-05 20:23 Tx date 2021-12-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$298,529
+57,415 vol $5.20 each |
716,775 | |
Filed 2022-01-05 20:22 Tx date 2021-12-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$419,454
+80,015 vol $5.24 each |
796,790 | |
Filed 2022-01-05 20:21 Tx date 2021-12-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$415,629
+80,015 vol $5.19 each |
659,360 | |
Filed 2022-01-05 20:19 Tx date 2021-12-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$311,738
+59,615 vol $5.23 each |
579,345 | |
Filed 2022-01-05 20:19 Tx date 2021-12-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$54,623
+10,400 vol $5.25 each |
519,730 | |
Filed 2022-01-05 20:18 Tx date 2021-12-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$190,072
+36,315 vol $5.23 each |
509,330 | |
Filed 2022-01-05 20:17 Tx date 2021-12-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$389,646
+74,615 vol $5.22 each |
473,015 | |
Filed 2022-01-05 20:16 Tx date 2021-12-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$418,960
+80,000 vol $5.24 each |
398,400 | |
Filed 2022-01-05 20:15 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$294,313
+56,200 vol $5.24 each |
318,400 | |
Filed 2022-01-05 20:14 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$353,692
+67,800 vol $5.22 each |
262,200 | |
Filed 2022-01-05 20:13 Tx date 2021-12-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$286,437
+54,600 vol $5.25 each |
194,400 | |
Filed 2022-01-05 20:12 Tx date 2021-12-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$362,241
+68,900 vol $5.26 each |
139,800 | |
Filed 2022-01-04 22:04 Tx date 2022-01-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,040
+18,000 vol $5.28 each |
59,700 | |
Filed 2022-01-04 14:06 Tx date 2022-01-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,883
+1,300 vol $5.29 each |
766,359 | |
Filed 2022-01-03 21:27 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,260
+1,000 vol $5.26 each |
21,667,133 | |
Filed 2022-01-03 18:46 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,280
+1,000 vol $5.28 each |
21,667,133 | |
Filed 2022-01-03 18:46 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,280
+1,000 vol $5.28 each |
||
Filed 2022-01-03 18:45 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,699
+10,000 vol $5.27 each |
21,666,133 | |
Filed 2022-01-03 18:44 Tx date 2021-01-06 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,058
+200 vol $5.29 each |
21,656,133 | |
Filed 2022-01-03 18:44 Tx date 2020-12-08 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$53,300
+10,000 vol $5.33 each |
21,655,933 | |
Filed 2022-01-03 18:43 Tx date 2020-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,250
+2,500 vol $5.30 each |
21,645,933 | |
Filed 2022-01-03 18:42 Tx date 2020-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$53,300
+10,000 vol $5.33 each |
21,643,433 | |
Filed 2022-01-03 18:41 Tx date 2019-06-21 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$91,080
+12,000 vol $7.59 each |
21,633,433 | |
Filed 2022-01-03 18:40 Tx date 2019-05-21 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$73,900
+10,000 vol $7.39 each |
21,621,433 | |
Filed 2022-01-03 18:39 Tx date 2019-03-26 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,650
+5,000 vol $7.33 each |
21,611,433 | |
Filed 2022-01-03 18:38 Tx date 2019-03-25 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$96,888
+13,200 vol $7.34 each |
21,606,433 | |
Filed 2022-01-03 18:37 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250,000
+25,000 vol $10.00 each |
21,593,233 | |
Filed 2022-01-03 18:36 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360,000
+45,000 vol $8.00 each |
21,568,233 | |
Filed 2021-12-23 15:44 Tx date 2021-12-23 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,864
+3,600 vol $5.24 each |
765,059 | |
Filed 2021-12-17 18:27 Tx date 2021-12-15 |
$GUD
Knight Therapeutics Inc. |
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,996
+1,915 vol $5.22 each |
1,915 | |
Filed 2021-12-17 18:26 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-17 18:24 Tx date 2021-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,470
+2,389 vol $5.22 each |
95,375 | |
Filed 2021-12-17 18:23 Tx date 2021-12-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,831
+734 vol $5.22 each |
10,947 | |
Filed 2021-12-17 18:21 Tx date 2021-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,278
+1,969 vol $5.22 each |
121,987 | |
Filed 2021-12-17 18:19 Tx date 2021-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,699
+1,475 vol $5.22 each |
761,459 | |
Filed 2021-12-15 14:45 Tx date 2021-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$93,060
+18,000 vol $5.17 each |
759,984 | |
Filed 2021-12-14 15:49 Tx date 2021-12-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$147,345
+28,500 vol $5.17 each |
741,984 | |
Filed 2021-12-14 15:49 Tx date 2021-12-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,972
+5,400 vol $5.18 each |
713,484 | |
Filed 2021-12-14 14:00 Tx date 2021-12-14 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,840
+9,200 vol $5.20 each |
92,986 | |
Filed 2021-12-13 21:58 Tx date 2021-12-13 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$82,160
+15,800 vol $5.20 each |
83,786 | |
Filed 2021-12-10 14:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
528,231 | |
Filed 2021-12-10 14:09 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
248,482 | |
Filed 2021-12-10 14:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,374 vol |
689,387 | |
Filed 2021-12-10 14:06 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
2,440,068 | |
Filed 2021-12-10 14:04 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$43,748
+8,397 vol $5.21 each |
8,397 | |
Filed 2021-12-10 14:03 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-10 14:03 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$21,876
+4,199 vol $5.21 each |
4,199 | |
Filed 2021-12-10 14:02 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-10 14:01 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,904
+15,381 vol $5.26 each |
15,381 | |
Filed 2021-12-10 14:01 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-10 14:00 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$24,268
+4,658 vol $5.21 each |
4,658 | |
Filed 2021-12-10 13:59 Tx date 2021-09-13 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-10 13:58 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,134
+2,329 vol $5.21 each |
2,329 | |
Filed 2021-12-10 13:56 Tx date 2021-09-13 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-10 13:55 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,883
+8,533 vol $5.26 each |
8,533 | |
Filed 2021-12-10 13:54 Tx date 2021-09-13 |
$GUD
Knight Therapeutics Inc. |
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-10 13:53 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,750
+8,888 vol $5.26 each |
8,888 | |
Filed 2021-12-10 13:52 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
2,426 | |
Filed 2021-12-10 13:51 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$25,278
+4,852 vol $5.21 each |
4,852 | |
Filed 2021-12-10 13:49 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-10 13:41 Tx date 2021-12-06 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$12,639
+2,426 vol $5.21 each |
||
Filed 2021-12-10 13:28 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-10 13:26 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-12-10 13:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
||
Filed 2021-12-10 13:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
528,231 | |
Filed 2021-12-10 13:09 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
||
Filed 2021-12-10 13:09 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
248,482 | |
Filed 2021-12-10 13:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
||
Filed 2021-12-10 13:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
2,440,068 | |
Filed 2021-12-10 13:06 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,374 vol |
||
Filed 2021-12-10 13:06 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,374 vol |
689,387 | |
Filed 2021-12-10 13:01 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
||
Filed 2021-12-10 13:01 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,798 vol |
||
Filed 2021-05-20 12:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 12:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 12:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 12:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 12:32 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
Filed 2021-05-20 12:32 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
Filed 2021-05-20 12:17 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
Filed 2021-05-20 12:17 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
Filed 2021-05-20 11:16 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 11:16 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 11:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 11:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 10:55 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
Filed 2021-05-20 10:55 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
Filed 2021-05-20 10:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
Filed 2021-05-20 10:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
Filed 2021-12-09 18:42 Tx date 2021-11-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$190,022
+35,705 vol $5.32 each |
3,267,170 | |
Filed 2021-12-06 21:32 Tx date 2021-11-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$190,022
+35,705 vol $5.32 each |
||
Filed 2021-12-06 21:35 Tx date 2021-11-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-3,287,670 vol |
70,900 | |
Filed 2021-12-06 21:34 Tx date 2021-11-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$224,980
+42,900 vol $5.24 each |
3,358,570 | |
Filed 2021-12-06 21:33 Tx date 2021-11-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$148,033
+28,000 vol $5.29 each |
3,315,670 | |
Filed 2021-12-06 21:32 Tx date 2021-11-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$108,574
+20,500 vol $5.30 each |
3,287,670 | |
Filed 2021-12-06 21:32 Tx date 2021-11-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$190,022
+35,705 vol $5.32 each |
3,267,170 | |
Filed 2021-12-06 21:31 Tx date 2021-11-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$285,676
+54,000 vol $5.29 each |
3,231,465 | |
Filed 2021-12-06 21:30 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$205,841
+39,100 vol $5.26 each |
3,177,465 | |
Filed 2021-12-06 21:30 Tx date 2021-11-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$374,267
+70,215 vol $5.33 each |
3,138,365 | |
Filed 2021-12-06 21:29 Tx date 2021-11-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$145,829
+27,315 vol $5.34 each |
3,068,150 | |
Filed 2021-12-06 21:28 Tx date 2021-11-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$230,111
+43,215 vol $5.32 each |
3,040,835 | |
Filed 2021-12-06 21:27 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,336,235
+2,151,170 vol $5.27 each |
2,997,620 | |
Filed 2021-12-06 21:27 Tx date 2021-11-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$28,350
+5,400 vol $5.25 each |
846,450 | |
Filed 2021-12-06 21:26 Tx date 2021-11-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$413,151
+78,715 vol $5.25 each |
841,050 | |
Filed 2021-12-06 21:25 Tx date 2021-11-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$169,246
+32,315 vol $5.24 each |
762,335 | |
Filed 2021-12-06 21:24 Tx date 2021-11-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$69,895
+13,315 vol $5.25 each |
730,020 | |
Filed 2021-12-06 21:23 Tx date 2021-11-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$91,980
+17,615 vol $5.22 each |
716,705 | |
Filed 2021-12-06 21:23 Tx date 2021-11-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$348,836
+67,115 vol $5.20 each |
699,090 | |
Filed 2021-12-06 21:22 Tx date 2021-11-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,387,089
+266,415 vol $5.21 each |
631,975 | |
Filed 2021-12-06 21:21 Tx date 2021-11-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$983,905
+189,515 vol $5.19 each |
365,560 | |
Filed 2021-12-06 21:20 Tx date 2021-11-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$199,067
+38,115 vol $5.22 each |
176,045 | |
Filed 2021-12-06 09:25 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,200
+1,000 vol $5.20 each |
41,700 | |
Filed 2021-12-06 09:24 Tx date 2021-12-03 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,032
+19,200 vol $5.21 each |
40,700 | |
Filed 2021-11-24 10:04 Tx date 2021-11-23 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$183,573
+35,100 vol $5.23 each |
708,084 | |
Filed 2021-11-24 10:01 Tx date 2021-11-23 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,375
+7,500 vol $5.25 each |
67,986 | |
Filed 2021-11-22 22:19 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,220
+18,000 vol $5.29 each |
21,685,133 | |
Filed 2021-11-22 16:55 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,184
+800 vol $5.23 each |
672,984 | |
Filed 2021-11-22 16:52 Tx date 2021-11-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,220
+18,000 vol $5.29 each |
21,541,233 | |
Filed 2021-11-19 18:02 Tx date 2021-11-16 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$34,130
+6,300 vol $5.42 each |
245,614 | |
Filed 2021-11-19 18:01 Tx date 2021-11-16 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,459
+3,600 vol $5.41 each |
239,314 | |
Filed 2021-11-19 17:48 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,375
+10,000 vol $5.24 each |
235,714 | |
Filed 2021-11-19 17:48 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$132,187
+25,000 vol $5.29 each |
225,714 | |
Filed 2021-11-19 17:48 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$132,187
+25,000 vol $5.29 each |
200,714 | |
Filed 2021-11-19 17:47 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,157
+13,300 vol $5.28 each |
175,614 | |
Filed 2021-11-19 17:46 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,250
+10,000 vol $5.22 each |
105,714 | |
Filed 2021-11-19 17:45 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,375
+10,000 vol $5.24 each |
||
Filed 2021-11-19 17:44 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$132,187
+25,000 vol $5.29 each |
||
Filed 2021-11-19 17:44 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$132,187
+25,000 vol $5.29 each |
||
Filed 2021-11-19 17:43 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,157
+13,300 vol $5.28 each |
||
Filed 2021-11-19 17:42 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,250
+10,000 vol $5.22 each |
||
Filed 2021-11-19 13:55 Tx date 2021-11-16 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$34,146
+6,300 vol $5.42 each |
||
Filed 2021-11-19 13:55 Tx date 2021-11-16 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$34,146
+6,300 vol $5.42 each |
245,614 | |
Filed 2021-11-19 13:55 Tx date 2021-11-16 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,476
+3,600 vol $5.41 each |
239,314 | |
Filed 2021-11-19 13:55 Tx date 2021-11-16 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,476
+3,600 vol $5.41 each |
||
Filed 2021-11-19 13:52 Tx date 2021-11-19 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$80,850
+15,000 vol $5.39 each |
260,614 | |
Filed 2021-11-19 13:45 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,400
+10,000 vol $5.24 each |
235,714 | |
Filed 2021-11-19 13:45 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,400
+10,000 vol $5.24 each |
||
Filed 2021-11-19 13:45 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$132,250
+25,000 vol $5.29 each |
225,714 | |
Filed 2021-11-19 13:45 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$132,250
+25,000 vol $5.29 each |
||
Filed 2021-11-19 13:44 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$132,250
+25,000 vol $5.29 each |
||
Filed 2021-11-19 13:44 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$132,250
+25,000 vol $5.29 each |
200,714 | |
Filed 2021-11-19 13:44 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$528.00
+100 vol $5.28 each |
175,714 | |
Filed 2021-11-19 13:44 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,224
+13,300 vol $5.28 each |
||
Filed 2021-11-19 13:44 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,224
+13,300 vol $5.28 each |
175,614 | |
Filed 2021-11-19 13:43 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,275
+3,100 vol $5.25 each |
162,314 | |
Filed 2021-11-19 13:43 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,875
+13,500 vol $5.25 each |
159,214 | |
Filed 2021-11-19 13:43 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$210,000
+40,000 vol $5.25 each |
145,714 | |
Filed 2021-11-19 13:42 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,300
+10,000 vol $5.23 each |
||
Filed 2021-11-19 13:42 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,300
+10,000 vol $5.23 each |
105,714 | |
Filed 2021-11-19 13:41 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,000
+10,000 vol $5.20 each |
95,714 | |
Filed 2021-11-19 13:30 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$94,320
+18,000 vol $5.24 each |
672,184 | |
Filed 2021-11-15 14:23 Tx date 2021-11-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$94,500
+18,000 vol $5.25 each |
654,184 | |
Filed 2021-11-09 10:17 Tx date 2021-10-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-168,675 vol |
137,930 | |
Filed 2021-11-07 19:16 Tx date 2021-10-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-306,605 vol |
||
Filed 2021-11-07 19:16 Tx date 2021-10-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-306,605 vol |
0 | |
Filed 2021-11-07 19:12 Tx date 2021-10-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,250
+1,000 vol $5.25 each |
23,415 | |
Filed 2021-11-07 19:07 Tx date 2021-10-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$297,144
+57,915 vol $5.13 each |
306,605 | |
Filed 2021-11-07 19:07 Tx date 2021-10-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$415,653
+80,015 vol $5.19 each |
248,690 | |
Filed 2021-11-07 19:06 Tx date 2021-10-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$417,046
+80,015 vol $5.21 each |
168,675 | |
Filed 2021-11-07 19:05 Tx date 2021-10-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$286,614
+54,615 vol $5.25 each |
88,660 | |
Filed 2021-11-07 19:04 Tx date 2021-10-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$32,079
+6,115 vol $5.25 each |
34,045 | |
Filed 2021-11-07 19:03 Tx date 2021-10-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,703
+4,515 vol $5.25 each |
27,930 | |
Filed 2021-11-07 19:03 Tx date 2021-10-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
$5,250
+1,000 vol $5.25 each |
||
Filed 2021-11-07 19:02 Tx date 2021-10-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$117,636
+22,415 vol $5.25 each |
22,415 | |
Filed 2021-10-06 12:42 Tx date 2021-09-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$38,398
+7,315 vol $5.25 each |
7,315 | |
Filed 2021-10-06 12:40 Tx date 2021-09-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,244
+6,915 vol $5.24 each |
231,990 | |
Filed 2021-10-06 12:39 Tx date 2021-09-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$298,785
+57,115 vol $5.23 each |
225,075 | |
Filed 2021-10-06 12:39 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$417,886
+80,015 vol $5.22 each |
167,960 | |
Filed 2021-10-06 12:39 Tx date 2021-09-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$418,502
+80,015 vol $5.23 each |
87,945 | |
Filed 2021-10-06 12:38 Tx date 2021-09-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,219
+615 vol $5.24 each |
7,930 | |
Filed 2021-10-06 12:38 Tx date 2021-09-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$38,398
+7,315 vol $5.25 each |
||
Filed 2021-10-06 12:34 Tx date 2021-09-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-231,990 vol |
0 | |
Filed 2021-10-06 12:30 Tx date 2021-09-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,244
+6,915 vol $5.24 each |
||
Filed 2021-10-06 12:29 Tx date 2021-09-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$298,785
+57,115 vol $5.23 each |
||
Filed 2021-10-06 12:28 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$417,886
+80,015 vol $5.22 each |
||
Filed 2021-10-06 12:27 Tx date 2021-09-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$418,502
+80,015 vol $5.23 each |
||
Filed 2021-10-06 12:26 Tx date 2021-09-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,219
+615 vol $5.24 each |
||
Filed 2021-10-06 12:25 Tx date 2021-09-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$38,398
+7,315 vol $5.25 each |
||
Filed 2021-09-21 16:46 Tx date 2021-09-21 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,560
+300 vol $5.20 each |
10,213 | |
Filed 2021-09-20 17:14 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,120
+600 vol $5.20 each |
9,913 | |
Filed 2021-09-20 12:30 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Noah Ezra Goodman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,036
+200 vol $5.18 each |
300 | |
Filed 2021-09-20 11:38 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$526.00
+100 vol $5.26 each |
4,800 | |
Filed 2021-09-20 11:37 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$518.00
+100 vol $5.18 each |
4,700 | |
Filed 2021-09-20 11:37 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,036
+200 vol $5.18 each |
4,600 | |
Filed 2021-09-20 11:36 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$518.00
+100 vol $5.18 each |
4,400 | |
Filed 2021-09-20 11:36 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,554
+300 vol $5.18 each |
4,300 | |
Filed 2021-09-20 11:36 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$518.00
+100 vol $5.18 each |
4,000 | |
Filed 2021-09-20 11:36 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,036
+200 vol $5.18 each |
3,900 | |
Filed 2021-09-20 11:35 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,036
+200 vol $5.18 each |
3,700 | |
Filed 2021-09-20 11:34 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,036
+200 vol $5.18 each |
3,500 | |
Filed 2021-09-20 11:34 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$518.00
+100 vol $5.18 each |
3,300 | |
Filed 2021-09-20 11:34 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,036
+200 vol $5.18 each |
3,200 | |
Filed 2021-09-20 11:33 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,360
+2,000 vol $5.18 each |
3,000 | |
Filed 2021-09-20 11:33 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,136
+800 vol $5.17 each |
1,000 | |
Filed 2021-09-20 11:33 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$517.00
+100 vol $5.17 each |
200 | |
Filed 2021-09-20 11:32 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$517.00
+100 vol $5.17 each |
100 | |
Filed 2021-09-20 11:31 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-20 11:28 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$103,600
+20,000 vol $5.18 each |
21,500 | |
Filed 2021-09-17 17:47 Tx date 2021-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,754
+2,402 vol $5.31 each |
60,486 | |
Filed 2021-09-17 17:44 Tx date 2021-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,651
+876 vol $5.31 each |
9,313 | |
Filed 2021-09-17 17:43 Tx date 2021-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,535
+1,984 vol $5.31 each |
120,018 | |
Filed 2021-09-17 17:40 Tx date 2021-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,598
+1,996 vol $5.31 each |
636,184 | |
Filed 2021-09-15 09:49 Tx date 2021-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+2,000 vol $5.25 each |
58,084 | |
Filed 2021-09-06 14:11 Tx date 2021-08-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$408,468
+80,015 vol $5.10 each |
213,845 | |
Filed 2021-09-06 14:07 Tx date 2021-08-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-645,150 vol |
0 | |
Filed 2021-09-06 14:05 Tx date 2021-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$283,599
+55,115 vol $5.15 each |
645,150 | |
Filed 2021-09-06 14:04 Tx date 2021-08-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$377,670
+72,215 vol $5.23 each |
590,035 | |
Filed 2021-09-06 14:03 Tx date 2021-08-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$197,117
+37,615 vol $5.24 each |
517,820 | |
Filed 2021-09-06 14:03 Tx date 2021-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$176,235
+33,715 vol $5.23 each |
480,205 | |
Filed 2021-09-06 14:01 Tx date 2021-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$375,194
+72,615 vol $5.17 each |
446,490 | |
Filed 2021-09-06 14:00 Tx date 2021-08-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$411,725
+80,015 vol $5.15 each |
373,875 | |
Filed 2021-09-06 13:59 Tx date 2021-08-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$406,460
+80,015 vol $5.08 each |
293,860 | |
Filed 2021-09-03 17:16 Tx date 2021-08-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$408,468
+80,015 vol $5.10 each |
||
Filed 2021-09-03 17:16 Tx date 2021-08-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$408,468
+80,015 vol $5.10 each |
213,845 | |
Filed 2021-09-03 09:24 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Lodola de San Martin, Nicolas Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
3,968 | ||
Filed 2021-09-03 09:23 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Lodola de San Martin, Nicolas Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
3,968 | ||
Filed 2021-09-03 09:21 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
3,821 | ||
Filed 2021-09-03 09:20 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
3,821 | ||
Filed 2021-09-03 09:19 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bertasi, Fernanda Pollo
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
4,100 | ||
Filed 2021-09-03 09:18 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bertasi, Fernanda Pollo
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
4,100 | ||
Filed 2021-09-03 09:12 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
4,723 | ||
Filed 2021-09-03 09:11 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
9,446 | ||
Filed 2021-09-03 09:10 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
2,653 | ||
Filed 2021-09-03 09:07 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
2,653 | ||
Filed 2021-09-02 16:31 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 16:29 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Lodola de San Martin, Nicolas Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 16:27 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 16:26 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bertasi, Fernanda Pollo
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 16:25 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 16:24 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 16:21 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Lodola de San Martin, Nicolas Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 16:19 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 16:18 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bertasi, Fernanda Pollo
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 16:15 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-02 18:24 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,400 | ||
Filed 2021-09-02 18:21 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
16,379 | ||
Filed 2021-09-02 16:31 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
2,654 | ||
Filed 2021-09-02 16:30 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
6,108 | ||
Filed 2021-09-02 16:29 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Lodola de San Martin, Nicolas Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
3,969 | ||
Filed 2021-09-02 16:27 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
3,822 | ||
Filed 2021-09-02 16:26 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bertasi, Fernanda Pollo
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
4,101 | ||
Filed 2021-09-02 16:25 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
4,724 | ||
Filed 2021-09-02 16:24 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
2,654 | ||
Filed 2021-09-02 16:22 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
6,108 | ||
Filed 2021-09-02 16:21 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Lodola de San Martin, Nicolas Maria
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
3,969 | ||
Filed 2021-09-02 16:19 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
3,822 | ||
Filed 2021-09-02 16:18 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Bertasi, Fernanda Pollo
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
4,101 | ||
Filed 2021-09-02 16:15 Tx date 2021-09-01 |
$GUD
Knight Therapeutics Inc. |
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
9,447 | ||
Filed 2021-08-25 12:02 Tx date 2021-08-24 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,066
+200 vol $5.33 each |
634,188 | |
Filed 2021-08-24 11:20 Tx date 2021-08-24 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,748
+2,200 vol $5.34 each |
633,988 | |
Filed 2021-08-23 20:24 Tx date 2021-08-23 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,048
+4,300 vol $5.36 each |
631,788 | |
Filed 2021-08-18 14:20 Tx date 2021-08-18 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$109,800
+20,000 vol $5.49 each |
85,714 | |
Filed 2021-08-18 14:16 Tx date 2021-08-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,084
+1,500 vol $5.39 each |
1,500 | |
Filed 2021-08-18 14:15 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Dana Caplan (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-08-18 14:13 Tx date 2021-08-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$97,200
+18,000 vol $5.40 each |
627,488 | |
Filed 2021-08-18 14:12 Tx date 2021-08-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$97,020
+18,000 vol $5.39 each |
609,488 | |
Filed 2021-08-04 20:03 Tx date 2021-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,562,727 vol |
133,830 | |
Filed 2021-08-04 20:03 Tx date 2021-07-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$451,446
+86,345 vol $5.23 each |
844,325 | |
Filed 2021-08-04 20:02 Tx date 2021-07-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$450,444
+86,345 vol $5.22 each |
757,980 | |
Filed 2021-08-04 20:01 Tx date 2021-07-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$452,965
+86,345 vol $5.25 each |
671,635 | |
Filed 2021-08-04 20:00 Tx date 2021-07-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$323,709
+61,700 vol $5.25 each |
585,290 | |
Filed 2021-08-04 19:59 Tx date 2021-07-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,925
+1,700 vol $5.25 each |
523,590 | |
Filed 2021-08-04 19:58 Tx date 2021-07-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$236,152
+45,045 vol $5.24 each |
521,890 | |
Filed 2021-08-04 19:55 Tx date 2021-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$409,980
+80,015 vol $5.12 each |
2,375,822 | |
Filed 2021-08-04 19:54 Tx date 2021-07-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$271,189
+53,815 vol $5.04 each |
2,295,807 | |
Filed 2021-08-04 19:48 Tx date 2021-07-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$216,889
+42,715 vol $5.08 each |
2,241,992 | |
Filed 2021-08-04 19:47 Tx date 2021-07-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$192,078
+37,715 vol $5.09 each |
2,199,277 | |
Filed 2021-08-04 19:44 Tx date 2021-07-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$300,860
+58,515 vol $5.14 each |
2,161,562 | |
Filed 2021-08-04 19:42 Tx date 2021-07-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$278,996
+54,415 vol $5.13 each |
2,103,047 | |
Filed 2021-08-04 19:41 Tx date 2021-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$411,429
+80,015 vol $5.14 each |
2,048,632 | |
Filed 2021-08-04 19:39 Tx date 2021-07-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,933,683
+760,882 vol $5.17 each |
1,968,617 | |
Filed 2021-08-04 19:37 Tx date 2021-07-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$411,437
+80,015 vol $5.14 each |
1,207,735 | |
Filed 2021-08-04 19:35 Tx date 2021-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$408,076
+80,015 vol $5.10 each |
1,127,720 | |
Filed 2021-08-04 19:34 Tx date 2021-07-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,751,603
+524,115 vol $5.25 each |
1,047,705 | |
Filed 2021-07-14 20:28 Tx date 2021-07-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,400
+18,000 vol $5.30 each |
591,488 | |
Filed 2021-07-07 15:30 Tx date 2021-07-07 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$94,320
+18,000 vol $5.24 each |
573,488 | |
Filed 2021-07-02 19:06 Tx date 2021-06-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-196,770 vol |
476,845 | |
Filed 2021-07-02 18:55 Tx date 2021-06-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$348,158
+66,345 vol $5.25 each |
673,615 | |
Filed 2021-07-02 18:50 Tx date 2021-06-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,155,125
+410,500 vol $5.25 each |
607,270 | |
Filed 2021-07-02 18:49 Tx date 2021-06-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$79,179
+15,100 vol $5.24 each |
196,770 | |
Filed 2021-07-02 18:47 Tx date 2021-06-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$188,168
+35,845 vol $5.25 each |
181,670 | |
Filed 2021-07-02 18:46 Tx date 2021-06-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,066
+6,300 vol $5.25 each |
145,825 | |
Filed 2021-07-02 18:44 Tx date 2021-06-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$142,800
+27,200 vol $5.25 each |
139,525 | |
Filed 2021-07-02 18:42 Tx date 2021-06-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$97,361
+18,545 vol $5.25 each |
112,325 | |
Filed 2021-07-02 18:40 Tx date 2021-06-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$98,353
+18,745 vol $5.25 each |
93,780 | |
Filed 2021-07-02 18:39 Tx date 2021-06-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$360,152
+68,645 vol $5.25 each |
75,035 | |
Filed 2021-07-02 18:37 Tx date 2021-06-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$28,056
+5,345 vol $5.25 each |
6,390 | |
Filed 2021-07-02 18:34 Tx date 2021-06-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,486
+1,045 vol $5.25 each |
1,045 | |
Filed 2021-07-02 17:03 Tx date 2021-07-02 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,956
+1,900 vol $5.24 each |
56,084 | |
Filed 2021-07-02 17:00 Tx date 2021-07-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$94,320
+18,000 vol $5.24 each |
555,488 | |
Filed 2021-06-18 19:53 Tx date 2021-06-15 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,996
+1,915 vol $5.22 each |
4,215 | |
Filed 2021-06-18 19:52 Tx date 2021-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,529
+1,998 vol $5.27 each |
54,184 | |
Filed 2021-06-18 19:51 Tx date 2021-06-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,857
+732 vol $5.27 each |
8,437 | |
Filed 2021-06-18 19:49 Tx date 2021-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,795
+1,669 vol $5.27 each |
118,034 | |
Filed 2021-06-18 19:47 Tx date 2021-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,047
+1,527 vol $5.27 each |
537,488 | |
Filed 2021-06-08 16:12 Tx date 2021-05-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-163,835 vol |
0 | |
Filed 2021-06-08 16:09 Tx date 2021-05-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$333,781
+63,845 vol $5.23 each |
163,835 | |
Filed 2021-06-08 16:07 Tx date 2021-05-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$388,445
+74,345 vol $5.22 each |
99,990 | |
Filed 2021-06-08 16:04 Tx date 2021-05-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$132,187
+25,645 vol $5.15 each |
25,645 | |
Filed 2021-05-27 11:18 Tx date 2021-05-27 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,430
+2,000 vol $5.21 each |
2,000 | |
Filed 2021-05-27 11:15 Tx date 2019-05-07 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-26 15:04 Tx date 2021-05-26 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,015
+1,915 vol $5.23 each |
52,186 | |
Filed 2021-05-26 11:27 Tx date 2021-05-26 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$176,400
+33,600 vol $5.25 each |
535,961 | |
Filed 2021-05-26 11:08 Tx date 2021-05-25 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,600
+2,400 vol $5.25 each |
502,361 | |
Filed 2021-05-26 10:43 Tx date 2021-05-26 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$176,400
+33,600 vol $5.25 each |
||
Filed 2021-05-26 10:43 Tx date 2021-05-26 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$176,400
+33,600 vol $5.25 each |
536,261 | |
Filed 2021-05-26 10:41 Tx date 2021-05-25 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,175
+2,700 vol $5.25 each |
502,661 | |
Filed 2021-05-26 10:41 Tx date 2021-05-25 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,175
+2,700 vol $5.25 each |
||
Filed 2021-05-24 15:40 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
Filed 2021-05-24 15:38 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
Filed 2021-05-24 15:37 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
Filed 2021-05-24 15:35 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
Filed 2021-05-24 15:34 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$45,002
+7,965 vol $5.65 each |
7,965 | |
Filed 2021-05-24 15:33 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$299,998
+53,097 vol $5.65 each |
53,097 | |
Filed 2021-05-24 15:32 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$228,751
+40,487 vol $5.65 each |
40,487 | |
Filed 2021-05-24 15:30 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$81,252
+14,381 vol $5.65 each |
14,381 | |
Filed 2021-05-24 15:29 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$40,623
+7,190 vol $5.65 each |
7,190 | |
Filed 2021-05-24 15:27 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$81,252
+14,381 vol $5.65 each |
14,381 | |
Filed 2021-05-24 15:25 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$40,623
+7,190 vol $5.65 each |
7,190 | |
Filed 2021-05-20 13:15 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
Filed 2021-05-20 13:13 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
Filed 2021-05-20 13:11 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
Filed 2021-05-20 13:04 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
Filed 2021-05-20 13:01 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$45,002
+7,965 vol $5.65 each |
||
Filed 2021-05-20 12:57 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
||
Filed 2021-05-20 12:54 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
||
Filed 2021-05-20 12:47 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
||
Filed 2021-05-20 12:46 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
||
Filed 2021-05-20 12:36 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$299,998
+53,097 vol $5.65 each |
||
Filed 2021-05-20 11:33 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$228,751
+40,487 vol $5.65 each |
||
Filed 2021-05-20 11:31 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
Filed 2021-05-20 11:30 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
Filed 2021-05-20 11:29 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
Filed 2021-05-20 11:27 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
Filed 2021-05-20 11:24 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$45,002
+7,965 vol $5.65 each |
||
Filed 2021-05-20 11:19 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
||
Filed 2021-05-20 11:18 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
||
Filed 2021-05-20 11:12 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
||
Filed 2021-05-20 11:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
||
Filed 2021-05-20 10:57 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$299,998
+53,097 vol $5.65 each |
||
Filed 2021-05-20 10:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
+40,487 vol |
||
Filed 2021-05-20 13:15 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
Filed 2021-05-20 13:14 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 13:13 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
Filed 2021-05-20 13:13 Tx date 2019-05-07 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 13:11 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
Filed 2021-05-20 13:11 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 13:10 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 13:06 Tx date 2014-08-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,000 vol |
85,000 | |
Filed 2021-05-20 13:04 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
Filed 2021-05-20 13:04 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 13:03 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
Filed 2021-05-20 13:01 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$45,002
+7,965 vol $5.65 each |
7,965 | |
Filed 2021-05-20 13:00 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 12:59 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
Filed 2021-05-20 12:57 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
14,381 | |
Filed 2021-05-20 12:56 Tx date 2014-08-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 12:54 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
7,190 | |
Filed 2021-05-20 12:53 Tx date 2014-08-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 12:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
528,238 | |
Filed 2021-05-20 12:47 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
7,190 | |
Filed 2021-05-20 12:46 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 12:46 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
14,381 | |
Filed 2021-05-20 12:45 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 12:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
248,489 | |
Filed 2021-05-20 12:36 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$299,998
+53,097 vol $5.65 each |
53,097 | |
Filed 2021-05-20 12:33 Tx date 2016-08-31 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 12:32 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
689,404 | |
Filed 2021-05-20 12:20 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,186,470 vol |
1,186,470 | |
Filed 2021-05-20 12:17 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
2,440,081 | |
Filed 2021-05-20 12:09 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:33 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$228,751
+40,487 vol $5.65 each |
40,487 | |
Filed 2021-05-20 11:31 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
Filed 2021-05-20 11:31 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
Filed 2021-05-20 11:31 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:31 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:30 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
Filed 2021-05-20 11:30 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
Filed 2021-05-20 11:29 Tx date 2019-05-07 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:29 Tx date 2019-05-07 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:29 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
Filed 2021-05-20 11:29 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
Filed 2021-05-20 11:28 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:28 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:27 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
5,310 | |
Filed 2021-05-20 11:27 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$30,001
+5,310 vol $5.65 each |
||
Filed 2021-05-20 11:26 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:26 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:26 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
Filed 2021-05-20 11:26 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
Filed 2021-05-20 11:24 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$45,002
+7,965 vol $5.65 each |
7,965 | |
Filed 2021-05-20 11:24 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$45,002
+7,965 vol $5.65 each |
||
Filed 2021-05-20 11:23 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:23 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:22 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
Filed 2021-05-20 11:22 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
Filed 2021-05-20 11:19 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
14,381 | |
Filed 2021-05-20 11:19 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
||
Filed 2021-05-20 11:18 Tx date 2014-08-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:18 Tx date 2014-08-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:18 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
||
Filed 2021-05-20 11:18 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
7,190 | |
Filed 2021-05-20 11:17 Tx date 2014-08-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:17 Tx date 2014-08-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:16 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
528,238 | |
Filed 2021-05-20 11:16 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 11:15 Tx date 2014-08-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,000 vol |
85,000 | |
Filed 2021-05-20 11:15 Tx date 2014-08-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,000 vol |
||
Filed 2021-05-20 11:12 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
14,381 | |
Filed 2021-05-20 11:12 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
||
Filed 2021-05-20 11:11 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:11 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
7,190 | |
Filed 2021-05-20 11:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
||
Filed 2021-05-20 11:08 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:08 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 11:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
Filed 2021-05-20 11:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
248,489 | |
Filed 2021-05-20 10:57 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$299,998
+53,097 vol $5.65 each |
53,097 | |
Filed 2021-05-20 10:57 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$299,998
+53,097 vol $5.65 each |
||
Filed 2021-05-20 10:55 Tx date 2016-08-31 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 10:55 Tx date 2016-08-31 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 10:55 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
689,404 | |
Filed 2021-05-20 10:55 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
Filed 2021-05-20 10:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
+40,487 vol |
||
Filed 2021-05-20 10:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
+40,487 vol |
40,487 | |
Filed 2021-05-20 10:49 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 10:49 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-20 10:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
2,440,081 | |
Filed 2021-05-20 10:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+46,811 vol |
||
Filed 2021-05-20 10:32 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,186,470 vol |
1,186,470 | |
Filed 2021-05-20 10:32 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,186,470 vol |
||
Filed 2020-07-03 16:15 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2014-08-27 18:03 Tx date 2014-08-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,000 vol |
||
Filed 2014-08-27 18:03 Tx date 2014-08-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,000 vol |
||
Filed 2014-06-06 15:23 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,186,470 vol |
||
Filed 2014-06-06 15:23 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,186,470 vol |
||
Filed 2014-06-05 11:24 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
Filed 2014-06-05 11:24 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
Filed 2014-06-05 11:20 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
Filed 2014-06-05 11:20 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
Filed 2021-05-04 12:20 Tx date 2021-04-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-494,626 vol |
0 | |
Filed 2021-05-04 12:15 Tx date 2021-04-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$237,902
+45,821 vol $5.19 each |
494,626 | |
Filed 2021-05-04 12:15 Tx date 2021-04-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$447,134
+86,321 vol $5.18 each |
448,805 | |
Filed 2021-05-04 12:14 Tx date 2021-04-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$68,313
+13,000 vol $5.25 each |
362,484 | |
Filed 2021-05-04 12:13 Tx date 2021-04-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$103,609
+19,600 vol $5.29 each |
349,484 | |
Filed 2021-05-04 12:10 Tx date 2021-04-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$28,070
+5,300 vol $5.30 each |
329,884 | |
Filed 2021-05-04 12:09 Tx date 2021-04-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$155,796
+29,400 vol $5.30 each |
324,584 | |
Filed 2021-05-04 12:07 Tx date 2021-04-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$275,538
+52,221 vol $5.28 each |
295,184 | |
Filed 2021-05-04 12:05 Tx date 2021-04-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$455,714
+86,321 vol $5.28 each |
242,963 | |
Filed 2021-05-04 12:04 Tx date 2021-04-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$91,747
+17,321 vol $5.30 each |
156,642 | |
Filed 2021-05-04 12:02 Tx date 2021-04-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$413,080
+78,121 vol $5.29 each |
139,321 | |
Filed 2021-05-04 12:00 Tx date 2021-04-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$286,572
+53,200 vol $5.39 each |
61,200 | |
Filed 2021-04-06 08:44 Tx date 2021-03-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,800
+728 vol $5.22 each |
7,705 | |
Filed 2021-04-06 08:42 Tx date 2021-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,712
+1,669 vol $5.22 each |
116,365 | |
Filed 2021-04-06 08:40 Tx date 2021-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,544
+2,020 vol $5.22 each |
499,961 | |
Filed 2021-04-06 08:33 Tx date 2021-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,740
+1,866 vol $5.22 each |
50,271 | |
Filed 2021-04-05 19:30 Tx date 2021-03-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,259,583 vol |
8,000 | |
Filed 2021-04-05 19:29 Tx date 2021-03-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$43,657
+8,000 vol $5.46 each |
2,267,583 | |
Filed 2021-04-05 19:29 Tx date 2021-03-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$227,241
+41,921 vol $5.42 each |
2,259,583 | |
Filed 2021-04-05 19:28 Tx date 2021-03-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$467,462
+86,321 vol $5.42 each |
2,217,662 | |
Filed 2021-04-05 19:26 Tx date 2021-03-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$450,880
+86,321 vol $5.22 each |
2,131,341 | |
Filed 2021-04-05 19:26 Tx date 2021-03-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,196,868
+439,321 vol $5.00 each |
2,045,020 | |
Filed 2021-04-05 19:25 Tx date 2021-03-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$434,980
+86,321 vol $5.04 each |
1,605,699 | |
Filed 2021-04-05 19:24 Tx date 2021-03-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$439,606
+86,321 vol $5.09 each |
1,519,378 | |
Filed 2021-04-05 19:22 Tx date 2021-03-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$438,312
+86,321 vol $5.08 each |
1,433,057 | |
Filed 2021-04-05 19:21 Tx date 2021-03-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$428,444
+84,621 vol $5.06 each |
1,346,736 | |
Filed 2021-04-05 19:18 Tx date 2021-03-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$426,925
+84,321 vol $5.06 each |
||
Filed 2021-04-05 19:17 Tx date 2021-03-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$439,641
+86,321 vol $5.09 each |
1,262,115 | |
Filed 2021-04-05 19:16 Tx date 2021-03-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$447,315
+86,321 vol $5.18 each |
1,175,794 | |
Filed 2021-04-05 19:15 Tx date 2021-03-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$452,002
+86,321 vol $5.24 each |
1,089,473 | |
Filed 2021-04-05 19:14 Tx date 2021-03-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$451,320
+86,321 vol $5.23 each |
1,003,152 | |
Filed 2021-04-05 19:13 Tx date 2021-03-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$447,237
+86,321 vol $5.18 each |
916,831 | |
Filed 2021-04-05 19:12 Tx date 2021-03-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$453,832
+86,321 vol $5.26 each |
830,510 | |
Filed 2021-04-05 19:12 Tx date 2021-03-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$342,404
+64,421 vol $5.32 each |
744,189 | |
Filed 2021-04-05 19:11 Tx date 2021-03-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$390,972
+75,521 vol $5.18 each |
679,768 | |
Filed 2021-04-05 19:10 Tx date 2021-03-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$435,316
+86,321 vol $5.04 each |
604,247 | |
Filed 2021-04-05 19:09 Tx date 2021-03-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$432,891
+86,321 vol $5.01 each |
517,926 | |
Filed 2021-04-05 19:07 Tx date 2021-03-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$436,836
+86,321 vol $5.06 each |
431,605 | |
Filed 2021-04-05 19:06 Tx date 2021-03-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$444,803
+86,321 vol $5.15 each |
345,284 | |
Filed 2021-04-05 19:05 Tx date 2021-03-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$448,385
+86,321 vol $5.19 each |
258,963 | |
Filed 2021-03-05 10:32 Tx date 2021-02-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,120,473 vol |
172,642 | |
Filed 2021-03-05 10:31 Tx date 2021-02-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$446,072
+86,321 vol $5.17 each |
1,293,115 | |
Filed 2021-03-05 10:30 Tx date 2021-02-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$453,927
+86,321 vol $5.26 each |
1,206,794 | |
Filed 2021-03-05 10:29 Tx date 2021-02-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$452,356
+86,321 vol $5.24 each |
1,120,473 | |
Filed 2021-03-05 10:28 Tx date 2021-02-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$452,365
+86,321 vol $5.24 each |
1,034,152 | |
Filed 2021-03-05 10:27 Tx date 2021-02-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$465,874
+86,321 vol $5.40 each |
947,831 | |
Filed 2021-03-05 10:26 Tx date 2021-02-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$473,522
+86,321 vol $5.49 each |
861,510 | |
Filed 2021-03-05 10:25 Tx date 2021-02-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$473,746
+86,321 vol $5.49 each |
775,189 | |
Filed 2021-03-05 10:24 Tx date 2021-02-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$471,614
+86,321 vol $5.46 each |
688,868 | |
Filed 2021-03-05 10:23 Tx date 2021-02-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$465,451
+86,321 vol $5.39 each |
602,547 | |
Filed 2021-03-05 10:22 Tx date 2021-02-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$460,349
+86,321 vol $5.33 each |
516,226 | |
Filed 2021-03-05 10:21 Tx date 2021-02-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$468,878
+86,321 vol $5.43 each |
429,905 | |
Filed 2021-03-05 10:21 Tx date 2021-02-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$459,077
+84,621 vol $5.43 each |
343,584 | |
Filed 2021-03-05 10:19 Tx date 2021-02-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$461,567
+86,321 vol $5.35 each |
258,963 | |
Filed 2021-02-09 16:25 Tx date 2021-01-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-169,284 vol |
172,642 | |
Filed 2021-02-09 16:23 Tx date 2021-01-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$457,501
+86,321 vol $5.30 each |
341,926 | |
Filed 2021-02-09 16:22 Tx date 2021-01-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$462,663
+86,321 vol $5.36 each |
255,605 | |
Filed 2021-02-09 16:20 Tx date 2021-01-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$429,932
+79,221 vol $5.43 each |
169,284 | |
Filed 2021-02-09 16:18 Tx date 2021-01-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$125,458
+22,821 vol $5.50 each |
90,063 | |
Filed 2021-02-09 16:17 Tx date 2021-01-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$93,995
+17,221 vol $5.46 each |
67,242 | |
Filed 2021-02-09 10:13 Tx date 2021-01-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$267,437
+50,021 vol $5.35 each |
50,021 | |
Filed 2021-01-14 15:24 Tx date 2021-01-14 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,650
+500 vol $5.30 each |
51,053 | |
Filed 2021-01-14 15:20 Tx date 2021-01-14 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,714
+4,500 vol $5.27 each |
50,553 | |
Filed 2021-01-14 15:17 Tx date 2021-01-14 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,714
+4,500 vol $5.27 each |
||
Filed 2021-01-13 16:34 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,260
+1,000 vol $5.26 each |
21,667,133 | |
Filed 2021-01-13 16:33 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,699
+10,000 vol $5.27 each |
21,666,133 | |
Filed 2021-01-13 16:08 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,240
+1,750 vol $5.28 each |
48,405 | |
Filed 2021-01-13 16:05 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,699
+10,000 vol $5.27 each |
65,714 | |
Filed 2021-01-13 15:59 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$42,240
+8,000 vol $5.28 each |
55,714 | |
Filed 2021-01-13 15:58 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,540
+2,000 vol $5.27 each |
47,714 | |
Filed 2021-01-13 15:56 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,120
+2,300 vol $5.27 each |
2,300 | |
Filed 2021-01-13 15:47 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-01-10 21:32 Tx date 2021-01-06 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,058
+200 vol $5.29 each |
21,656,133 | |
Filed 2021-01-07 17:44 Tx date 2020-12-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-8,521 vol |
0 | |
Filed 2021-01-07 17:43 Tx date 2020-12-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$44,058
+8,521 vol $5.17 each |
8,521 | |
Filed 2020-12-21 19:01 Tx date 2020-12-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,153
+595 vol $5.30 each |
6,977 | |
Filed 2020-12-21 18:59 Tx date 2020-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,352
+1,576 vol $5.30 each |
46,655 | |
Filed 2020-12-21 18:57 Tx date 2020-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,036
+1,705 vol $5.30 each |
497,941 | |
Filed 2020-12-21 18:55 Tx date 2020-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,467
+1,409 vol $5.30 each |
114,696 | |
Filed 2020-12-09 10:30 Tx date 2020-12-08 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$53,300
+10,000 vol $5.33 each |
21,655,933 | |
Filed 2020-12-04 18:08 Tx date 2020-12-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,645
+9,800 vol $5.27 each |
496,236 | |
Filed 2020-12-04 09:46 Tx date 2020-12-03 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,250
+2,500 vol $5.30 each |
21,645,933 | |
Filed 2020-12-04 09:45 Tx date 2020-12-03 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$53,300
+10,000 vol $5.33 each |
21,643,433 | |
Filed 2020-12-01 15:31 Tx date 2020-11-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-137,800 vol |
0 | |
Filed 2020-12-01 15:30 Tx date 2020-11-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$333,600
+62,500 vol $5.34 each |
137,800 | |
Filed 2020-12-01 15:28 Tx date 2020-11-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$399,007
+75,300 vol $5.30 each |
75,300 | |
Filed 2020-11-09 09:11 Tx date 2020-10-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-172,642 vol |
0 | |
Filed 2020-10-05 14:52 Tx date 2020-09-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-625,310 vol |
172,642 | |
Filed 2020-10-04 19:05 Tx date 2020-09-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$500,696
+86,321 vol $5.80 each |
797,952 | |
Filed 2020-10-04 19:04 Tx date 2020-09-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$507,576
+86,321 vol $5.88 each |
711,631 | |
Filed 2020-10-04 19:03 Tx date 2020-09-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$396,174
+67,121 vol $5.90 each |
625,310 | |
Filed 2020-10-04 19:01 Tx date 2020-09-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$513,903
+86,321 vol $5.95 each |
558,189 | |
Filed 2020-10-04 19:00 Tx date 2020-09-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$515,094
+86,321 vol $5.97 each |
471,868 | |
Filed 2020-10-04 18:59 Tx date 2020-09-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$321,672
+53,621 vol $6.00 each |
385,547 | |
Filed 2020-10-04 18:58 Tx date 2020-09-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$211,107
+35,221 vol $5.99 each |
331,926 | |
Filed 2020-10-04 18:57 Tx date 2020-09-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$480,772
+80,221 vol $5.99 each |
296,705 | |
Filed 2020-10-04 18:56 Tx date 2020-09-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$312,486
+52,121 vol $6.00 each |
216,484 | |
Filed 2020-10-04 18:54 Tx date 2020-09-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$467,300
+77,921 vol $6.00 each |
164,363 | |
Filed 2020-10-04 18:51 Tx date 2020-09-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$135,040
+22,521 vol $6.00 each |
86,442 | |
Filed 2020-10-04 18:50 Tx date 2020-09-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$257,241
+42,900 vol $6.00 each |
63,921 | |
Filed 2020-10-04 18:49 Tx date 2020-09-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$125,558
+21,021 vol $5.97 each |
21,021 | |
Filed 2020-09-28 16:52 Tx date 2020-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,709
+1,442 vol $6.04 each |
113,287 | |
Filed 2020-09-28 16:50 Tx date 2020-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,742
+1,613 vol $6.04 each |
45,079 | |
Filed 2020-09-28 16:48 Tx date 2020-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,539
+1,745 vol $6.04 each |
486,436 | |
Filed 2020-09-28 16:45 Tx date 2020-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,424
+567 vol $6.04 each |
6,382 | |
Filed 2020-07-03 16:38 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
150,000 | |
Filed 2020-07-03 16:23 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+84,288 vol |
223,549 | |
Filed 2020-07-03 16:22 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+84,288 vol |
503,298 | |
Filed 2020-07-03 16:18 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+135,556 vol |
628,013 | |
Filed 2020-07-03 16:16 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
Filed 2020-07-03 16:15 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-07-03 16:14 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
Filed 2020-07-03 16:13 Tx date 2020-06-25 |
$GUD
Knight Therapeutics Inc. |
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-07-03 16:11 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
40,000 | |
Filed 2020-07-03 16:09 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
140,000 | |
Filed 2020-07-03 15:55 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+189,848 vol |
2,393,270 | |
Filed 2020-06-19 10:31 Tx date 2020-06-15 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,124
+300 vol $7.08 each |
5,815 | |
Filed 2020-06-19 10:29 Tx date 2020-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,354
+1,180 vol $7.08 each |
43,466 | |
Filed 2020-06-19 10:24 Tx date 2020-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,462
+1,054 vol $7.08 each |
111,845 | |
Filed 2020-06-19 10:21 Tx date 2020-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,034
+1,276 vol $7.08 each |
484,691 | |
Filed 2020-05-05 21:40 Tx date 2020-04-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,635,165 vol |
0 | |
Filed 2020-04-27 15:33 Tx date 2020-04-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$358,501
+50,089 vol $7.16 each |
2,635,165 | |
Filed 2020-04-27 15:32 Tx date 2020-04-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$612,783
+88,853 vol $6.90 each |
2,585,076 | |
Filed 2020-04-27 15:30 Tx date 2020-04-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$624,103
+88,853 vol $7.02 each |
2,496,223 | |
Filed 2020-04-27 15:27 Tx date 2020-04-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$608,056
+88,853 vol $6.84 each |
2,407,370 | |
Filed 2020-04-27 15:26 Tx date 2020-04-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,463,470
+1,806,300 vol $6.90 each |
2,318,517 | |
Filed 2020-04-27 15:24 Tx date 2020-04-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$585,017
+88,853 vol $6.58 each |
512,217 | |
Filed 2020-04-27 15:22 Tx date 2020-04-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$571,591
+88,853 vol $6.43 each |
423,364 | |
Filed 2020-04-27 15:20 Tx date 2020-04-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$577,004
+88,852 vol $6.49 each |
334,511 | |
Filed 2020-04-27 15:19 Tx date 2020-04-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$574,105
+88,853 vol $6.46 each |
245,659 | |
Filed 2020-04-09 08:13 Tx date 2020-03-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,901,666 vol |
156,806 | |
Filed 2020-04-09 08:11 Tx date 2020-03-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$566,944
+88,853 vol $6.38 each |
2,058,472 | |
Filed 2020-04-09 08:10 Tx date 2020-03-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$408,608
+67,953 vol $6.01 each |
1,969,619 | |
Filed 2020-04-09 08:09 Tx date 2020-03-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$519,345
+88,853 vol $5.84 each |
1,901,666 | |
Filed 2020-04-09 08:08 Tx date 2020-03-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$527,991
+88,853 vol $5.94 each |
1,812,813 | |
Filed 2020-04-09 08:07 Tx date 2020-03-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$504,054
+88,853 vol $5.67 each |
1,723,960 | |
Filed 2020-04-09 08:05 Tx date 2020-03-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$483,298
+88,853 vol $5.44 each |
1,635,107 | |
Filed 2020-04-09 08:04 Tx date 2020-03-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$469,623
+88,853 vol $5.29 each |
1,546,254 | |
Filed 2020-04-09 08:03 Tx date 2020-03-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$479,255
+88,853 vol $5.39 each |
1,457,401 | |
Filed 2020-04-09 08:02 Tx date 2020-03-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$451,080
+88,853 vol $5.08 each |
1,368,548 | |
Filed 2020-04-09 08:00 Tx date 2020-03-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$448,325
+88,853 vol $5.05 each |
1,279,695 | |
Filed 2020-04-09 07:59 Tx date 2020-03-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$471,969
+88,853 vol $5.31 each |
1,190,842 | |
Filed 2020-04-09 07:58 Tx date 2020-03-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$480,401
+88,853 vol $5.41 each |
1,101,989 | |
Filed 2020-04-09 07:56 Tx date 2020-03-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$503,458
+88,853 vol $5.67 each |
1,013,136 | |
Filed 2020-04-09 07:55 Tx date 2020-03-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$504,160
+88,853 vol $5.67 each |
924,283 | |
Filed 2020-04-09 07:54 Tx date 2020-03-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$552,763
+88,853 vol $6.22 each |
835,430 | |
Filed 2020-04-09 07:53 Tx date 2020-03-10 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$571,689
+88,853 vol $6.43 each |
746,577 | |
Filed 2020-04-09 07:52 Tx date 2020-03-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$580,885
+88,853 vol $6.54 each |
657,724 | |
Filed 2020-04-09 07:51 Tx date 2020-03-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$605,559
+88,853 vol $6.82 each |
568,871 | |
Filed 2020-04-09 07:49 Tx date 2020-03-05 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$609,869
+88,853 vol $6.86 each |
480,018 | |
Filed 2020-04-09 07:47 Tx date 2020-03-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$410,054
+59,953 vol $6.84 each |
391,165 | |
Filed 2020-04-09 07:46 Tx date 2020-03-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$610,029
+88,853 vol $6.87 each |
331,212 | |
Filed 2020-04-09 07:45 Tx date 2020-03-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$590,037
+88,853 vol $6.64 each |
242,359 | |
Filed 2020-03-16 11:53 Tx date 2020-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,679
+1,437 vol $6.04 each |
110,791 | |
Filed 2020-03-16 11:51 Tx date 2020-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,712
+1,608 vol $6.04 each |
42,286 | |
Filed 2020-03-16 11:48 Tx date 2020-03-15 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,379
+394 vol $6.04 each |
5,515 | |
Filed 2020-03-16 11:46 Tx date 2020-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,503
+1,739 vol $6.04 each |
483,415 | |
Filed 2020-03-02 15:11 Tx date 2020-02-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-267,612 vol |
153,506 | |
Filed 2020-03-02 15:09 Tx date 2020-02-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$589,628
+88,853 vol $6.64 each |
421,118 | |
Filed 2020-03-02 15:08 Tx date 2020-02-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$443,067
+64,653 vol $6.85 each |
332,265 | |
Filed 2020-03-02 15:06 Tx date 2020-02-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$622,148
+88,853 vol $7.00 each |
267,612 | |
Filed 2020-03-02 15:04 Tx date 2020-02-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$628,901
+88,853 vol $7.08 each |
178,759 | |
Filed 2020-03-02 15:01 Tx date 2020-02-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$644,717
+88,853 vol $7.26 each |
89,906 | |
Filed 2020-03-02 14:57 Tx date 2020-02-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,760
+1,053 vol $7.37 each |
1,053 | |
Filed 2019-12-18 11:22 Tx date 2019-12-15 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,034
+267 vol $7.62 each |
5,121 | |
Filed 2019-12-18 11:17 Tx date 2019-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,999
+1,181 vol $7.62 each |
481,676 | |
Filed 2019-12-18 11:15 Tx date 2019-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,321
+1,092 vol $7.62 each |
40,678 | |
Filed 2019-12-18 11:12 Tx date 2019-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,444
+977 vol $7.62 each |
109,354 | |
Filed 2019-11-04 15:34 Tx date 2019-10-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-88,012 vol |
0 | |
Filed 2019-11-04 15:33 Tx date 2019-10-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$58,613
+7,953 vol $7.37 each |
88,012 | |
Filed 2019-11-04 15:32 Tx date 2019-10-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,080
+3,000 vol $7.36 each |
80,059 | |
Filed 2019-11-04 15:31 Tx date 2019-10-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$55,665
+7,553 vol $7.37 each |
77,059 | |
Filed 2019-11-04 15:31 Tx date 2019-10-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,088
+4,900 vol $7.37 each |
69,506 | |
Filed 2019-11-04 15:30 Tx date 2019-10-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$160,448
+21,800 vol $7.36 each |
64,606 | |
Filed 2019-11-04 15:29 Tx date 2019-10-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$85,492
+11,600 vol $7.37 each |
42,806 | |
Filed 2019-11-04 15:29 Tx date 2019-10-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$40,425
+5,500 vol $7.35 each |
31,206 | |
Filed 2019-11-04 15:28 Tx date 2019-10-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,857
+253 vol $7.34 each |
25,706 | |
Filed 2019-11-04 15:28 Tx date 2019-10-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$733.50
+100 vol $7.33 each |
25,453 | |
Filed 2019-11-04 15:27 Tx date 2019-10-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,398
+600 vol $7.33 each |
25,353 | |
Filed 2019-11-04 15:26 Tx date 2019-10-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,685
+500 vol $7.37 each |
24,753 | |
Filed 2019-11-04 15:25 Tx date 2019-10-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$34,246
+4,653 vol $7.36 each |
24,253 | |
Filed 2019-11-04 15:24 Tx date 2019-10-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,905
+2,300 vol $7.35 each |
19,600 | |
Filed 2019-11-04 15:24 Tx date 2019-10-04 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$32,296
+4,400 vol $7.34 each |
17,300 | |
Filed 2019-10-09 15:54 Tx date 2019-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$745.00
+100 vol $7.45 each |
260,406 | |
Filed 2019-10-09 15:54 Tx date 2019-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$744.50
+100 vol $7.45 each |
260,306 | |
Filed 2019-10-09 15:54 Tx date 2019-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,720
+500 vol $7.44 each |
260,206 | |
Filed 2019-10-09 15:53 Tx date 2019-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,458
+600 vol $7.43 each |
259,706 | |
Filed 2019-10-09 15:53 Tx date 2019-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,485
+200 vol $7.42 each |
259,106 | |
Filed 2019-10-09 15:51 Tx date 2019-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$77,910
+10,500 vol $7.42 each |
258,906 | |
Filed 2019-10-09 15:51 Tx date 2019-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,223
+300 vol $7.41 each |
248,406 | |
Filed 2019-10-09 15:50 Tx date 2019-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,960
+400 vol $7.40 each |
248,106 | |
Filed 2019-10-09 15:50 Tx date 2019-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,478
+200 vol $7.39 each |
247,706 | |
Filed 2019-10-09 15:31 Tx date 2019-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$95,723
+12,900 vol $7.42 each |
||
Filed 2019-09-30 16:22 Tx date 2019-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$95,723
+12,900 vol $7.42 each |
||
Filed 2019-10-04 13:35 Tx date 2019-09-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-247,506 vol |
12,900 | |
Filed 2019-09-30 16:22 Tx date 2019-09-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$95,723
+12,900 vol $7.42 each |
260,406 | |
Filed 2019-09-30 16:20 Tx date 2019-09-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,444
+1,400 vol $7.46 each |
247,506 | |
Filed 2019-09-30 16:20 Tx date 2019-09-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$92,380
+12,400 vol $7.45 each |
246,106 | |
Filed 2019-09-30 16:19 Tx date 2019-09-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$55,450
+7,453 vol $7.44 each |
233,706 | |
Filed 2019-09-30 16:19 Tx date 2019-09-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$67,613
+9,100 vol $7.43 each |
226,253 | |
Filed 2019-09-30 16:18 Tx date 2019-09-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,678
+900 vol $7.42 each |
217,153 | |
Filed 2019-09-30 16:16 Tx date 2019-09-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,717
+2,235 vol $7.48 each |
216,253 | |
Filed 2019-09-30 16:16 Tx date 2019-09-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,699
+1,700 vol $7.47 each |
214,018 | |
Filed 2019-09-30 16:15 Tx date 2019-09-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$70,870
+9,500 vol $7.46 each |
212,318 | |
Filed 2019-09-30 16:15 Tx date 2019-09-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,195
+1,100 vol $7.45 each |
202,818 | |
Filed 2019-09-30 16:14 Tx date 2019-09-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,233
+300 vol $7.45 each |
201,718 | |
Filed 2019-09-30 16:14 Tx date 2019-09-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,976
+400 vol $7.44 each |
201,418 | |
Filed 2019-09-30 16:13 Tx date 2019-09-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$743.50
+100 vol $7.43 each |
201,018 | |
Filed 2019-09-30 15:16 Tx date 2019-09-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,750
+1,700 vol $7.50 each |
200,918 | |
Filed 2019-09-30 15:16 Tx date 2019-09-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$68,908
+9,200 vol $7.49 each |
199,218 | |
Filed 2019-09-30 15:15 Tx date 2019-09-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,497
+200 vol $7.49 each |
190,018 | |
Filed 2019-09-30 15:15 Tx date 2019-09-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$71,808
+9,600 vol $7.48 each |
189,818 | |
Filed 2019-09-30 15:14 Tx date 2019-09-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,242
+300 vol $7.47 each |
180,218 | |
Filed 2019-09-30 15:14 Tx date 2019-09-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$62,748
+8,400 vol $7.47 each |
179,918 | |
Filed 2019-09-30 15:11 Tx date 2019-09-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$746.50
+100 vol $7.46 each |
171,518 | |
Filed 2019-09-30 15:10 Tx date 2019-09-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$48,490
+6,500 vol $7.46 each |
171,418 | |
Filed 2019-09-30 15:09 Tx date 2019-09-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$745.50
+100 vol $7.46 each |
164,918 | |
Filed 2019-09-30 15:09 Tx date 2019-09-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$40,624
+5,453 vol $7.45 each |
164,818 | |
Filed 2019-09-30 15:08 Tx date 2019-09-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,976
+400 vol $7.44 each |
159,365 | |
Filed 2019-09-30 15:02 Tx date 2019-09-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,603
+4,900 vol $7.47 each |
158,965 | |
Filed 2019-09-30 15:01 Tx date 2019-09-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$47,744
+6,400 vol $7.46 each |
154,065 | |
Filed 2019-09-30 15:01 Tx date 2019-09-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$79,023
+10,600 vol $7.46 each |
147,665 | |
Filed 2019-09-30 15:00 Tx date 2019-09-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$88,304
+11,853 vol $7.45 each |
137,065 | |
Filed 2019-09-30 15:00 Tx date 2019-09-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$81,895
+11,000 vol $7.45 each |
125,212 | |
Filed 2019-09-30 14:59 Tx date 2019-09-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,528
+3,700 vol $7.44 each |
114,212 | |
Filed 2019-09-30 14:58 Tx date 2019-09-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,916
+1,200 vol $7.43 each |
110,512 | |
Filed 2019-09-30 14:43 Tx date 2019-09-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,000
+800 vol $7.50 each |
109,312 | |
Filed 2019-09-30 14:43 Tx date 2019-09-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,897
+1,853 vol $7.50 each |
108,512 | |
Filed 2019-09-30 14:42 Tx date 2019-09-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$147,000
+19,600 vol $7.50 each |
106,659 | |
Filed 2019-09-30 14:42 Tx date 2019-09-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$29,230
+3,900 vol $7.50 each |
87,059 | |
Filed 2019-09-30 14:41 Tx date 2019-09-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,619
+2,753 vol $7.49 each |
83,159 | |
Filed 2019-09-30 14:27 Tx date 2019-09-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$77,010
+10,200 vol $7.55 each |
80,406 | |
Filed 2019-09-30 14:26 Tx date 2019-09-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$754.50
+100 vol $7.54 each |
70,206 | |
Filed 2019-09-30 14:26 Tx date 2019-09-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$136,474
+18,100 vol $7.54 each |
70,106 | |
Filed 2019-09-30 14:25 Tx date 2019-09-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,507
+200 vol $7.54 each |
52,006 | |
Filed 2019-09-30 14:24 Tx date 2019-09-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$91,113
+12,100 vol $7.53 each |
51,806 | |
Filed 2019-09-30 14:24 Tx date 2019-09-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,942
+2,253 vol $7.52 each |
39,706 | |
Filed 2019-09-30 14:24 Tx date 2019-09-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$751.50
+100 vol $7.51 each |
37,453 | |
Filed 2019-09-30 14:23 Tx date 2019-09-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,506
+600 vol $7.51 each |
37,353 | |
Filed 2019-09-30 14:22 Tx date 2019-09-03 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,750
+500 vol $7.50 each |
36,753 | |
Filed 2019-09-18 11:47 Tx date 2019-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,707
+1,251 vol $7.76 each |
39,586 | |
Filed 2019-09-18 11:37 Tx date 2019-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,675
+1,118 vol $7.76 each |
108,377 | |
Filed 2019-09-18 11:17 Tx date 2019-09-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,498
+322 vol $7.76 each |
45,714 | |
Filed 2019-09-18 11:07 Tx date 2019-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,499
+1,353 vol $7.76 each |
480,495 | |
Filed 2019-09-18 11:03 Tx date 2019-09-15 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,439
+701 vol $7.76 each |
4,854 | |
Filed 2019-09-09 10:33 Tx date 2019-08-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-2,345,349 vol |
36,253 | |
Filed 2019-09-09 10:30 Tx date 2019-08-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$68,350
+9,053 vol $7.55 each |
2,381,602 | |
Filed 2019-09-09 10:30 Tx date 2019-08-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,620
+3,000 vol $7.54 each |
2,372,549 | |
Filed 2019-09-09 10:29 Tx date 2019-08-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$80,571
+10,700 vol $7.53 each |
2,369,549 | |
Filed 2019-09-09 10:28 Tx date 2019-08-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$752.50
+100 vol $7.53 each |
2,358,849 | |
Filed 2019-09-09 10:27 Tx date 2019-08-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,256
+300 vol $7.52 each |
2,358,749 | |
Filed 2019-09-09 10:26 Tx date 2019-08-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$98,905
+13,100 vol $7.55 each |
2,358,449 | |
Filed 2019-09-09 10:24 Tx date 2019-08-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,460
+1,253 vol $7.55 each |
2,345,349 | |
Filed 2019-09-09 10:23 Tx date 2019-08-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,198
+4,400 vol $7.54 each |
2,344,096 | |
Filed 2019-09-09 10:23 Tx date 2019-08-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,850
+2,500 vol $7.54 each |
2,339,696 | |
Filed 2019-09-09 10:22 Tx date 2019-08-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,851
+2,900 vol $7.54 each |
2,337,196 | |
Filed 2019-09-09 10:22 Tx date 2019-08-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,554
+1,800 vol $7.53 each |
2,334,296 | |
Filed 2019-09-09 10:19 Tx date 2019-08-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$95,504
+12,700 vol $7.52 each |
2,332,496 | |
Filed 2019-09-09 10:19 Tx date 2019-08-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$39,078
+5,200 vol $7.51 each |
2,319,796 | |
Filed 2019-09-09 10:18 Tx date 2019-08-28 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,032
+3,200 vol $7.51 each |
2,314,596 | |
Filed 2019-09-09 10:14 Tx date 2019-08-27 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,775
+500 vol $7.55 each |
2,311,396 | |
Filed 2019-09-09 10:11 Tx date 2019-08-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,775
+500 vol $7.55 each |
||
Filed 2019-09-09 10:09 Tx date 2019-08-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$31,898
+4,100 vol $7.78 each |
2,310,896 | |
Filed 2019-09-09 10:08 Tx date 2019-08-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,555
+200 vol $7.78 each |
2,306,796 | |
Filed 2019-09-09 10:08 Tx date 2019-08-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$162,804
+20,953 vol $7.77 each |
2,306,596 | |
Filed 2019-09-09 10:01 Tx date 2019-08-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$35,467
+4,553 vol $7.79 each |
2,285,643 | |
Filed 2019-09-09 10:00 Tx date 2019-08-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,892
+500 vol $7.79 each |
2,281,090 | |
Filed 2019-09-09 09:55 Tx date 2019-08-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$82,468
+10,600 vol $7.78 each |
2,280,590 | |
Filed 2019-09-09 09:55 Tx date 2019-08-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$777.50
+100 vol $7.78 each |
2,269,990 | |
Filed 2019-09-09 09:51 Tx date 2019-08-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$395,493
+50,900 vol $7.77 each |
2,269,890 | |
Filed 2019-09-09 09:51 Tx date 2019-08-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,329
+300 vol $7.76 each |
2,218,990 | |
Filed 2019-09-09 09:50 Tx date 2019-08-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$149,768
+19,300 vol $7.76 each |
2,218,690 | |
Filed 2019-09-09 09:49 Tx date 2019-08-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,326
+300 vol $7.75 each |
2,199,390 | |
Filed 2019-09-09 09:48 Tx date 2019-08-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,950
+1,800 vol $7.75 each |
2,199,090 | |
Filed 2019-09-09 09:48 Tx date 2019-08-21 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,872
+500 vol $7.75 each |
2,197,290 | |
Filed 2019-09-09 09:40 Tx date 2019-08-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$31,939
+4,100 vol $7.79 each |
2,196,790 | |
Filed 2019-09-09 09:39 Tx date 2019-08-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,677
+1,500 vol $7.79 each |
2,192,690 | |
Filed 2019-09-09 09:38 Tx date 2019-08-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$238,480
+30,653 vol $7.78 each |
2,191,190 | |
Filed 2019-09-09 09:38 Tx date 2019-08-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$34,987
+4,500 vol $7.78 each |
2,160,537 | |
Filed 2019-09-09 09:37 Tx date 2019-08-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,972
+3,600 vol $7.77 each |
2,156,037 | |
Filed 2019-09-09 09:37 Tx date 2019-08-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$117,176
+15,100 vol $7.76 each |
2,152,437 | |
Filed 2019-09-09 09:36 Tx date 2019-08-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$134,075
+17,300 vol $7.75 each |
2,137,337 | |
Filed 2019-09-09 09:36 Tx date 2019-08-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,966
+900 vol $7.74 each |
2,120,037 | |
Filed 2019-09-09 09:34 Tx date 2019-08-20 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,865
+500 vol $7.73 each |
2,119,137 | |
Filed 2019-09-06 15:46 Tx date 2019-08-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,099,490
+1,303,160 vol $7.75 each |
2,118,637 | |
Filed 2019-09-06 15:41 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$185,640
+23,800 vol $7.80 each |
815,477 | |
Filed 2019-09-06 15:40 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$779.50
+100 vol $7.79 each |
791,677 | |
Filed 2019-09-06 15:39 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,033
+2,700 vol $7.79 each |
791,577 | |
Filed 2019-09-06 15:39 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$73,910
+9,500 vol $7.78 each |
788,877 | |
Filed 2019-09-06 15:38 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,324
+1,200 vol $7.77 each |
779,377 | |
Filed 2019-09-06 15:38 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$38,024
+4,900 vol $7.76 each |
778,177 | |
Filed 2019-09-06 15:37 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$69,750
+9,000 vol $7.75 each |
773,277 | |
Filed 2019-09-06 15:37 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$79,722
+10,300 vol $7.74 each |
764,277 | |
Filed 2019-09-06 15:37 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$773.50
+100 vol $7.74 each |
753,977 | |
Filed 2019-09-06 15:36 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$51,018
+6,600 vol $7.73 each |
753,877 | |
Filed 2019-09-06 15:36 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$772.50
+100 vol $7.72 each |
747,277 | |
Filed 2019-09-06 15:36 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,088
+400 vol $7.72 each |
747,177 | |
Filed 2019-09-06 15:35 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,034
+653 vol $7.71 each |
746,777 | |
Filed 2019-09-06 15:35 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,160
+800 vol $7.70 each |
746,124 | |
Filed 2019-09-06 15:34 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,072
+400 vol $7.68 each |
745,324 | |
Filed 2019-09-06 15:34 Tx date 2019-08-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,534
+200 vol $7.67 each |
744,924 | |
Filed 2019-09-06 14:12 Tx date 2019-08-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,103,340
+142,000 vol $7.77 each |
744,724 | |
Filed 2019-09-06 14:12 Tx date 2019-08-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,184
+153 vol $7.74 each |
602,724 | |
Filed 2019-09-06 14:12 Tx date 2019-08-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,865
+500 vol $7.73 each |
602,571 | |
Filed 2019-09-06 14:11 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,156
+400 vol $7.89 each |
602,071 | |
Filed 2019-09-06 14:10 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$28,368
+3,600 vol $7.88 each |
601,671 | |
Filed 2019-09-06 14:10 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,444
+1,200 vol $7.87 each |
598,071 | |
Filed 2019-09-06 14:08 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,990
+1,400 vol $7.85 each |
596,871 | |
Filed 2019-09-06 14:08 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$80,752
+10,300 vol $7.84 each |
595,471 | |
Filed 2019-09-06 14:07 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,405
+3,500 vol $7.83 each |
585,171 | |
Filed 2019-09-06 14:07 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$39,882
+5,100 vol $7.82 each |
581,671 | |
Filed 2019-09-06 14:07 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$102,311
+13,100 vol $7.81 each |
576,571 | |
Filed 2019-09-06 14:06 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,902
+500 vol $7.80 each |
563,471 | |
Filed 2019-09-06 14:06 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$313,560
+40,200 vol $7.80 each |
562,971 | |
Filed 2019-09-06 14:05 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,118
+400 vol $7.79 each |
522,771 | |
Filed 2019-09-06 14:05 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$43,624
+5,600 vol $7.79 each |
522,371 | |
Filed 2019-09-06 14:04 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,784
+2,800 vol $7.78 each |
516,771 | |
Filed 2019-09-06 14:04 Tx date 2019-08-14 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,850
+753 vol $7.77 each |
513,971 | |
Filed 2019-09-05 16:37 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$37,824
+4,800 vol $7.88 each |
513,218 | |
Filed 2019-09-05 16:36 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,362
+300 vol $7.88 each |
508,418 | |
Filed 2019-09-05 16:36 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$45,646
+5,800 vol $7.87 each |
508,118 | |
Filed 2019-09-05 16:35 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$786.50
+100 vol $7.87 each |
502,318 | |
Filed 2019-09-05 16:35 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$127,332
+16,200 vol $7.86 each |
502,218 | |
Filed 2019-09-05 16:34 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$182,905
+23,300 vol $7.85 each |
486,018 | |
Filed 2019-09-05 16:33 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,276
+800 vol $7.84 each |
462,718 | |
Filed 2019-09-05 16:32 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$79,968
+10,200 vol $7.84 each |
461,918 | |
Filed 2019-09-05 16:32 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,103
+1,800 vol $7.83 each |
451,718 | |
Filed 2019-09-05 16:32 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,660
+2,000 vol $7.83 each |
449,918 | |
Filed 2019-09-05 16:31 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,715
+1,500 vol $7.81 each |
447,918 | |
Filed 2019-09-05 16:30 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$780.50
+100 vol $7.80 each |
446,418 | |
Filed 2019-09-05 16:29 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$100,620
+12,900 vol $7.80 each |
446,318 | |
Filed 2019-09-05 16:29 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$53,751
+6,900 vol $7.79 each |
433,418 | |
Filed 2019-09-05 16:28 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,750
+2,153 vol $7.78 each |
426,518 | |
Filed 2019-09-05 16:11 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,624
+1,600 vol $7.89 each |
424,365 | |
Filed 2019-09-05 16:11 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,308
+800 vol $7.88 each |
422,765 | |
Filed 2019-09-05 16:10 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$44,128
+5,600 vol $7.88 each |
421,965 | |
Filed 2019-09-05 16:10 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,575
+200 vol $7.88 each |
416,365 | |
Filed 2019-09-05 16:09 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,675
+2,500 vol $7.87 each |
416,165 | |
Filed 2019-09-05 16:09 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,359
+300 vol $7.87 each |
413,665 | |
Filed 2019-09-05 16:08 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,004
+1,400 vol $7.86 each |
413,365 | |
Filed 2019-09-05 16:08 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,485
+2,100 vol $7.85 each |
411,965 | |
Filed 2019-09-05 16:07 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,491
+700 vol $7.84 each |
409,865 | |
Filed 2019-09-05 16:07 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$32,144
+4,100 vol $7.84 each |
409,165 | |
Filed 2019-09-05 16:06 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,575
+2,500 vol $7.83 each |
405,065 | |
Filed 2019-09-05 16:01 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,347
+300 vol $7.83 each |
402,565 | |
Filed 2019-09-05 16:00 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$30,498
+3,900 vol $7.82 each |
402,265 | |
Filed 2019-09-05 15:59 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$781.50
+100 vol $7.82 each |
398,365 | |
Filed 2019-09-05 15:58 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,335
+3,500 vol $7.81 each |
398,265 | |
Filed 2019-09-05 15:58 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,902
+500 vol $7.80 each |
394,765 | |
Filed 2019-09-05 15:57 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$71,760
+9,200 vol $7.80 each |
394,265 | |
Filed 2019-09-05 15:57 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,897
+500 vol $7.79 each |
385,065 | |
Filed 2019-09-05 15:56 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$34,276
+4,400 vol $7.79 each |
384,565 | |
Filed 2019-09-05 15:54 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,120
+1,300 vol $7.79 each |
380,165 | |
Filed 2019-09-05 15:53 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,892
+1,400 vol $7.78 each |
378,865 | |
Filed 2019-09-05 15:53 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,330
+1,200 vol $7.78 each |
377,465 | |
Filed 2019-09-05 15:52 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,550
+200 vol $7.75 each |
376,265 | |
Filed 2019-09-05 15:52 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$272,448
+35,200 vol $7.74 each |
376,065 | |
Filed 2019-09-05 15:51 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,036
+1,300 vol $7.72 each |
340,865 | |
Filed 2019-09-05 15:51 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$771.00
+100 vol $7.71 each |
339,565 | |
Filed 2019-09-05 15:50 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,240
+1,200 vol $7.70 each |
339,465 | |
Filed 2019-09-05 15:50 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,680
+1,000 vol $7.68 each |
338,265 | |
Filed 2019-09-05 15:49 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,835
+500 vol $7.67 each |
337,265 | |
Filed 2019-09-05 15:48 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,935
+253 vol $7.65 each |
336,765 | |
Filed 2019-09-05 15:48 Tx date 2019-08-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,292
+300 vol $7.64 each |
336,512 | |
Filed 2019-09-04 14:44 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$30,996
+4,100 vol $7.56 each |
336,212 | |
Filed 2019-09-04 14:44 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$95,885
+12,700 vol $7.55 each |
332,112 | |
Filed 2019-09-04 14:43 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$38,454
+5,100 vol $7.54 each |
319,412 | |
Filed 2019-09-04 14:43 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,507
+200 vol $7.54 each |
314,312 | |
Filed 2019-09-04 14:42 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$30,873
+4,100 vol $7.53 each |
314,112 | |
Filed 2019-09-04 14:42 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$46,655
+6,200 vol $7.53 each |
310,012 | |
Filed 2019-09-04 14:41 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$42,112
+5,600 vol $7.52 each |
303,812 | |
Filed 2019-09-04 14:41 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,254
+300 vol $7.51 each |
298,212 | |
Filed 2019-09-04 14:40 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,522
+2,200 vol $7.51 each |
297,912 | |
Filed 2019-09-04 14:39 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$45,750
+6,100 vol $7.50 each |
295,712 | |
Filed 2019-09-04 14:38 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,497
+600 vol $7.50 each |
289,612 | |
Filed 2019-09-04 14:38 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,498
+200 vol $7.49 each |
289,012 | |
Filed 2019-09-04 14:36 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,876
+1,053 vol $7.48 each |
288,812 | |
Filed 2019-09-04 14:35 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,458
+1,400 vol $7.47 each |
287,759 | |
Filed 2019-09-04 14:35 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$31,353
+4,200 vol $7.46 each |
286,359 | |
Filed 2019-09-04 14:34 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$169,342
+22,700 vol $7.46 each |
282,159 | |
Filed 2019-09-04 14:34 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,691
+1,300 vol $7.46 each |
259,459 | |
Filed 2019-09-04 14:33 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$44,700
+6,000 vol $7.45 each |
258,159 | |
Filed 2019-09-04 14:32 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,416
+1,400 vol $7.44 each |
252,159 | |
Filed 2019-09-04 14:32 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,346
+2,200 vol $7.43 each |
250,759 | |
Filed 2019-09-04 14:31 Tx date 2019-08-09 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,904
+1,200 vol $7.42 each |
248,559 | |
Filed 2019-09-04 14:19 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-240,712 vol |
247,359 | |
Filed 2019-09-04 14:12 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,789
+1,300 vol $7.53 each |
488,071 | |
Filed 2019-09-04 14:11 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,096
+4,800 vol $7.52 each |
486,771 | |
Filed 2019-09-04 14:10 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,272
+1,500 vol $7.51 each |
481,971 | |
Filed 2019-09-04 14:10 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,265
+1,500 vol $7.51 each |
480,471 | |
Filed 2019-09-04 14:09 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,000
+1,200 vol $7.50 each |
478,971 | |
Filed 2019-09-04 14:09 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$100,013
+13,353 vol $7.49 each |
477,771 | |
Filed 2019-09-04 14:08 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$77,095
+10,300 vol $7.49 each |
464,418 | |
Filed 2019-09-04 14:08 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$58,344
+7,800 vol $7.48 each |
454,118 | |
Filed 2019-09-04 14:07 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$74,750
+10,000 vol $7.47 each |
446,318 | |
Filed 2019-09-04 14:06 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$31,374
+4,200 vol $7.47 each |
436,318 | |
Filed 2019-09-04 14:06 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,620
+3,700 vol $7.46 each |
432,118 | |
Filed 2019-09-04 14:05 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$90,266
+12,100 vol $7.46 each |
428,418 | |
Filed 2019-09-04 14:05 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$33,547
+4,500 vol $7.46 each |
416,318 | |
Filed 2019-09-04 14:04 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$68,540
+9,200 vol $7.45 each |
411,818 | |
Filed 2019-09-04 14:03 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,696
+900 vol $7.44 each |
402,618 | |
Filed 2019-09-04 14:03 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,631
+1,700 vol $7.43 each |
401,718 | |
Filed 2019-09-04 14:02 Tx date 2019-08-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,936
+800 vol $7.42 each |
400,018 | |
Filed 2019-09-04 13:42 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,232
+300 vol $7.44 each |
399,218 | |
Filed 2019-09-04 13:42 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,230
+300 vol $7.43 each |
398,918 | |
Filed 2019-09-04 13:41 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,804
+2,800 vol $7.43 each |
398,618 | |
Filed 2019-09-04 13:41 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$101,654
+13,700 vol $7.42 each |
395,818 | |
Filed 2019-09-04 13:40 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,224
+300 vol $7.42 each |
382,118 | |
Filed 2019-09-04 13:40 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$125,970
+17,000 vol $7.41 each |
381,818 | |
Filed 2019-09-04 13:39 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,924
+800 vol $7.41 each |
364,818 | |
Filed 2019-09-04 13:39 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$189,832
+25,653 vol $7.40 each |
364,018 | |
Filed 2019-09-04 13:38 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,697
+500 vol $7.39 each |
338,365 | |
Filed 2019-09-04 13:38 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$59,859
+8,100 vol $7.39 each |
337,865 | |
Filed 2019-09-04 13:37 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,477
+200 vol $7.38 each |
329,765 | |
Filed 2019-09-04 12:30 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$43,147
+5,753 vol $7.50 each |
329,565 | |
Filed 2019-09-04 12:30 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,227
+2,300 vol $7.49 each |
323,812 | |
Filed 2019-09-04 12:29 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$16,456
+2,200 vol $7.48 each |
321,512 | |
Filed 2019-09-04 12:28 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,446
+1,800 vol $7.47 each |
319,312 | |
Filed 2019-09-04 12:28 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$103,555
+13,900 vol $7.45 each |
317,512 | |
Filed 2019-09-04 12:27 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$744.50
+100 vol $7.45 each |
303,612 | |
Filed 2019-09-04 12:27 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$126,480
+17,000 vol $7.44 each |
303,512 | |
Filed 2019-09-04 12:26 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,974
+400 vol $7.43 each |
286,512 | |
Filed 2019-09-04 12:26 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$187,236
+25,200 vol $7.43 each |
286,112 | |
Filed 2019-09-04 12:25 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,940
+800 vol $7.42 each |
260,912 | |
Filed 2019-09-04 12:24 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$89,040
+12,000 vol $7.42 each |
260,112 | |
Filed 2019-09-04 12:24 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,966
+400 vol $7.42 each |
248,112 | |
Filed 2019-09-04 12:23 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$29,640
+4,000 vol $7.41 each |
247,712 | |
Filed 2019-09-04 12:23 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$740.50
+100 vol $7.41 each |
243,712 | |
Filed 2019-09-04 12:22 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,580
+1,700 vol $7.40 each |
243,612 | |
Filed 2019-09-04 12:21 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$739.50
+100 vol $7.39 each |
241,912 | |
Filed 2019-09-04 12:21 Tx date 2019-08-06 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,129
+1,100 vol $7.39 each |
241,812 | |
Filed 2019-09-04 12:05 Tx date 2019-08-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,797
+500 vol $7.59 each |
240,712 | |
Filed 2019-09-04 12:05 Tx date 2019-08-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$98,670
+13,000 vol $7.59 each |
240,212 | |
Filed 2019-09-04 12:04 Tx date 2019-08-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$48,913
+6,453 vol $7.58 each |
227,212 | |
Filed 2019-09-04 12:04 Tx date 2019-08-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,332
+1,100 vol $7.58 each |
220,759 | |
Filed 2019-09-04 12:03 Tx date 2019-08-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$31,037
+4,100 vol $7.57 each |
219,659 | |
Filed 2019-09-04 12:03 Tx date 2019-08-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,704
+3,400 vol $7.56 each |
215,559 | |
Filed 2019-09-04 12:02 Tx date 2019-08-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$45,300
+6,000 vol $7.55 each |
212,159 | |
Filed 2019-09-04 12:02 Tx date 2019-08-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$28,652
+3,800 vol $7.54 each |
206,159 | |
Filed 2019-09-04 12:01 Tx date 2019-08-02 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,012
+400 vol $7.53 each |
202,359 | |
Filed 2019-09-04 11:40 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$69,069
+9,100 vol $7.59 each |
201,959 | |
Filed 2019-09-04 11:40 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$758.50
+100 vol $7.58 each |
192,859 | |
Filed 2019-09-04 11:39 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$60,640
+8,000 vol $7.58 each |
192,759 | |
Filed 2019-09-04 11:39 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,028
+400 vol $7.57 each |
184,759 | |
Filed 2019-09-04 11:38 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,780
+500 vol $7.56 each |
184,359 | |
Filed 2019-09-04 11:37 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,875
+2,500 vol $7.55 each |
183,859 | |
Filed 2019-09-04 11:37 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,866
+2,900 vol $7.54 each |
181,359 | |
Filed 2019-09-04 11:36 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,260
+300 vol $7.54 each |
178,459 | |
Filed 2019-09-04 11:34 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,096
+3,200 vol $7.53 each |
178,159 | |
Filed 2019-09-04 11:34 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,525
+1,000 vol $7.53 each |
174,959 | |
Filed 2019-09-04 11:33 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$42,112
+5,600 vol $7.52 each |
173,959 | |
Filed 2019-09-04 11:32 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,024
+1,600 vol $7.51 each |
168,359 | |
Filed 2019-09-04 11:32 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$125,417
+16,700 vol $7.51 each |
166,759 | |
Filed 2019-09-04 11:31 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$83,250
+11,100 vol $7.50 each |
150,059 | |
Filed 2019-09-04 11:30 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$749.50
+100 vol $7.50 each |
138,959 | |
Filed 2019-09-04 11:29 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$44,191
+5,900 vol $7.49 each |
138,859 | |
Filed 2019-09-04 11:29 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$748.50
+100 vol $7.49 each |
132,959 | |
Filed 2019-09-04 11:26 Tx date 2019-08-01 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,096
+2,553 vol $7.48 each |
132,859 | |
Filed 2019-08-16 15:59 Tx date 2019-08-13 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$349,168
+45,054 vol $7.75 each |
139,261 | |
Filed 2019-08-16 15:39 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,153 | ||
Filed 2019-08-12 16:06 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-08-13 15:57 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
94,207 | ||
Filed 2019-08-12 16:17 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-08-12 16:17 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
94,207 | ||
Filed 2019-08-12 16:06 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,430 | ||
Filed 2019-08-08 16:40 Tx date 2019-07-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-4,327,670 vol |
130,306 | |
Filed 2019-08-08 16:34 Tx date 2019-07-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,120
+2,400 vol $7.55 each |
4,457,976 | |
Filed 2019-08-08 16:34 Tx date 2019-07-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$22,620
+3,000 vol $7.54 each |
4,455,576 | |
Filed 2019-08-08 16:33 Tx date 2019-07-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$56,874
+7,553 vol $7.53 each |
4,452,576 | |
Filed 2019-08-08 16:33 Tx date 2019-07-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$115,056
+15,300 vol $7.52 each |
4,445,023 | |
Filed 2019-08-08 16:32 Tx date 2019-07-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$48,815
+6,500 vol $7.51 each |
4,429,723 | |
Filed 2019-08-08 16:32 Tx date 2019-07-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$144,750
+19,300 vol $7.50 each |
4,423,223 | |
Filed 2019-08-08 16:31 Tx date 2019-07-31 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$47,936
+6,400 vol $7.49 each |
4,403,923 | |
Filed 2019-08-08 15:52 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,800
+500 vol $7.60 each |
4,397,523 | |
Filed 2019-08-08 15:52 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,493
+2,700 vol $7.59 each |
4,397,023 | |
Filed 2019-08-08 15:51 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,517
+200 vol $7.58 each |
4,394,323 | |
Filed 2019-08-08 15:50 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,612
+1,400 vol $7.58 each |
4,394,123 | |
Filed 2019-08-08 15:48 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,515
+200 vol $7.58 each |
4,392,723 | |
Filed 2019-08-08 15:48 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,682
+2,600 vol $7.57 each |
4,392,523 | |
Filed 2019-08-08 15:47 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$46,116
+6,100 vol $7.56 each |
4,389,923 | |
Filed 2019-08-08 15:46 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,777
+500 vol $7.55 each |
4,383,823 | |
Filed 2019-08-08 15:45 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$261,985
+34,700 vol $7.55 each |
4,383,323 | |
Filed 2019-08-08 15:44 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,032
+800 vol $7.54 each |
4,348,623 | |
Filed 2019-08-08 15:44 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,024
+800 vol $7.53 each |
4,347,823 | |
Filed 2019-08-08 15:43 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$108,288
+14,400 vol $7.52 each |
4,347,023 | |
Filed 2019-08-08 15:42 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,024
+2,400 vol $7.51 each |
4,332,623 | |
Filed 2019-08-08 15:41 Tx date 2019-07-30 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$19,147
+2,553 vol $7.50 each |
4,330,223 | |
Filed 2019-08-08 15:23 Tx date 2019-07-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,280
+1,500 vol $7.52 each |
4,327,670 | |
Filed 2019-08-08 15:22 Tx date 2019-07-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,273
+2,300 vol $7.51 each |
4,326,170 | |
Filed 2019-08-08 15:21 Tx date 2019-07-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$137,250
+18,300 vol $7.50 each |
4,323,870 | |
Filed 2019-08-08 15:21 Tx date 2019-07-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,499
+200 vol $7.50 each |
4,305,570 | |
Filed 2019-08-08 15:17 Tx date 2019-07-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$77,896
+10,400 vol $7.49 each |
4,305,370 | |
Filed 2019-08-08 15:17 Tx date 2019-07-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,245
+300 vol $7.49 each |
4,294,970 | |
Filed 2019-08-08 15:16 Tx date 2019-07-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,684
+3,300 vol $7.48 each |
4,294,670 | |
Filed 2019-08-08 15:15 Tx date 2019-07-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$47,456
+6,353 vol $7.47 each |
4,291,370 | |
Filed 2019-08-08 15:15 Tx date 2019-07-29 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,238
+300 vol $7.46 each |
4,285,017 | |
Filed 2019-08-08 14:51 Tx date 2019-07-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$81,314
+10,900 vol $7.46 each |
4,284,717 | |
Filed 2019-08-08 14:51 Tx date 2019-07-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,473
+600 vol $7.46 each |
4,273,817 | |
Filed 2019-08-08 14:50 Tx date 2019-07-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$134,845
+18,100 vol $7.45 each |
4,273,217 | |
Filed 2019-08-08 14:50 Tx date 2019-07-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,656
+1,700 vol $7.45 each |
4,255,117 | |
Filed 2019-08-08 14:49 Tx date 2019-07-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$40,920
+5,500 vol $7.44 each |
4,253,417 | |
Filed 2019-08-08 14:48 Tx date 2019-07-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$70,632
+9,500 vol $7.43 each |
4,247,917 | |
Filed 2019-08-08 14:48 Tx date 2019-07-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$55,888
+7,522 vol $7.43 each |
4,238,417 | |
Filed 2019-08-08 14:47 Tx date 2019-07-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,970
+400 vol $7.42 each |
4,230,895 | |
Filed 2019-08-08 14:47 Tx date 2019-07-26 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$256,568
+34,578 vol $7.42 each |
4,230,495 | |
Filed 2019-08-08 14:40 Tx date 2019-07-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$84,298
+11,300 vol $7.46 each |
4,195,917 | |
Filed 2019-08-08 14:39 Tx date 2019-07-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$226,480
+30,400 vol $7.45 each |
4,184,617 | |
Filed 2019-08-08 14:38 Tx date 2019-07-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,870
+2,000 vol $7.43 each |
4,154,217 | |
Filed 2019-08-08 14:38 Tx date 2019-07-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,603
+2,100 vol $7.43 each |
4,152,217 | |
Filed 2019-08-08 14:37 Tx date 2019-07-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$57,172
+7,700 vol $7.42 each |
4,150,117 | |
Filed 2019-08-08 14:37 Tx date 2019-07-25 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,970
+3,500 vol $7.42 each |
4,142,417 | |
Filed 2019-08-08 14:24 Tx date 2019-07-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,520
+1,000 vol $7.52 each |
4,138,917 | |
Filed 2019-08-08 14:24 Tx date 2019-07-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,750
+900 vol $7.50 each |
4,137,917 | |
Filed 2019-08-08 14:23 Tx date 2019-07-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,248
+300 vol $7.50 each |
4,137,017 | |
Filed 2019-08-08 14:22 Tx date 2019-07-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$830,641
+110,900 vol $7.49 each |
4,136,717 | |
Filed 2019-08-08 14:22 Tx date 2019-07-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,742
+500 vol $7.49 each |
4,025,817 | |
Filed 2019-08-08 14:21 Tx date 2019-07-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$50,116
+6,700 vol $7.48 each |
4,025,317 | |
Filed 2019-08-08 14:21 Tx date 2019-07-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$747.50
+100 vol $7.47 each |
4,018,617 | |
Filed 2019-08-08 14:20 Tx date 2019-07-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,603
+4,900 vol $7.47 each |
4,018,517 | |
Filed 2019-08-08 14:19 Tx date 2019-07-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,698
+1,300 vol $7.46 each |
4,013,617 | |
Filed 2019-08-08 14:19 Tx date 2019-07-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$745.50
+100 vol $7.46 each |
4,012,317 | |
Filed 2019-08-08 14:18 Tx date 2019-07-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,215
+700 vol $7.45 each |
4,012,217 | |
Filed 2019-08-08 14:18 Tx date 2019-07-24 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,904
+1,600 vol $7.44 each |
4,011,517 | |
Filed 2019-08-08 14:01 Tx date 2019-07-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,907
+253 vol $7.54 each |
4,009,917 | |
Filed 2019-08-08 14:00 Tx date 2019-07-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$753.50
+100 vol $7.54 each |
4,009,664 | |
Filed 2019-08-08 14:00 Tx date 2019-07-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,765
+500 vol $7.53 each |
4,009,564 | |
Filed 2019-08-08 13:59 Tx date 2019-07-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,759
+900 vol $7.51 each |
4,009,064 | |
Filed 2019-08-08 13:59 Tx date 2019-07-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,752
+500 vol $7.50 each |
4,008,164 | |
Filed 2019-08-08 13:58 Tx date 2019-07-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$229,500
+30,600 vol $7.50 each |
4,007,664 | |
Filed 2019-08-08 13:56 Tx date 2019-07-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$749.50
+100 vol $7.50 each |
3,977,064 | |
Filed 2019-08-08 13:55 Tx date 2019-07-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$47,936
+6,400 vol $7.49 each |
3,976,964 | |
Filed 2019-08-08 13:55 Tx date 2019-07-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$44,880
+6,000 vol $7.48 each |
3,970,564 | |
Filed 2019-08-08 13:54 Tx date 2019-07-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$53,784
+7,200 vol $7.47 each |
3,964,564 | |
Filed 2019-08-08 13:54 Tx date 2019-07-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$160,175
+21,500 vol $7.45 each |
3,957,364 | |
Filed 2019-08-08 13:53 Tx date 2019-07-23 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,189
+1,100 vol $7.45 each |
3,935,864 | |
Filed 2019-08-08 13:38 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$26,705
+3,500 vol $7.63 each |
3,934,764 | |
Filed 2019-08-08 13:37 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$29,718
+3,900 vol $7.62 each |
3,931,264 | |
Filed 2019-08-08 13:36 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$41,855
+5,500 vol $7.61 each |
3,927,364 | |
Filed 2019-08-08 13:35 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$38,785
+5,100 vol $7.61 each |
3,921,864 | |
Filed 2019-08-08 13:35 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$83,600
+11,000 vol $7.60 each |
3,916,764 | |
Filed 2019-08-08 13:33 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$759.50
+100 vol $7.59 each |
3,905,764 | |
Filed 2019-08-08 13:32 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$26,565
+3,500 vol $7.59 each |
3,905,664 | |
Filed 2019-08-08 13:31 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$15,160
+2,000 vol $7.58 each |
3,902,164 | |
Filed 2019-08-08 13:31 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,841
+1,300 vol $7.57 each |
3,900,164 | |
Filed 2019-08-08 13:30 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,305
+1,100 vol $7.55 each |
3,898,864 | |
Filed 2019-08-08 13:29 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,556
+1,400 vol $7.54 each |
3,897,764 | |
Filed 2019-08-08 13:29 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$42,921
+5,700 vol $7.53 each |
3,896,364 | |
Filed 2019-08-08 13:28 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$157,920
+21,000 vol $7.52 each |
3,890,664 | |
Filed 2019-08-08 13:26 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,265
+1,500 vol $7.51 each |
3,869,664 | |
Filed 2019-08-08 13:26 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$27,750
+3,700 vol $7.50 each |
3,868,164 | |
Filed 2019-08-08 13:25 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$28,462
+3,800 vol $7.49 each |
3,864,464 | |
Filed 2019-08-08 13:24 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,952
+2,400 vol $7.48 each |
3,860,664 | |
Filed 2019-08-08 13:23 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,465
+1,400 vol $7.47 each |
3,858,264 | |
Filed 2019-08-08 13:23 Tx date 2019-07-22 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,229
+700 vol $7.47 each |
3,856,864 | |
Filed 2019-08-08 10:51 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$80,348
+10,600 vol $7.58 each |
3,856,164 | |
Filed 2019-08-08 10:50 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$757.50
+100 vol $7.58 each |
3,845,564 | |
Filed 2019-08-08 10:50 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$129,447
+17,100 vol $7.57 each |
3,845,464 | |
Filed 2019-08-08 10:49 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,347
+1,500 vol $7.57 each |
3,828,364 | |
Filed 2019-08-08 10:49 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$38,556
+5,100 vol $7.56 each |
3,826,864 | |
Filed 2019-08-08 10:48 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$30,975
+4,100 vol $7.55 each |
3,821,764 | |
Filed 2019-08-08 10:47 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$136,655
+18,100 vol $7.55 each |
3,817,664 | |
Filed 2019-08-08 10:47 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$754.50
+100 vol $7.54 each |
3,799,564 | |
Filed 2019-08-08 10:46 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,260
+300 vol $7.54 each |
3,799,464 | |
Filed 2019-08-08 10:45 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$41,415
+5,500 vol $7.53 each |
3,799,164 | |
Filed 2019-08-08 10:45 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$41,360
+5,500 vol $7.52 each |
3,793,664 | |
Filed 2019-08-08 10:44 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$54,823
+7,300 vol $7.51 each |
3,788,164 | |
Filed 2019-08-08 10:44 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$750.50
+100 vol $7.50 each |
3,780,864 | |
Filed 2019-08-08 10:43 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,244
+300 vol $7.48 each |
3,780,764 | |
Filed 2019-08-08 10:05 Tx date 2019-07-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,305
+1,100 vol $7.55 each |
3,780,464 | |
Filed 2019-08-08 10:05 Tx date 2019-07-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,865
+3,300 vol $7.54 each |
3,779,364 | |
Filed 2019-08-08 10:04 Tx date 2019-07-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,765
+500 vol $7.53 each |
3,776,064 | |
Filed 2019-08-08 10:03 Tx date 2019-07-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$18,812
+2,500 vol $7.53 each |
3,775,564 | |
Filed 2019-08-08 10:01 Tx date 2019-07-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$40,608
+5,400 vol $7.52 each |
3,773,064 | |
Filed 2019-08-08 10:00 Tx date 2019-07-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,024
+1,600 vol $7.51 each |
3,767,664 | |
Filed 2019-08-08 09:59 Tx date 2019-07-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,032
+3,200 vol $7.51 each |
3,766,064 | |
Filed 2019-08-08 09:58 Tx date 2019-07-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$168,862
+22,500 vol $7.50 each |
3,762,864 | |
Filed 2019-08-08 09:57 Tx date 2019-07-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$315,397
+42,053 vol $7.50 each |
3,740,364 | |
Filed 2019-08-08 09:56 Tx date 2019-07-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,248
+300 vol $7.50 each |
3,698,311 | |
Filed 2019-08-08 09:56 Tx date 2019-07-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$45,689
+6,100 vol $7.49 each |
3,698,011 | |
Filed 2019-08-08 09:55 Tx date 2019-07-18 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,244
+300 vol $7.48 each |
3,691,911 | |
Filed 2019-08-07 12:30 Tx date 2019-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$7,166
+953 vol $7.52 each |
3,691,611 | |
Filed 2019-08-07 12:29 Tx date 2019-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,783
+3,300 vol $7.51 each |
3,690,658 | |
Filed 2019-08-07 12:28 Tx date 2019-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$84,000
+11,200 vol $7.50 each |
3,687,358 | |
Filed 2019-08-07 12:28 Tx date 2019-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$41,944
+5,600 vol $7.49 each |
3,676,158 | |
Filed 2019-08-07 12:27 Tx date 2019-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,472
+1,400 vol $7.48 each |
3,670,558 | |
Filed 2019-08-07 12:26 Tx date 2019-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$747.50
+100 vol $7.47 each |
3,669,158 | |
Filed 2019-08-07 12:26 Tx date 2019-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$24,651
+3,300 vol $7.47 each |
3,669,058 | |
Filed 2019-08-07 12:25 Tx date 2019-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$746.50
+100 vol $7.46 each |
3,665,758 | |
Filed 2019-08-07 12:24 Tx date 2019-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,364
+3,400 vol $7.46 each |
3,665,658 | |
Filed 2019-08-07 12:23 Tx date 2019-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,725
+500 vol $7.45 each |
3,662,258 | |
Filed 2019-08-07 12:22 Tx date 2019-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,392
+1,800 vol $7.44 each |
3,661,758 | |
Filed 2019-08-07 12:22 Tx date 2019-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,201
+700 vol $7.43 each |
3,659,958 | |
Filed 2019-08-07 12:21 Tx date 2019-07-17 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,904
+1,200 vol $7.42 each |
3,659,258 | |
Filed 2019-08-07 12:08 Tx date 2019-07-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$749,000
+100,000 vol $7.49 each |
3,658,058 | |
Filed 2019-08-07 12:07 Tx date 2019-07-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$8,228
+1,100 vol $7.48 each |
3,558,058 | |
Filed 2019-08-07 12:07 Tx date 2019-07-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,737
+500 vol $7.47 each |
3,556,958 | |
Filed 2019-08-07 12:06 Tx date 2019-07-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$12,347
+1,653 vol $7.47 each |
3,556,458 | |
Filed 2019-08-07 12:05 Tx date 2019-07-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$26,110
+3,500 vol $7.46 each |
3,554,805 | |
Filed 2019-08-07 12:05 Tx date 2019-07-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$3,727
+500 vol $7.46 each |
3,551,305 | |
Filed 2019-08-07 12:04 Tx date 2019-07-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$59,600
+8,000 vol $7.45 each |
3,550,805 | |
Filed 2019-08-07 12:03 Tx date 2019-07-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$744.50
+100 vol $7.45 each |
3,542,805 | |
Filed 2019-08-07 12:01 Tx date 2019-07-16 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$13,392
+1,800 vol $7.44 each |
3,542,705 | |
Filed 2019-08-07 11:49 Tx date 2019-07-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,777
+900 vol $7.53 each |
3,540,905 | |
Filed 2019-08-07 11:40 Tx date 2019-07-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$287,264
+38,200 vol $7.52 each |
3,540,005 | |
Filed 2019-08-07 11:40 Tx date 2019-07-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$14,250
+1,900 vol $7.50 each |
3,501,805 | |
Filed 2019-08-07 11:39 Tx date 2019-07-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$11,235
+1,500 vol $7.49 each |
3,499,905 | |
Filed 2019-08-07 11:38 Tx date 2019-07-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,497
+200 vol $7.49 each |
3,498,405 | |
Filed 2019-08-07 11:37 Tx date 2019-07-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,732
+900 vol $7.48 each |
3,498,205 | |
Filed 2019-08-07 11:37 Tx date 2019-07-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,495
+200 vol $7.47 each |
3,497,305 | |
Filed 2019-08-07 11:36 Tx date 2019-07-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,283
+2,853 vol $7.46 each |
3,497,105 | |
Filed 2019-08-07 11:35 Tx date 2019-07-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,491
+200 vol $7.46 each |
3,494,252 | |
Filed 2019-08-07 11:34 Tx date 2019-07-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,685
+1,300 vol $7.45 each |
3,494,052 | |
Filed 2019-08-07 11:34 Tx date 2019-07-15 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,976
+400 vol $7.44 each |
3,492,752 | |
Filed 2019-08-07 10:50 Tx date 2019-07-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,259
+300 vol $7.53 each |
3,492,352 | |
Filed 2019-08-07 10:49 Tx date 2019-07-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,776
+1,300 vol $7.52 each |
3,492,052 | |
Filed 2019-08-07 10:49 Tx date 2019-07-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,503
+200 vol $7.51 each |
3,490,752 | |
Filed 2019-08-07 10:48 Tx date 2019-07-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$36,799
+4,900 vol $7.51 each |
3,490,552 | |
Filed 2019-08-07 10:47 Tx date 2019-07-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$2,251
+300 vol $7.50 each |
3,485,652 | |
Filed 2019-08-07 10:46 Tx date 2019-07-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$128,647
+17,153 vol $7.50 each |
3,485,352 | |
Filed 2019-08-07 10:43 Tx date 2019-07-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$749.50
+100 vol $7.50 each |
3,468,199 | |
Filed 2019-08-07 10:43 Tx date 2019-07-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$25,368,225
+3,386,946 vol $7.49 each |
3,468,099 | |
Filed 2019-08-07 10:42 Tx date 2019-07-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,944
+2,800 vol $7.48 each |
81,153 | |
Filed 2019-08-07 10:41 Tx date 2019-07-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$21,663
+2,900 vol $7.47 each |
78,353 | |
Filed 2019-08-07 10:40 Tx date 2019-07-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,476
+600 vol $7.46 each |
75,453 | |
Filed 2019-08-07 10:39 Tx date 2019-07-12 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$745.50
+100 vol $7.46 each |
74,853 | |
Filed 2019-08-06 17:38 Tx date 2019-07-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$57,981
+7,700 vol $7.53 each |
74,753 | |
Filed 2019-08-06 17:38 Tx date 2019-07-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$118,816
+15,800 vol $7.52 each |
67,053 | |
Filed 2019-08-06 17:37 Tx date 2019-07-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$9,018
+1,200 vol $7.51 each |
51,253 | |
Filed 2019-08-06 17:36 Tx date 2019-07-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$142,690
+19,000 vol $7.51 each |
50,053 | |
Filed 2019-08-06 17:35 Tx date 2019-07-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$49,897
+6,653 vol $7.50 each |
31,053 | |
Filed 2019-08-06 17:34 Tx date 2019-07-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$81,641
+10,900 vol $7.49 each |
24,400 | |
Filed 2019-08-06 17:33 Tx date 2019-07-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$32,912
+4,400 vol $7.48 each |
13,500 | |
Filed 2019-08-06 17:32 Tx date 2019-07-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$20,169
+2,700 vol $7.47 each |
9,100 | |
Filed 2019-08-06 17:31 Tx date 2019-07-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$10,444
+1,400 vol $7.46 each |
6,400 | |
Filed 2019-08-06 17:30 Tx date 2019-07-11 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$37,250
+5,000 vol $7.45 each |
5,000 | |
Filed 2019-07-26 12:02 Tx date 2019-07-08 |
$GUD
Knight Therapeutics Inc. |
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-07-24 15:49 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,660
+1,008 vol $7.60 each |
107,259 | |
Filed 2019-07-15 09:28 Tx date 2019-07-11 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$150,300
+20,000 vol $7.51 each |
45,392 | |
Filed 2019-06-28 17:22 Tx date 2019-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,572
+1,128 vol $7.60 each |
38,335 | |
Filed 2019-06-28 17:19 Tx date 2018-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,211
+872 vol $8.27 each |
22,327 | |
Filed 2019-06-27 10:24 Tx date 2019-06-26 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,416
+3,200 vol $7.63 each |
479,142 | |
Filed 2019-06-21 17:00 Tx date 2019-06-21 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$91,080
+12,000 vol $7.59 each |
21,633,433 | |
Filed 2019-06-19 14:44 Tx date 2019-06-19 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,287
+1,222 vol $7.60 each |
475,942 | |
Filed 2019-06-05 10:25 Tx date 2019-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+201 vol |
22,388 | |
Filed 2019-06-04 14:45 Tx date 2019-05-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+201 vol |
||
Filed 2019-06-04 14:46 Tx date 2019-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,209
+960 vol $7.51 each |
23,147 | |
Filed 2019-06-04 14:45 Tx date 2019-05-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+201 vol |
36,335 | |
Filed 2019-06-04 14:43 Tx date 2019-03-19 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$883,108
+115,138 vol $7.67 each |
492,457 | |
Filed 2019-05-21 12:10 Tx date 2019-05-21 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$73,900
+10,000 vol $7.39 each |
21,621,433 | |
Filed 2019-05-17 17:36 Tx date 2019-05-14 |
$GUD
Knight Therapeutics Inc. |
Cameron, Kevin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
Filed 2019-05-17 17:33 Tx date 2019-05-07 |
$GUD
Knight Therapeutics Inc. |
Cameron, Kevin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-17 16:01 Tx date 2019-05-14 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
Filed 2019-05-17 15:58 Tx date 2019-05-07 |
$GUD
Knight Therapeutics Inc. |
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-16 10:24 Tx date 2019-05-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$131,186
+17,800 vol $7.37 each |
474,720 | |
Filed 2019-05-15 15:28 Tx date 2019-05-14 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
120,000 | |
Filed 2019-05-15 15:26 Tx date 2019-05-14 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
125,000 | |
Filed 2019-05-15 15:24 Tx date 2019-05-14 |
$GUD
Knight Therapeutics Inc. |
Tendler, Sylvie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
120,000 | |
Filed 2019-05-15 15:22 Tx date 2019-05-14 |
$GUD
Knight Therapeutics Inc. |
Harrison, Nancy Elizabeth
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
35,000 | |
Filed 2019-04-24 16:28 Tx date 2019-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+173 vol |
106,251 | |
Filed 2019-04-24 16:27 Tx date 2019-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,300
+839 vol $7.51 each |
106,078 | |
Filed 2019-04-11 10:09 Tx date 2019-04-10 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$66,780
+9,000 vol $7.42 each |
456,920 | |
Filed 2019-04-08 15:26 Tx date 2019-04-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,460
+3,600 vol $7.35 each |
447,920 | |
Filed 2019-04-08 15:24 Tx date 2019-04-04 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,568
+3,600 vol $7.38 each |
444,320 | |
Filed 2019-03-28 Tx date 2019-03-25 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,220
+5,200 vol $7.35 each |
440,720 | |
Filed 2019-03-28 Tx date 2019-03-26 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,650
+5,000 vol $7.33 each |
21,611,433 | |
Filed 2019-03-28 Tx date 2019-03-25 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$96,888
+13,200 vol $7.34 each |
21,606,433 | |
Filed 2019-03-26 Tx date 2019-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$136,800
+18,000 vol $7.60 each |
354,520 | |
Filed 2019-03-26 Tx date 2019-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$134,820
+18,000 vol $7.49 each |
399,520 | |
Filed 2019-03-26 Tx date 2019-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$135,360
+18,000 vol $7.52 each |
435,520 | |
Filed 2019-03-26 Tx date 2019-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$135,720
+18,000 vol $7.54 each |
381,520 | |
Filed 2019-03-26 Tx date 2019-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$134,100
+18,000 vol $7.45 each |
417,520 | |
Filed 2019-03-26 Tx date 2019-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$68,220
+9,000 vol $7.58 each |
363,520 | |
Filed 2019-03-22 Tx date 2019-03-19 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+161,252 vol |
2,203,422 | |
Filed 2019-03-20 Tx date 2019-03-19 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,999
+12,987 vol $7.70 each |
35,174 | |
Filed 2019-03-20 Tx date 2019-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,965
+1,327 vol $7.51 each |
336,520 | |
Filed 2019-01-25 Tx date 2018-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,401
+640 vol $8.44 each |
105,086 | |
Filed 2019-01-25 Tx date 2019-01-03 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+153 vol |
||
Filed 2019-01-25 Tx date 2019-01-03 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,401
+640 vol $8.44 each |
||
Filed 2019-01-25 Tx date 2018-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+153 vol |
105,239 | |
Filed 2019-01-17 Tx date 2018-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,178
+732 vol $8.44 each |
22,187 | |
Filed 2018-12-19 Tx date 2018-12-17 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,794
+1,042 vol $8.44 each |
335,193 | |
Filed 2018-10-18 Tx date 2018-09-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+110 vol |
104,446 | |
Filed 2018-10-18 Tx date 2018-09-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,301
+762 vol $8.27 each |
104,336 | |
Filed 2018-09-19 Tx date 2018-09-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,452
+1,143 vol $8.27 each |
||
Filed 2018-09-19 Tx date 2018-09-17 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,452
+1,143 vol $8.27 each |
334,151 | |
Filed 2018-09-19 Tx date 2018-09-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,023
+1,143 vol $5.27 each |
||
Filed 2018-09-19 Tx date 2018-09-17 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,998
+1,209 vol $8.27 each |
25,392 | |
Filed 2018-09-19 Tx date 2018-09-14 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,998
+1,209 vol $8.27 each |
||
Filed 2018-09-17 Tx date 2018-09-14 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,998
+1,209 vol $8.27 each |
25,392 | |
Filed 2018-09-17 Tx date 2018-09-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,023
+1,143 vol $5.27 each |
||
Filed 2018-09-17 Tx date 2018-09-14 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,452
+1,143 vol $8.27 each |
334,151 | |
Filed 2018-08-30 Tx date 2018-08-14 |
$GUD
Knight Therapeutics Inc. |
Harrison, Nancy Elizabeth
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
15,000 | |
Filed 2018-08-30 Tx date 2018-08-08 |
$GUD
Knight Therapeutics Inc. |
Harrison, Nancy Elizabeth
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-08-14 Tx date 2018-06-26 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,405
+674 vol $8.02 each |
103,460 | |
Filed 2018-08-14 Tx date 2018-06-26 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+114 vol |
103,574 | |
Filed 2018-07-18 Tx date 2018-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,175
+770 vol $8.02 each |
21,455 | |
Filed 2018-06-19 Tx date 2018-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,286
+1,032 vol $8.03 each |
333,008 | |
Filed 2018-06-05 Tx date 2018-06-04 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-48,120
-6,000 vol $8.02 each |
3,065,697 | |
Filed 2018-06-05 Tx date 2018-06-04 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,200
-5,000 vol $8.04 each |
2,361,557 | |
Filed 2018-06-05 Tx date 2018-06-04 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,000
-5,000 vol $8.00 each |
2,356,557 | |
Filed 2018-06-05 Tx date 2018-06-04 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-93,264
-11,600 vol $8.04 each |
3,054,097 | |
Filed 2018-06-04 Tx date 2018-05-31 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,200
-5,000 vol $8.04 each |
3,080,097 | |
Filed 2018-06-04 Tx date 2018-05-31 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,818
-3,800 vol $8.11 each |
3,076,297 | |
Filed 2018-06-04 Tx date 2018-06-01 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,984
-4,600 vol $8.04 each |
3,071,697 | |
Filed 2018-06-01 Tx date 2018-05-30 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,600
-5,000 vol $8.12 each |
3,094,097 | |
Filed 2018-06-01 Tx date 2018-05-31 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,020
-500 vol $8.04 each |
2,366,557 | |
Filed 2018-06-01 Tx date 2018-05-31 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,135
-4,500 vol $8.03 each |
2,367,057 | |
Filed 2018-06-01 Tx date 2018-05-30 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-72,180
-9,000 vol $8.02 each |
3,085,097 | |
Filed 2018-05-31 Tx date 2018-05-28 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,628
-200 vol $8.14 each |
2,392,557 | |
Filed 2018-05-31 Tx date 2018-05-28 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,970
-3,800 vol $8.15 each |
2,392,757 | |
Filed 2018-05-31 Tx date 2018-05-28 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-60,347
-7,400 vol $8.15 each |
||
Filed 2018-05-31 Tx date 2018-05-25 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,086
-2,600 vol $8.11 each |
2,396,557 | |
Filed 2018-05-31 Tx date 2018-05-25 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,180
-1,500 vol $8.12 each |
2,399,157 | |
Filed 2018-05-31 Tx date 2018-05-25 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,317
-900 vol $8.13 each |
2,400,657 | |
Filed 2018-05-31 Tx date 2018-05-25 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,850
-5,000 vol $8.17 each |
2,401,557 | |
Filed 2018-05-31 Tx date 2018-05-25 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,430
-10,000 vol $8.14 each |
||
Filed 2018-05-31 Tx date 2018-05-24 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,650
-5,000 vol $8.13 each |
2,406,557 | |
Filed 2018-05-31 Tx date 2018-05-24 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,550
-10,000 vol $8.15 each |
||
Filed 2018-05-31 Tx date 2018-05-24 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,900
-5,000 vol $8.18 each |
2,411,557 | |
Filed 2018-05-31 Tx date 2018-05-30 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-101,430
-12,600 vol $8.05 each |
2,371,557 | |
Filed 2018-05-31 Tx date 2018-05-28 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,632
-2,400 vol $8.18 each |
2,389,157 | |
Filed 2018-05-31 Tx date 2018-05-28 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,120
-1,000 vol $8.12 each |
2,391,557 | |
Filed 2018-05-30 Tx date 2018-05-29 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,500
-5,000 vol $8.10 each |
2,384,157 | |
Filed 2018-05-29 Tx date 2018-05-28 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-60,347
-7,400 vol $8.15 each |
2,389,157 | |
Filed 2018-05-28 Tx date 2018-05-25 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,430
-10,000 vol $8.14 each |
2,396,557 | |
Filed 2018-05-28 Tx date 2018-03-20 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$908,259
+117,498 vol $7.73 each |
377,319 | |
Filed 2018-05-28 Tx date 2018-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,070
+886 vol $7.98 each |
20,685 | |
Filed 2018-05-28 Tx date 2018-05-24 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,550
-10,000 vol $8.15 each |
2,406,557 | |
Filed 2018-05-24 Tx date 2018-05-23 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-63,911
-7,900 vol $8.09 each |
2,416,557 | |
Filed 2018-05-24 Tx date 2018-05-23 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,550
-5,000 vol $8.11 each |
2,424,457 | |
Filed 2018-05-23 Tx date 2018-05-22 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,094
-2,100 vol $8.14 each |
2,429,457 | |
Filed 2018-05-23 Tx date 2018-05-22 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,250
-5,000 vol $8.05 each |
2,431,557 | |
Filed 2018-05-22 Tx date 2018-05-17 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,628
-700 vol $8.04 each |
2,439,357 | |
Filed 2018-05-22 Tx date 2018-05-17 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,928
-1,600 vol $8.08 each |
2,436,557 | |
Filed 2018-05-22 Tx date 2018-05-17 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-807.00
-100 vol $8.07 each |
2,438,157 | |
Filed 2018-05-22 Tx date 2018-05-17 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,224
-400 vol $8.06 each |
2,438,257 | |
Filed 2018-05-22 Tx date 2018-05-17 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,635
-700 vol $8.05 each |
2,438,657 | |
Filed 2018-05-22 Tx date 2018-05-17 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,045
-1,500 vol $8.03 each |
2,440,057 | |
Filed 2018-05-17 Tx date 2018-05-16 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-80,000
-10,000 vol $8.00 each |
2,441,557 | |
Filed 2018-05-16 Tx date 2018-05-15 |
$GUD
Knight Therapeutics Inc. |
Assouline, Sarit
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
40,000 | |
Filed 2018-05-16 Tx date 2018-05-15 |
$GUD
Knight Therapeutics Inc. |
Tendler, Sylvie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
100,000 | |
Filed 2018-05-16 Tx date 2018-05-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
100,000 | |
Filed 2018-05-16 Tx date 2018-05-15 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-62,634
-7,800 vol $8.03 each |
2,451,557 | |
Filed 2018-05-16 Tx date 2018-05-15 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
100,000 | |
Filed 2018-05-01 Tx date 2018-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+103 vol |
102,786 | |
Filed 2018-05-01 Tx date 2018-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,176
+774 vol $7.98 each |
102,683 | |
Filed 2018-03-30 Tx date 2018-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,165
+1,150 vol $7.97 each |
331,976 | |
Filed 2018-03-30 Tx date 2018-03-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,654
+333 vol $7.97 each |
24,183 | |
Filed 2018-03-30 Tx date 2018-03-20 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+182,482 vol |
2,042,170 | |
Filed 2018-03-30 Tx date 2018-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,177
+1,150 vol $7.98 each |
||
Filed 2018-03-23 Tx date 2018-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Lilah Rose Goodman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$777.00
+100 vol $7.77 each |
100 | |
Filed 2018-03-23 Tx date 2018-03-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Orly Anne Goodman (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$777.00
+100 vol $7.77 each |
100 | |
Filed 2018-03-23 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Orly Anne Goodman (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-23 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Lilah Rose Goodman (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-19 Tx date 2017-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,106
+1,068 vol $7.59 each |
330,826 | |
Filed 2018-03-19 Tx date 2018-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,177
+1,150 vol $7.98 each |
331,976 | |
Filed 2018-03-19 Tx date 2017-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,876
+906 vol $7.59 each |
||
Filed 2018-02-14 Tx date 2017-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,294
+693 vol $7.64 each |
101,787 | |
Filed 2018-02-14 Tx date 2017-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+122 vol |
101,909 | |
Filed 2018-01-15 Tx date 2017-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,058
+793 vol $7.64 each |
19,799 | |
Filed 2017-12-18 Tx date 2017-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,876
+906 vol $7.59 each |
330,664 | |
Filed 2017-10-06 Tx date 2017-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+110 vol |
100,282 | |
Filed 2017-10-06 Tx date 2017-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,063
+810 vol $8.72 each |
19,006 | |
Filed 2017-10-06 Tx date 2017-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+103 vol |
101,094 | |
Filed 2017-10-06 Tx date 2017-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,182
+709 vol $8.72 each |
100,991 | |
Filed 2017-10-06 Tx date 2017-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,163
+627 vol $9.83 each |
100,172 | |
Filed 2017-09-19 Tx date 2017-09-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,089
+813 vol $8.72 each |
168,717 | |
Filed 2017-09-19 Tx date 2017-09-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,001
+1,147 vol $8.72 each |
23,850 | |
Filed 2017-09-19 Tx date 2017-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,074
+926 vol $8.72 each |
329,758 | |
Filed 2017-07-03 Tx date 2017-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,067
+719 vol $9.83 each |
18,196 | |
Filed 2017-06-20 Tx date 2017-06-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,244
+737 vol $9.83 each |
167,904 | |
Filed 2017-06-19 Tx date 2017-06-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,489
+355 vol $9.83 each |
22,703 | |
Filed 2017-06-19 Tx date 2017-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,080
+822 vol $9.83 each |
328,832 | |
Filed 2017-05-19 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
-25,000 vol |
21,523,233 | |
Filed 2017-05-19 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
-45,000 vol |
21,523,233 | |
Filed 2017-05-19 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
+25,000 vol |
327,342 | |
Filed 2017-05-19 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
+45,000 vol |
300,175 | |
Filed 2017-05-17 Tx date 2017-02-21 |
$GUD
Knight Therapeutics Inc. |
Assouline, Sarit
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-05-17 Tx date 2017-05-16 |
$GUD
Knight Therapeutics Inc. |
Assouline, Sarit
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
Filed 2017-05-17 Tx date 2017-05-16 |
$GUD
Knight Therapeutics Inc. |
Tendler, Sylvie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
80,000 | |
Filed 2017-05-17 Tx date 2017-05-16 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
80,000 | |
Filed 2017-05-17 Tx date 2017-05-16 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
80,000 | |
Filed 2017-04-12 Tx date 2017-02-27 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Options
52 - Expiration of options
|
-278,000 vol |
0 | |
Filed 2017-04-12 Tx date 2017-02-27 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-222,000 vol |
0 | |
Filed 2017-04-06 Tx date 2017-04-03 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-52,050
-5,000 vol $10.41 each |
2,459,357 | |
Filed 2017-04-06 Tx date 2017-04-03 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-33,440
-3,200 vol $10.45 each |
2,464,357 | |
Filed 2017-03-31 Tx date 2017-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,185
+500 vol $10.37 each |
99,457 | |
Filed 2017-03-31 Tx date 2017-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+88 vol |
99,545 | |
Filed 2017-03-28 Tx date 2017-03-21 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+133,218 vol |
1,859,688 | |
Filed 2017-03-28 Tx date 2017-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,056
+584 vol $10.37 each |
17,477 | |
Filed 2017-03-28 Tx date 2017-03-21 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+74,010 vol |
419,010 | |
Filed 2017-03-28 Tx date 2017-03-21 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+74,010 vol |
419,010 | |
Filed 2017-03-28 Tx date 2017-03-21 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$351,692
+34,821 vol $10.10 each |
259,821 | |
Filed 2017-03-17 Tx date 2017-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,927
+668 vol $10.37 each |
258,010 | |
Filed 2017-03-17 Tx date 2017-03-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,107
+589 vol $10.37 each |
167,167 | |
Filed 2017-03-16 Tx date 2017-02-21 |
$GUD
Knight Therapeutics Inc. |
Assouline, Sarit
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,100 | ||
Filed 2016-12-23 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$250,000
+25,000 vol $10.00 each |
21,593,233 | |
Filed 2016-12-23 Tx date 2016-12-15 |
$GUD
Knight Therapeutics Inc. |
Tendler, Sylvie
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,668
+368 vol $9.97 each |
1,842 | |
Filed 2016-12-23 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$250,000
+25,000 vol $10.00 each |
21,593,233 | |
Filed 2016-12-23 Tx date 2016-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,194
+521 vol $9.97 each |
93,957 | |
Filed 2016-12-23 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+10,000 vol $10.00 each |
166,578 | |
Filed 2016-12-23 Tx date 2016-12-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,420
+644 vol $9.97 each |
156,578 | |
Filed 2016-12-23 Tx date 2016-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,588
+1,062 vol $9.97 each |
257,342 | |
Filed 2016-12-22 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+10,000 vol $10.00 each |
16,893 | |
Filed 2016-12-22 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$50,000
+5,000 vol $10.00 each |
98,436 | |
Filed 2016-09-26 Tx date 2016-09-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,842
+538 vol $9.00 each |
256,280 | |
Filed 2016-09-26 Tx date 2016-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,636
+404 vol $9.00 each |
93,436 | |
Filed 2016-09-26 Tx date 2016-09-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,636
+404 vol $9.00 each |
155,934 | |
Filed 2016-09-23 Tx date 2016-08-31 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-09-23 Tx date 2016-09-21 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,160,000
+225,000 vol $9.60 each |
225,000 | |
Filed 2016-08-31 Tx date 2016-08-31 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,893 | ||
Filed 2016-06-20 Tx date 2016-06-16 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$1,152,309
+139,000 vol $8.29 each |
3,099,097 | |
Filed 2016-06-20 Tx date 2016-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,853
+567 vol $8.56 each |
255,742 | |
Filed 2016-06-20 Tx date 2016-06-16 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$920,189
+111,000 vol $8.29 each |
2,467,557 | |
Filed 2016-06-20 Tx date 2016-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,638
+425 vol $8.56 each |
93,032 | |
Filed 2016-06-20 Tx date 2016-06-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,638
+425 vol $8.56 each |
155,530 | |
Filed 2016-06-03 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Long Zone Holdings Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$360,000
+45,000 vol $8.00 each |
21,568,233 | |
Filed 2016-06-03 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$360,000
+45,000 vol $8.00 each |
21,568,233 | |
Filed 2016-06-03 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+12,500 vol $8.00 each |
92,607 | |
Filed 2016-06-03 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+12,500 vol $8.00 each |
155,105 | |
Filed 2016-04-04 Tx date 2016-03-30 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,999
+1,328 vol $7.53 each |
22,348 | |
Filed 2016-03-25 Tx date 2016-03-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,116
+415 vol $7.51 each |
142,605 | |
Filed 2016-03-25 Tx date 2016-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,109
+414 vol $7.51 each |
80,107 | |
Filed 2016-03-25 Tx date 2016-03-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,153
+553 vol $7.51 each |
255,175 | |
Filed 2015-12-18 Tx date 2015-12-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,847
+648 vol $7.48 each |
254,622 | |
Filed 2015-12-18 Tx date 2015-12-16 |
$GUD
Knight Therapeutics Inc. |
Tendler, Sylvie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
60,000 | |
Filed 2015-12-18 Tx date 2015-12-16 |
$GUD
Knight Therapeutics Inc. |
Schutter, Edward James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
40,000 | |
Filed 2015-12-18 Tx date 2015-12-16 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
60,000 | |
Filed 2015-12-18 Tx date 2015-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,635
+486 vol $7.48 each |
79,693 | |
Filed 2015-12-18 Tx date 2015-12-16 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
345,000 | |
Filed 2015-12-18 Tx date 2015-12-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,635
+486 vol $7.48 each |
142,190 | |
Filed 2015-12-18 Tx date 2015-12-16 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
1,726,470 | |
Filed 2015-12-18 Tx date 2015-12-16 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
345,000 | |
Filed 2015-12-18 Tx date 2015-12-16 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
60,000 | |
Filed 2015-09-23 Tx date 2015-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,118
+413 vol $7.55 each |
79,207 | |
Filed 2015-09-23 Tx date 2015-09-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,110
+412 vol $7.55 each |
141,704 | |
Filed 2015-09-11 Tx date 2015-09-09 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,356,557 | ||
Filed 2015-09-11 Tx date 2015-09-09 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
Filed 2015-09-11 Tx date 2015-09-09 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,960,097 | ||
Filed 2015-09-11 Tx date 2015-09-09 |
$GUD
Knight Therapeutics Inc. |
Jakobsohn, Meir
4 - Director of Issuer
Holder: Medison Biotech (1995) Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,014,230 | ||
Filed 2015-06-18 Tx date 2015-06-15 |
$GUD
Knight Therapeutics Inc. |
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,118
+443 vol $7.04 each |
141,292 | |
Filed 2015-06-18 Tx date 2015-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,111
+442 vol $7.04 each |
78,794 | |
Filed 2015-06-18 Tx date 2015-06-15 |
$GUD
Knight Therapeutics Inc. |
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,996
+1,420 vol $7.04 each |
21,020 |